<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="publisher-id">ci</journal-id>
    <journal-id journal-id-type="coden">jcisd8</journal-id>
    <journal-title-group>
      <journal-title>Journal of Chemical Information and Modeling</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1549-9596</issn>
    <issn pub-type="epub">1549-960X</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10685454</article-id>
    <article-id pub-id-type="pmid">37947586</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jcim.3c00950</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MMPatho: Leveraging Multilevel Consensus and Evolutionary
Information for Enhanced Missense Mutation Pathogenic Prediction</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Ge</surname>
          <given-names>Fang</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Arif</surname>
          <given-names>Muhammad</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">∥</xref>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>Yan</surname>
          <given-names>Zihao</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <name>
          <surname>Alahmadi</surname>
          <given-names>Hanin</given-names>
        </name>
        <xref rid="aff6" ref-type="aff">#</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <name>
          <surname>Worachartcheewan</surname>
          <given-names>Apilak</given-names>
        </name>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath6">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6786-8053</contrib-id>
        <name>
          <surname>Yu</surname>
          <given-names>Dong-Jun</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath7">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3394-8709</contrib-id>
        <name>
          <surname>Shoombuatong</surname>
          <given-names>Watshara</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <aff id="aff1"><label>†</label>School
of Geographic and Biologic Information, <institution>Nanjing University of Posts and Telecommunications</institution>, 9 Wenyuanlu, Nanjing 210023, <country>China</country></aff>
      <aff id="aff2"><label>‡</label>Center
for Research Innovation and Biomedical Informatics, Faculty of Medical
Technology, <institution>Mahidol University</institution>, Bangkok 10700, <country>Thailand</country></aff>
      <aff id="aff3"><label>§</label>School
of Computer Science and Engineering, <institution>Nanjing
University of Science and Technology</institution>, 200 Xiaolingwei, Nanjing 210094, <country>China</country></aff>
      <aff id="aff4"><label>∥</label>College
of Science and Engineering, <institution>Hamad Bin Khalifa
University</institution>, Doha 34110, <country>Qatar</country></aff>
      <aff id="aff5"><label>⊥</label>Department
of Community Medical Technology, Faculty of Medical Technology, <institution>Mahidol University</institution>, Bangkok 10700, <country>Thailand</country></aff>
      <aff id="aff6"><label>#</label>College of
Computer Science and Engineering, <institution>Taibah
University</institution>, Madinah 344, <country>Saudi Arabia</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label> Email: <email>njyudj@njust.edu.cn</email>.</corresp>
      <corresp id="cor2"><label>*</label> Email: <email>watshara.sho@mahidol.ac.th</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>10</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>27</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <volume>63</volume>
    <issue>22</issue>
    <fpage>7239</fpage>
    <lpage>7257</lpage>
    <history>
      <date date-type="received">
        <day>22</day>
        <month>06</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>23</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>21</day>
        <month>10</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0012" id="ab-tgr1"/>
      </p>
      <p>Understanding the
pathogenicity of missense mutation (MM) is essential
for shed light on genetic diseases, gene functions, and individual
variations. In this study, we propose a novel computational approach,
called MMPatho, for enhancing missense mutation pathogenic prediction.
First, we established a large-scale nonredundant MM benchmark data
set based on the entire Ensembl database, complemented by a focused
blind test set specifically for pathogenic GOF/LOF MM. Based on this
data set, for each mutation, we utilized Ensembl VEP v104 and dbNSFP
v4.1a to extract variant-level, amino acid-level, individuals’
outputs, and genome-level features. Additionally, protein sequences
were generated using ENSP identifiers with the Ensembl API, and then
encoded. The mutant sites’ ESM-1b and ProtTrans-T5 embeddings
were subsequently extracted. Then, our model group (MMPatho) was developed
by leveraging upon these efforts, which comprised ConsMM and EvoIndMM.
To be specific, ConsMM employs individuals’ outputs and XGBoost
with SHAP explanation analysis, while EvoIndMM investigates the potential
enhancement of predictive capability by incorporating evolutionary
information from ESM-1b and ProtT5-XL-U50, large protein language
embeddings. Through rigorous comparative experiments, both ConsMM
and EvoIndMM were capable of achieving remarkable AUROC (0.9836 and
0.9854) and AUPR (0.9852 and 0.9902) values on the blind test set
devoid of overlapping variations and proteins from the training data,
thus highlighting the superiority of our computational approach in
the prediction of MM pathogenicity. Our Web server, available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>, allows researchers to predict the pathogenicity (alongside the
reliability index score) of MMs using the ConsMM and EvoIndMM models
and provides extensive annotations for user input. Additionally, the
newly constructed benchmark data set and blind test set can be accessed
via the data page of our web server.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="doi">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61772273</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Nanjing University of Posts and Telecommunications</institution>
            <institution-id institution-id-type="doi">10.13039/501100005374</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NY223062</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Research Council of Thailand</institution>
            <institution-id institution-id-type="doi">10.13039/501100004704</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>N42A660380</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Natural Science Foundation of Jiangsu Province</institution>
            <institution-id institution-id-type="doi">10.13039/501100004608</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>BK20201304</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Mahidol University</institution>
            <institution-id institution-id-type="doi">10.13039/501100004156</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>N42A660380</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="doi">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>62072243</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ci3c00950</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ci3c00950</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <label>1</label>
    <title>Introduction</title>
    <p>The investigation of genetic variations, including MM, insertion,
deletion, and other genetic alteration, profoundly influences an individual’s
physiology, susceptibility to diseases, and response to medications.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Specially, studying these variations offers insights into genetic
diversity and its associations with disease onset, progression, and
treatment response.<sup><xref ref-type="bibr" rid="ref3">3</xref>−<xref ref-type="bibr" rid="ref5">5</xref></sup> This comprehension of genetic factors facilitates
the identification of specific alterations that contribute to disease
development and enables the advancement of targeted therapies and
personalized medicine approaches.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p>
    <p>MMs are common genetic variations associated with human diseases.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Till now, various computational methods have
been developed to predict MM pathogenicity.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Traditional machine learning techniques (e.g., SVM and RF) have
laid foundations for advanced methodologies<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> (like SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> PolyPhen,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> PROVEAN,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> CADD<sup><xref ref-type="bibr" rid="ref4">4</xref></sup>). These methodologies utilize sophisticated feature extraction
techniques from diverse data sources (e.g., sequence, structure, and
evolution) to differentiate between pathogenic and benign variations.
Deep learning technologies (e.g., Transformer) have emerged in variation
pathogenicity prediction, autonomously learning complex patterns and
features from extensive genomic and proteomic data sets.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Consensus methods integrate individual predictions
to improve accuracy and reliability, addressing biases and providing
comprehensive pathogenicity assessments.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref></sup> Benchmark data (e.g., ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> dbSNP<sup><xref ref-type="bibr" rid="ref15">15</xref></sup>) have been established for performance comparisons
of prediction methods.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> More specifically,
deep learning excels at capturing complex relationships in data, but
requires larger training sets and computational resources.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Consensus methods enhance reliability by integrating
multiple predictions,<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> while traditional methods offers
interpretable models for biological insights.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p>
    <p>ESM<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtTrans<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> are prominent models in protein sequence analysis
and interpretation,
trained on extensive protein sequence databases. ESM models (e.g.,
ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup>) capture evolutionary information
using self-attention mechanisms, accounting for long-range dependencies
in protein sequences. ProtTrans models (e.g, ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup>) leverage NLP transformers to capture relationships
between amino acids (AA) and structural, functional, and evolutionary
characteristics of proteins.</p>
    <p>Despite considerable efforts, there
are several critical issues
that need to be addressed. First, it is crucial to establish a comprehensive
and nonredundant data set on a large-scale, which incorporates known
effects. In-depth discussions regarding data quality, integration
methods, and potential biases are necessary. Second, it is essential
to develop computational models and perform analyses on feature importance,
interactions, and contributions. Lastly, it holds significant importance
to compare the classification abilities of individual outputs and
embeddings derived from large-scale protein language models.</p>
    <p>In this work, we focused on the following key aspects. (1) Construction
of benchmark data sets: We constructed one nonredundant MM benchmark
data set and one blind test set (focusing especially on pathogenic
GOF/LOF MM). (2) Feature generation: By utilizing the Ensembl VEP
v104 and its plugins (e.g., dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup>), we generated variant-level, AA-level, individuals’ outputs,
and genome-level features. (3) Protein sequence retrieval: By leveraging
ENSP identifiers and the Ensembl API, we retrieved encoded protein
sequences corresponding to query variations. (4) Embedding generation:
We used bio_embeddings<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> to generate ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> embeddings for each mutant site, which captured essential characteristics
and features of mutant AAs. (5) Model development: We developed an
interpretable model group, MMPatho, which consisted of ConsMM and
EvoIndMM. ConsMM utilized individuals’ outputs and employed
XGBoost with SHAP analyses. On the other hand, EvoIndMM incorporated
evolutionary information from ESM-1b and ProtT5-XL-U50 to enhance
the predictive capability.</p>
  </sec>
  <sec id="sec2">
    <label>2</label>
    <title>Materials and Methods</title>
    <sec id="sec2.1">
      <label>2.1</label>
      <title>Construction of the Benchmark Data Set and
Blind Test Set</title>
      <sec id="sec2.1.1">
        <label>2.1.1</label>
        <title>Benchmark Data Set Construction</title>
        <p>We downloaded the entire Ensembl database (6.18GB) from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://web.expasy.org/swissvar.html">https://web.expasy.org/swissvar.html</uri>, which includes variants from various sources (e.g., ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> gnomAD,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> UniProt,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> COSMIC<sup><xref ref-type="bibr" rid="ref24">24</xref></sup>) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A). To select related MMs, we applied two filters: variant
type (setting as MM or missense) and clinical significance (setting
as benign/likely benign or pathogenic/likely pathogenic), getting
622,270 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). We then applied five additional filters to remove unwanted
mutations: (1) those with conflicting interpretations of pathogenicity,
(2) uncertain significance, (3) repetitive and inconsistent MMs from
different sources, (4) variants classified as benign and pathogenic/likely
pathogenic, and (5) variants being likely benign and pathogenic/likely
pathogenic (obtaining 91,072 variants, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C). Using the Ensembl variant effect predictor,
we mapped the mutations to GRCh38, excluding inconsistent chromosome/position
and unmatched mutations, getting 77,700 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D). Following the processing
illustrated in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, the benchmark data set consists of 37,317 benign and 40,383 pathogenic
in 2,595 and 3,294 proteins, respectively. However, a subset of variants
lacked annotations when processed with Ensembl VEP. Consequently,
we excluded these variants/proteins. Eventually, we obtained a large-scale
nonredundant MM benchmark data set (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p>
        <fig id="fig1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Workflow of benchmark data set and blind test
set construction.
(A) Variations in the Ensembl Database, (B) Selecting, (C) Filtering,
and (D) Mapping: the procedures for benchmark data forming. (E) GOF/LOF
Variations and (F) gnomAD Database (v2.1.1): pathogenic GOF/LOF and
benign variants sources.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0001" id="gr1" position="float"/>
        </fig>
        <table-wrap id="tbl1" position="float">
          <label>Table 1</label>
          <caption>
            <title>Statistical
Summary of Missense Mutations
and Proteins in the Benchmark Data Set and Blind Test Set</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center"> </th>
                <th colspan="2" align="center" char=".">number
of variant<hr/></th>
                <th colspan="2" align="center" char=".">number
of protein<hr/></th>
              </tr>
              <tr>
                <th style="border:none;" align="center">data type</th>
                <th style="border:none;" align="center" char=".">benign/likely benign</th>
                <th style="border:none;" align="center" char=".">pathogenic/likely pathogenic</th>
                <th style="border:none;" align="center" char=".">benign/likely benign</th>
                <th style="border:none;" align="center" char=".">pathogenic/likely pathogenic</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">Benchmark data
set</td>
                <td style="border:none;" align="char" char=".">34,602</td>
                <td style="border:none;" align="char" char=".">38,476</td>
                <td style="border:none;" align="char" char=".">2439</td>
                <td style="border:none;" align="char" char=".">3115</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">blind test set</td>
                <td style="border:none;" align="char" char=".">2919</td>
                <td style="border:none;" align="char" char=".">3039</td>
                <td style="border:none;" align="char" char=".">675</td>
                <td style="border:none;" align="char" char=".">703</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="sec2.1.2">
        <label>2.1.2</label>
        <title>Blind
Test Set Construction</title>
        <p>We
downloaded pathogenic GOF/LOF variants<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> (HGMD_based), which contains 9,619 variants. From this set, we selected
single nucleotide variants occurring in protein coding regions, excluded
variants overlapped with in the benchmark data set (getting 3039 variants, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E). Subsequently,
for the gene set within the GOF/LOF data, we searched each gene in
gnomAD and applied the following filters to get benign variants: (1)
remove variants stored in ClinVar; (2) retained MMs with an allele
frequency &gt;0.1%; (3) kept MMs with clinical significance being
as
benign or likely benign; (4) remove MMs overlapped with the benchmark
data set. This process yielded 2919 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>F). Finally, we merged the pathogenic and
benign variants, removing redundant ones to construct a blind test
set (presented in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p>
      </sec>
    </sec>
    <sec id="sec2.2">
      <label>2.2</label>
      <title>Feature Extraction</title>
      <sec id="sec2.2.1">
        <label>2.2.1</label>
        <title>Ensembl
VEP Outputs and Individual Predictions/Annotations</title>
        <p>On a CentOS
v6.10 computer with 32 CPU kernels, we installed Ensembl
VEP v140<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> along with the formatted and
well-indexed human GRCh37 assembly data. Additionally, we incorporated
various plugins (e.g., dbNSFP v4.1a,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> Blosum62,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> ExAC<sup><xref ref-type="bibr" rid="ref23">23</xref></sup>) (please refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Texts S1 and S2</ext-link> detailed information about database versions and
plugins). These tools offer comprehensive features for each variant,
categorizing into four groups: variant-level, AA-level, individuals’
outputs, and genome-level features.</p>
        <p>(1) Variant-level features.
Location: variant’s coordinates for annotation extraction.
Allele: variant allele used for consequence calculation. Consequence:
type of consequence associated with the variant. Position: cDNA_position,
CDS_position, and Protein_position indicate relative base pair positions
in cDNA sequence, coding sequence, and protein AAs, respectively.
IMPACT: subjective impact classification of consequence type (e.g.,
moderate, modifier, low). CANONICAL: indicates whether the transcript
is canonical for the gene. ENSP: Protein identifier. GENE_PHENO: indicates
whether the gene is associated with a phenotype, disease, or trait.
CLIN_SIG: ClinVar clinical significance of the dbSNP variant.</p>
        <p>(2) AA-level features. Wildtype and mutant AAs were obtained from
Ensembl VEP v104.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Additional features
(including molecular weight, hydrophobicity, isoelectric point, residue
volume) were extracted for wild-type and mutant AAs. Furthermore,
the differences between two type AAs were also calculated, namely,
damino_frq_diff, V_residue_diff, Hydrophobicity_diff, Isoelectric_point_diff,
etc.</p>
        <p>(3) Individuals’ outputs. Ensembl VEP v104<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> and dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> offer an extensive
range of MM effect predictions and annotations using multiple methods.
This encompasses thirty-one prediction algorithms, such as (SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Polyphen2-HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> FATHMM,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> DANN,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Eigen,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> REVEL,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> PrimateAI,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> ClinPred<sup><xref ref-type="bibr" rid="ref34">34</xref></sup>). Additionally,
nine conservation scores (e.g., bStatistic, phyloP30way_mammal, GERP++<sup><xref ref-type="bibr" rid="ref35">35</xref></sup>) and other functional annotations are also provided.</p>
        <p>(4) Genome-level features. We acquired genome-level features from
multiple databases, including gnomAD_exomes, ESP6500, and ExAC. For
example, 1000Gp3_AFR_AF represents the alternative allele frequency
in 1000Gp3 African descendant samples. ESP6500_EA_AF denotes the alternative
allele frequency in European American samples from ESP6500 (Please
refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S1</ext-link> for more information
about the extracted features).</p>
      </sec>
    </sec>
    <sec id="sec2.2.2">
      <label>2.2.2</label>
      <title>Amino
acid embeddings</title>
      <p>For each
MM, we calculated AA-level embedding features from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtTransT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> These features originated from protein sequences acquired by using
the ENSP ID and API functions. During protein sequence retrieval,
some variants returned empty information. To maintain the embedding
quality, we filtered out such variants with empty returns.</p>
      <p>(1)
ESM-1b embeddings. We utilized the bio_embeddings<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> to obtain ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> embeddings
for each AA at the mutant site. These 1280-dimensional vectors effectively
encode crucial AA properties, including physicochemical properties,
and evolutionary conservations.</p>
      <p>(2) ProtTransT5-XL-U50 embeddings.
By employing the ProtTransT5XLU5<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> embedder
from bio_embeddings,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> we leveraged the
potential of the 1024-dimensional vector
for each mutant AA. This approach facilitated the extraction of valuable
insights from protein sequences, capturing AA’s properties
such as hydrophobicity, charge, and size.</p>
    </sec>
  </sec>
  <sec id="sec2.2.3">
    <label>2.2.3</label>
    <title>Distribution of Features</title>
    <p>We executed an elaborate investigation
into the disparities in
distribution of features utilized for classifying genome variations
as either pathogenic or benign, with a particular emphasis on the
annotated “benchmark data set” missense mutations (listed
in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). We applied
Kernel Density Estimation (KDE)<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> to portray
efficiently the intricate dynamism of these distributions in a continuous,
and unbiased manner.</p>
    <p>We opted to showcase a subset of 12 distinct
features out of the
total 884 features extracted in <xref rid="sec2.2.1" ref-type="other">Sections 2.2.1–2.2.2</xref>. The features selected for presentation exhibited remarkable differences
in their distributions. For instance, as depicted in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A, the gnomAD_exomes_ASJ_AF
feature demonstrated a highly significant distribution contrast (<italic>p</italic>-value: 1.622517e-274). Similarly, <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>E highlighted the distribution disparity
of the Hydrophobicity_diff feature (<italic>p</italic>-value: 1.587287e-48),
while <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>K revealed
the distinct distribution pattern of esm1b_90 (<italic>p</italic>-value:
2.531859e-235). <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>L illustrated the pronounced distribution discrepancy of prott5_570
(<italic>p</italic>-value: 4.379378e-220). These exemplary features
were chosen to exemplify the analytical power of feature distributions
in discerning the classification potential of the extracted attributes.</p>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Analyses
of the extracted features with <italic>p</italic>-values
using the KDE function. (A) gnomAD_exomes_ASJ_AF (<italic>p</italic>-value = 1.622817e-274), (B) Isoelectric_point_diff (<italic>p</italic>-value = 2.627391e-21), (C) Molecular_weight_diff (<italic>p</italic>-value = 0.00074061), (D) Molecular_weight_wt (<italic>p</italic>-value = 1.560005e-11), (E) Hydrophobicity_diff (<italic>p</italic>-value = 1.587287e-48), (F) codeToVal_diff (<italic>p</italic>-value
= 0.00102270), (G) V_residue_wt (<italic>p</italic>-value = 1.286094e-16),
(H) V_residue_diff (<italic>p</italic>-value = 4.680308e-12), (I)
CADD_raw_rankscore_gh19 (<italic>p</italic>-value = 0.0), (J) GERP++_NR
(<italic>p</italic>-value = 1.118603e-46), (K) esm1b_90 (<italic>p</italic>-value = 2.531859e-235), and (L) prott5_570 (<italic>p</italic>-value
= 4.379378e-220). Note: “Label 0” and “Label
1” represent the benign and pathogenic variation class, respectively.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0002" id="gr2" position="float"/>
    </fig>
    <p>In conclusion, our comprehensive analysis effectively
demonstrates
how feature distributions, aided by KDE and selective visualization,
aid in distinguishing different classes of genome variations, thereby
enhancing the understanding of genome variation impacts.</p>
  </sec>
  <sec id="sec3">
    <label>3</label>
    <title>Workflow of ConsMM and EvoIndMM</title>
    <p>In this work, we developed
an integrated model group of models
termed MMPatho, consisting of two distinct models: ConsMM (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>) and EvoIndMM (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). Importantly, ConsMM
solely employs individual outputs as inputs, whereas EvoIndMM integrates
Ensembl VEP outputs along with embeddings generated from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p>
    <fig id="fig3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Workflow
of the ConsMM model. (A) Feature Extraction, (B) Pathogenic
Mutation Identification using LightGBM, XGBoost, and CatBoost, (C)
Utilizing the Optimal Model for Prediction and Model Explanation,
(D) Analysis of Feature Dependence, and (E) Analysis of Feature Importance.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0003" id="gr3" position="float"/>
    </fig>
    <fig id="fig4" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Architecture of the EvoIndMM model. (A) Protein Sequence
Generation
and Inputs Creation for ProtT5-XL-U50 and ESM-1b embedders, embedding
Generation from ProtT5-XL-U50 and ESM-1b, (B) Feature Extraction via
Ensembl VEP and its Plugins, (C) Feature Selection through PCA, and
(D) XGBoost Model Training.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0004" id="gr4" position="float"/>
    </fig>
    <p>Within ConsMM, we e exclusively implemented 34 individuals’
predictions or conservation scores procured from Ensembl VEP and dbNSFP,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> which include SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> ClinPred,<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> DANN,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Eigen,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> FATHMM<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> (fathmm-MKL,<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> fathmm-XF<sup><xref ref-type="bibr" rid="ref38">38</xref></sup>), FitCons<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> (GM12878, H1_hESC, HUVEC), GenoCanyon,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> LRT,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> MPC,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> MutPred2,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> MutationTaster,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> MutationAssessor,<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> Polyphen2_HDIV and Polyphen2_HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> REVEL,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> SIFT4G,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> PrimateAI.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> Also
include nine conservation scores, e.g., bStatistic, phyloP100way_vertebrate,
phastCons17way_primate,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> GERP++,<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> SiPhy,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> and others.</p>
    <p>Conversely, for EvoIndMM, we broadened the feature set beyond mere
predictions/annotations, integrating additional variant-level, amino
acid-level, and genome-level features sourced from dbSNP,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> UniProt,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> gnomAD,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> 1000Gp3,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> ESP<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and others. Additionally, we also generated
variant characteristic from ESM-1b,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and
ProtT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Please refer to the Readme
page of our Web server for viewing feature contributions in the ConsMM
or EvoIndMM model.</p>
    <sec id="sec3.1">
      <label>3.1</label>
      <title>ConsMM</title>
      <p>The ConsMM
workflow (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>)
comprises three
key components: feature extraction (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A), prediction (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B), feature importance analysis, and model
explanation (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C–<xref rid="fig3" ref-type="fig">3</xref>E). In <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A, Ensembl VEP v104 and dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> were used to obtain predictions and annotations for multiple individuals(e.g.,
SIFT<sup><xref ref-type="bibr" rid="ref10">10</xref></sup>). In <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B, the extracted features were input into
LightGBM, XGBoost, and CatBoost to derive the optimal model. Finally,
in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C–E,
the feature importance and interaction dependencies were analyzed
using SHAP<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S3</ext-link> introduced SHAP and XGBoost), aiming to provide a comprehensive
explanation for the prediction model (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S4</ext-link> listed the evaluation indices).</p>
    </sec>
    <sec id="sec3.2">
      <label>3.2</label>
      <title>EvoIndMM</title>
      <p><xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref> depicts
the stepwise construction process
of EvoIndMM, involving the following key steps: (1) Retrieval of Encoded
Protein Sequences: Protein sequences in FASTA format are retrieved
for ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> and ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> embedders using the Ensembl API and ENSP identifiers.
Filter options are applied to exclude specific mutations (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). (2) Feature Extraction
through the Ensembl VEP: Ensembl VEP v104 is employed to extract feature
vectors, including variant-level, AA-level, individual outputs, and
genome-level features. Additionally, for each mutant site AA, ESM-1b
and ProtT5-XL-U50 embedders generate 1120 and 1280-dimensional feature
vectors, respectively (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A, <xref rid="fig4" ref-type="fig">4</xref>B). (3) Benchmark Data Splitting
and Model Training: The benchmark data is partitioned into training
data and test set. PCA is then utilized to select features from VEP,
ESM-1b, and ProtT5-XL-U50, using a threshold of &gt;0.1 or 0.05. Subsequently,
the XGBoost model is trained using the training data (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref><bold>C-</bold><xref rid="fig4" ref-type="fig">4</xref><bold>D</bold>). By following this systematic approach, EvoIndMM
ensures the accurate prediction of MM pathogenicity by integrating
diverse features and embedding techniques.</p>
    </sec>
    <sec id="sec3.3">
      <label>3.3</label>
      <title>Avoiding
Protein Overlap for Model Fairness</title>
      <p>The study by Grimm et
al. highlights a potential flaw in the modeling
process: the inclusion of different variations of a single protein
in both the training and testing sets may lead to artificially inflated
model performance during testing.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Such
inflation can occur if the model merely mimics specific variation
patterns from the training data without genuinely learning to apply
these patterns to novel variations. To ensure validity and prevent
data leakage, it is critical to maintain separate training and testing
sets that do not concurrently include different variations of the
same protein.</p>
      <p>To this end, we employed protein IDs as sorting
criteria when distributing distinct protein variations between the
training (80%) and testing (20%) sets of the benchmark data set (training:
58786 and testing: 14292 for ConsMM), utilizing “train_test_split”
from sklearn.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> This allocation strategy
ensures that proteins and their variations are exclusively assigned
to either the training or the testing set, thereby boosting the reliability
of the model’s performance assessment.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <label>4</label>
    <title>Results and Discussions</title>
    <sec id="sec4.1">
      <label>4.1</label>
      <title>Performance Comparison
of ConsMM and EvoIndMM</title>
      <sec id="sec4.1.1">
        <label>4.1.1</label>
        <title>Performance of ConsMM
on the Test Set of
Benchmark Data Set</title>
        <p>To optimize parameter settings and experimental
design, the following steps were taken. (1) Grid Search Cross-Validation
and Model Selection: in GridSearchCV, we conducted 5-fold cross-validation
with 3 repetitions to thoroughly explore a predefined grid of hyperparameters
and determine the best-performing model. (2) Parameter Settings: For
XGBoost, the chosen settings were a “learning rate”
of 0.01, a binary logistic regression objective, a subsample ratio
of 0.5, the “base_score” as the mean of “y_train”,
the “eval_metric” as “log_loss”, “max_depth”
of 4, and “n_estimators” of 300. In contrast, CatBoost
and LightGBM underwent extensive grid searches for iterations, learning
rates, and tree depths. The best parameter configurations were identified
as follows: CatBoost (“iterations”=400, “learning_rate”=0.1,
“depth”=4) and LightGBM (“iterations”=400,
“learning_rate”=0.01, “depth”=4). The
CatBoost, XGBoost, and LightGBM models were meticulously fine-tuned
and evaluated, and the comparison results are documented in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> (further details for LightGBM,
XGBoost, and CatBoost can be found in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Texts S5–S7</ext-link>).</p>
        <fig id="fig5" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Comparison of CatBoost, XGBoost, and LightGBM on the test set of
the benchmark data set. (A) ROC curves of CatBoost, XGBoost, and LightGBM.
(B) PR curves of CatBoost, XGBoost, and LightGBM. (C) <italic>Pre</italic>, <italic>NPV</italic>, <italic>Recall</italic>, <italic>Spe</italic>, <italic>ACC</italic>, <italic>MCC</italic>, and <italic>F</italic><sub>1</sub> values of CatBoost, XGBoost, and LightGBM.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0005" id="gr5" position="float"/>
        </fig>
        <table-wrap id="tbl2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Confusion Matrix and Three Types of
Errors of CatBoost, XGBoost, and LightGBM on the Test Set of Benchmark
Data Set</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">model name</th>
                <th style="border:none;" align="center">TP</th>
                <th style="border:none;" align="center">TN</th>
                <th style="border:none;" align="center">FP</th>
                <th style="border:none;" align="center">FN</th>
                <th style="border:none;" align="center" char=".">ER</th>
                <th style="border:none;" align="center" char=".">FPR</th>
                <th style="border:none;" align="center" char=".">FNR</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">CatBoost</td>
                <td style="border:none;" align="left">7339 (51.35%)</td>
                <td style="border:none;" align="left">5516 (38.60%)</td>
                <td style="border:none;" align="left">839 (5.87%)</td>
                <td style="border:none;" align="left">598 (4.18%)</td>
                <td style="border:none;" align="char" char=".">0.0587</td>
                <td style="border:none;" align="char" char=".">0.1320</td>
                <td style="border:none;" align="char" char=".">0.0753</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">XGBoost</td>
                <td style="border:none;" align="left">7242 (50.67%)</td>
                <td style="border:none;" align="left">5675 (39.71%)</td>
                <td style="border:none;" align="left">680 (4.76%)</td>
                <td style="border:none;" align="left">695 (4.86%)</td>
                <td style="border:none;" align="char" char=".">0.0476</td>
                <td style="border:none;" align="char" char=".">0.1070</td>
                <td style="border:none;" align="char" char=".">0.0876</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">LightGBM</td>
                <td style="border:none;" align="left">7302 (51.09%)</td>
                <td style="border:none;" align="left">5513 (38.57%)</td>
                <td style="border:none;" align="left">842 (5.89%)</td>
                <td style="border:none;" align="left">635 (4.44%)</td>
                <td style="border:none;" align="char" char=".">0.0589</td>
                <td style="border:none;" align="char" char=".">0.1325</td>
                <td style="border:none;" align="char" char=".">0.0800</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>When comparing the performance of CatBoost,
XGBoost, and LightGBM,
we evaluated multiple metrics (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>) to assess their effectiveness; analyses are given below:
(1) XGBoost outperformed CatBoost and LightGBM with MCC of 0.8052,
compared to 0.7961 and 0.7904, respectively. MCC can capture the overall
model performance, by considering TP, TN, FP, and FN. (2) XGBoost
achieved an ACC score of 0.9038, surpassing CatBoost (0.8995) and
LightGBM (0.8967), indicating better pathogenic variant classification
ability. (3) XGBoost demonstrated a Spe value of 0.8930, outperforming
CatBoost (0.8680) and LightGBM (0.8675), indicating better identification
of negative cases. (4) XGBoost achieved a Pre score of 0.9142, higher
than CatBoost (0.8974) and LightGBM (0.8966), indicating a higher
proportion of correctly predicted positive cases. (5) XGBoost obtained
the highest F<sub>1</sub> score of 0.9133, which combines precision
and recall to represent the balance between them. Considering the
comparisons, XGBoost consistently demonstrated a competitive performance
across multiple metrics. Therefore, we selected XGBoost as the preferred
model for subsequent comparisons and referred to the entire model
as ConsMM for further analyses.</p>
      </sec>
      <sec id="sec4.1.2">
        <label>4.1.2</label>
        <title>Assessing
ConsMM Efficacy: Protein ID-Based
Splitting Vs Nonprotein ID-Based splitting</title>
        <p>To ensure a robust
evaluation of ConsMM, we conducted supplementary testing using data
that did not split based on protein ID. Detailed results from these
tests are provided in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S8, Figure S1, and Table S2</ext-link>.</p>
        <p>Comparative analysis between findings detailed
in <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> and those outlined in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S8, Figure S1, and Table S2</ext-link> reveals subtly lower metrics in the former. For instance,
with reference to the XGBoost classifier, its AUROC value in <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> stands at 0.9650
(Protein ID-Based Separation), which is marginally below that depicted
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S1</ext-link> (0.9764, Non-Protein ID-Based
Separation), marking a decrease of approximately 0.0114. A similar
trend is observed in XGBoost’s AUPR, where <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> displays a score of 0.9715,
slightly under the corresponding value in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S1</ext-link> (0.9802), indicating a decline of roughly 0.0093. This suggests
that employing a protein ID for data segregation provides a more conservative
appraisal of model performance. The ACC and MCC values of XGBoost
in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> (0.9038
and 0.8052 respectively) are fractionally under those given in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S2</ext-link> (0.9208 and 0.8416 respectively), demonstrating
marginal decreases of 0.017 and 0.0364, implying a reduced capacity
of the models to handle imbalanced data and produce balanced predictions
when protein ID separation is used.</p>
        <p>In summary, the results
from the Supporting Information show superior
AUROC, AUPR, ACC, and MCC scores, suggesting improved overall model
performance. Nonetheless, the experiments delineated in <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> utilizing
protein ID for data splitting provide a more conservative and reliable
evaluation, taking into account potential data leakage and model overfitting.
The selection between these two methodologies should be guided by
the specific demands of the task at hand with a preference for <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> when a
dependable estimation of model generalizability is required.</p>
      </sec>
      <sec id="sec4.1.3">
        <label>4.1.3</label>
        <title>Feature Importance in ConsMM</title>
        <p>To
gain comprehensive insight into the key features of ConsMM, we plotted
the top 35 features with the highest SHAP values (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A). The findings can be summarized
as follows: (1) The ClinPred_rankscore demonstrates that a higher
value significantly contributes ConsMM to predicting pathogenic variants,
whereas a lower value has a greater impact on predicting benign variants.
Similar contribution patterns can be observed on BayesDel_addAF_score.
(2) Furthermore, the prevalence of red color in features (e.g., BayesDel_addAF_rcore,
BayesDel_addAF_rankscore, MutPred_rankscore, MPC_rankscore, REVEL_rankscore,
ClinPred_score, and CADD_raw_rankscore) indicates feature higher values
strong correlation with classes and their crucial predictive capabilities
in accurately identifying pathogenic variants. (3) Additionally, the
lower values of features (e.g., FATHMM_converted_rankscore, Reliability_index,
SIFT_converted_rankscore, PrimateAI_rankscore, GERP++_NR) highlight
their significant impact on predicting pathogenic variants. (SHAP
values of all features for ConsMM and feature analyses were documented
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S3 and Text S9</ext-link>).</p>
        <fig id="fig6" position="float">
          <label>Figure 6</label>
          <caption>
            <p>SHAP summary plot and
feature interactions for ConsMM. (A) SHAP
summary plot, (B) ClinPred_rankscore with phyloP100way_vertebrate_rankscore,
(C) BayesDel_addAF_rankscore with ClinPred_score, (D) MutPred_rankscore
with ClinPred_rankscore, (E) Eigen_phred_coding with BayesDel_addAF_score,
(F) GERP++_RS with ClinPred_score, (G) Polyphen2_HVAR_rankscore with
BayesDel_addAF_rankscore, (H) bStatistic_converted_rankscore with
GERP++_NR, and <bold>(I)</bold> phastCons100way_vertebrate with CADD_phred.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0006" id="gr6" position="float"/>
        </fig>
        <p>The feature interactions depicted in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B–<xref rid="fig6" ref-type="fig">6</xref>I offer
valuable insights into the joint effects of various features on the
output of ConsMM’s output. Detailed analyses are as follows:<list list-type="simple"><list-item><label>(1)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B, <xref rid="fig6" ref-type="fig">6</xref>C display analogous patterns.
Feature interaction plots exhibit regions of red and blue overlap,
signifying that when both features possess higher values, they synergistically
amplify each other’s impact on ConsMM’s output. In essence,
evaluating these two features collectively augments ConsMM’s
predictive capacity and exerts a positive influence on its predictions.</p></list-item><list-item><label>(2)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>E,<xref rid="fig6" ref-type="fig">6</xref>G, and I reveal
similar patterns.
The aggregate effect of these feature interactions on predictions
deviates from their individual impacts, alluding to the presence of
intricate interactions between features. When one feature exhibits
high while another displays low values, they mutually reinforce each
other, culminating in enhanced predictive prowess for pathogenic variants.</p></list-item><list-item><label>(3)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>D,<xref rid="fig6" ref-type="fig">6</xref>F, and <xref rid="fig6" ref-type="fig">6</xref>H exhibit similar influence. The observed concave
shape indicates
a complex interplay between feature pairs. Within a specific range,
the feature interaction significantly influences prediction outcomes
and combined effect becomes more potent, resulting in a striking aggregation
of red areas. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S2</ext-link> displays the interactions
of other 12 features for ConsMM.</p></list-item></list></p>
      </sec>
    </sec>
    <sec id="sec4.2">
      <label>4.2</label>
      <title>Performance of EvoIndMM with VEP Outputs,
ESM-1b and ProtT5-XL-U50 Embeddings</title>
      <sec id="sec4.2.1">
        <label>4.2.1</label>
        <title>Assessing
the Contribution of Different
Feature Sets</title>
        <p>To assess the impact of different feature sets
on EvoIndMM predictions, ablation experiments were conducted. Experiments
results (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>) provide insights
into feature contributions. <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>A highlights that EvoIndMM with the “Combined”
feature set achieves the highest TN (5515, 47.47%) and lowest FP (416,
3.58%), indicating superior classification performance compared to
EvoIndMM with other feature sets. Additionally, the “Combined”
feature set exhibits the lowest ER (0.0358) among all feature sets.
EvoIndMM with “VEP” demonstrates the lowest FPR (0.0701),
revealing its proficiency in accurately identifying benign variants.
Conversely, EvoIndMM with the “VEP” feature set exhibits
the highest FNR (0.0895), indicating challenges in correctly identifying
pathogenic variants.</p>
        <fig id="fig7" position="float">
          <label>Figure 7</label>
          <caption>
            <p>ROC and PR curves of EvoIndMM on the test set of the benchmark
data set. (A) Confusion matrix of EvoIndMM with VEP outputs, ESM-1b,
ProtT5-XL-U50, or combined feature set, (B) ROC curves, and (C) PR
curves.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0007" id="gr7" position="float"/>
        </fig>
        <table-wrap id="tbl3" position="float">
          <label>Table 3</label>
          <caption>
            <title>Performance Comparison
of EvoIndMM
with Different Features on the Test Set of Benchmark Data Set<xref rid="t3fn1" ref-type="table-fn">a</xref></title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">features</th>
                <th style="border:none;" align="center" char=".">MCC</th>
                <th style="border:none;" align="center" char=".">ACC</th>
                <th style="border:none;" align="center" char=".">recall/sen</th>
                <th style="border:none;" align="center" char=".">Spe</th>
                <th style="border:none;" align="center" char=".">Pre</th>
                <th style="border:none;" align="center" char=".">NPV</th>
                <th style="border:none;" align="center" char=".">F<sub>1</sub></th>
                <th style="border:none;" align="center" char=".">ER</th>
                <th style="border:none;" align="center" char=".">FPR</th>
                <th style="border:none;" align="center" char=".">FNR</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">VEP<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.8348</td>
                <td style="border:none;" align="char" char=".">0.9175</td>
                <td style="border:none;" align="char" char=".">0.9105</td>
                <td style="border:none;" align="char" char=".">0.9241</td>
                <td style="border:none;" align="char" char=".">0.9200</td>
                <td style="border:none;" align="char" char=".">0.9150</td>
                <td style="border:none;" align="char" char=".">0.9152</td>
                <td style="border:none;" align="char" char=".">0.0387</td>
                <td style="border:none;" align="char" char=".">0.0759</td>
                <td style="border:none;" align="char" char=".">0.0895</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">ESM-1b<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.5801</td>
                <td style="border:none;" align="char" char=".">0.7901</td>
                <td style="border:none;" align="char" char=".">0.7633</td>
                <td style="border:none;" align="char" char=".">0.8157</td>
                <td style="border:none;" align="char" char=".">0.7989</td>
                <td style="border:none;" align="char" char=".">0.7823</td>
                <td style="border:none;" align="char" char=".">0.7807</td>
                <td style="border:none;" align="char" char=".">0.0941</td>
                <td style="border:none;" align="char" char=".">0.1843</td>
                <td style="border:none;" align="char" char=".">0.2367</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">ProtT5-XL-U50<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.6137</td>
                <td style="border:none;" align="char" char=".">0.8068</td>
                <td style="border:none;" align="char" char=".">0.7772</td>
                <td style="border:none;" align="char" char=".">0.8351</td>
                <td style="border:none;" align="char" char=".">0.8188</td>
                <td style="border:none;" align="char" char=".">0.7963</td>
                <td style="border:none;" align="char" char=".">0.7975</td>
                <td style="border:none;" align="char" char=".">0.0842</td>
                <td style="border:none;" align="char" char=".">0.1649</td>
                <td style="border:none;" align="char" char=".">0.2228</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">combined<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.8390</td>
                <td style="border:none;" align="char" char=".">0.9195</td>
                <td style="border:none;" align="char" char=".">0.9087</td>
                <td style="border:none;" align="char" char=".">0.9299</td>
                <td style="border:none;" align="char" char=".">0.9255</td>
                <td style="border:none;" align="char" char=".">0.9140</td>
                <td style="border:none;" align="char" char=".">0.9170</td>
                <td style="border:none;" align="char" char=".">0.0358</td>
                <td style="border:none;" align="char" char=".">0.0701</td>
                <td style="border:none;" align="char" char=".">0.0913</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t3fn1">
              <label>a</label>
              <p>Note: VEP<sup>#</sup>, ESM-1b<sup>#</sup>, ProtT5-XL-U50<sup>#</sup> mean EvoIndMM only with VEP outputs,
or ESM-1b embeddings, or ProtT5-XL-U50 embeddings. Combined<sup>#</sup> represents the concatenation of VEP outputs, ESM-1b and ProtT5-XL-U50
embeddings.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Analyzing the
results presented in <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>, it is evident that EvoIndMM with the “Combined”
feature set achieves outstanding performance, as reflected by its
highest AUROC (0.9736) and AUPR (0.9738) values. Additionally, EvoIndMM
demonstrates robust agreement between predicted and true classes with
the highest MCC (0.8390) and ACC (0.9195) values, indicating accurate
classification. Besides, EvoIndMM with “VEP” exhibits
superior Recall/Sen (0.9105), showcasing its ability to identify positive
variants effectively. In contrast, EvoIndMM with “ESM-1b″
shows a lower Spe (0.8157), suggesting a higher rate of false positives.
Notably, EvoIndMM with “Combined” achieves the highest
Pre score (0.9255) and F<sub>1</sub> score (0.9170), indicating a
favorable balance between precision and recall.</p>
        <p>In summary,
the “Combined” feature set consistently
outperforms other feature sets across various metrics. The limited
effectiveness of ESM-1b and ProtT5-XL-U50 embeddings in predicting
MM pathogenicity can be attributed to their insufficient individual
pathogenic predictions and annotations, limited coverage of mutation
features, and inadequate representation of functional impacts. In
contrast, the “Combined” feature set outperforms each
single set, indicating the combination provides complementary information
that can enhance predictive performance. The inclusion of the “VEP”
feature set in “Combined”, with its extensive individual-level
predictions and annotations, likely compensates for any limitations
in ESM-1b and ProtT5-XL-U50 embeddings, resulting in improved accuracy
in predicting MM pathogenicity.</p>
      </sec>
      <sec id="sec4.2.2">
        <label>4.2.2</label>
        <title>Assessing
EvoIndMM Efficacy: Protein ID-Based
Splitting vs Nonprotein ID-Based Splitting</title>
        <p>To robustly evaluate
the differential attributes of EvoIndMM, we performed additional analyses
on data that did not split based on protein ID. Detailed results from
these tests are encapsulated in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S10, Table S4, and Figure S3</ext-link>. The “Combined<sup>#</sup>″
feature set of EvoIndMM is employed for a detailed comparative assessment
of performance metrics.</p>
        <p>With respect to the MCC Value, a subtle
decrease of approximately 0.0828 is observed from <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S4</ext-link> (0.8390) to <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> (0.9218), indicating a modest reduction in proficiency
of sample classification. In terms of ACC, a minor decrement of about
0.0416 is noted upon comparison of <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S4</ext-link> with <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>, signaling
a slight decline in the model’s ability to classify samples
correctly. Considering the AUROC Value, a marginal fall of roughly
0.0173 is seen transitioning from <xref rid="fig7" ref-type="fig">Figures <xref rid="fig7" ref-type="fig">7</xref></xref> to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S3</ext-link>, suggesting
a minimal decrease in the model’s competence in distinguishing
positive from negative samples. Regarding the AUPR value, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S3</ext-link> demonstrates a decrease of nearly 0.0185
relative to <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>, denotes a slight deterioration in the equilibrium between precision
and recall. In summation, notwithstanding the apparent reductions
in performance metrics in <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> for EvoIndMM with the “Combined<sup>#</sup>″ feature set, these decreases remain relatively trivial.
This indicates that the model preserves its robust performance even
when adopting protein ID for data partitioning, thereby emphasizing
its dependability in real-world scenarios.</p>
        <p>In light of the experimental
data associated with the data splitting
strategy in <xref rid="sec3.3" ref-type="other">Section <xref rid="sec3.3" ref-type="other">3.3</xref></xref>, along with the comparative evaluations of <xref rid="sec4.2.2" ref-type="other">sections <xref rid="sec4.2.2" ref-type="other">4.2.2</xref></xref> and <xref rid="sec4.1.2" ref-type="other">4.1.2</xref>, it can be deduced that the slight performance decline
noted in the predictive model, attributable to the strategy detailed
in <xref rid="sec3.3" ref-type="other">Section <xref rid="sec3.3" ref-type="other">3.3</xref></xref>, is
an acceptable trade-off. This approach ensures more reliable performance
appraisals and fosters superior generalizability, thereby endorsing
the corresponding marginal decreases in performance.</p>
      </sec>
      <sec id="sec4.2.3">
        <label>4.2.3</label>
        <title>Feature Importance in EvoIndMM</title>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>A presents
the top 35 features for EvoIndMM, ranked by their SHAP values. These
features demonstrate unique impact patterns, summarized as follows:
(1) Features (e.g., ClinPred_rankscore, BayesDel_addAF_rankscore,
REVEL_rankscore, bStatistic_converted_rankscore, VEST4_rankscore,
MutPred_rankscore, MVP_rankscore, CADD_raw_rankscore) enhance significant
the EvoIndMM’s ability to predict pathogenic variants. (2)
Conversely, features like MAX_AF, Reliability_index, gnomAD_exomes_AF,
FATHMM_converted_rankscore, and Molecular_weight_diff have a notable
impact on predicting pathogenic variants when their values are lower.
These observed impact patterns validate the relevance and crucial
predictive capabilities of these features in EvoIndMM (SHAP values
of the top 160 features and feature analyses were documented in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S5 and Text S11</ext-link>).</p>
        <fig id="fig8" position="float">
          <label>Figure 8</label>
          <caption>
            <p>SHAP summary plot and
feature interactions for EvoIndMM. (A) SHAP
summary plot, (B) ClinPred_score interacting with phyloP100way_vertebrate_rankscore,
(C) Eigen_PC_phred_coding with esm1b_909, (D) esm1b_781 with ClinPred_Score,
(E) MPC_rankscore with esm1b_909, (F) MAX_AF with BayesDel_addAF_rankscore,
(G) MutPred_rankscore with ClinPred_rankscore, (H) phyloP100way_vertebrate
with ClinPred_Score, and <bold>(I)</bold> prott5_32 with prott5_410.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0008" id="gr8" position="float"/>
        </fig>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>B–<xref rid="fig8" ref-type="fig">8</xref>I depicts eight feature interactions
that effect
EvoIndMM, with detailed analyses provided below: (1) In <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>B, within the ClinPred_rankscore
range of [0, 0.80], the ClinPred_rankscore and phyloP100way_vertebrate
interaction exerts minimal influence on EvoIndMM’s output.
However, when ClinPred_rankscore values fall within [0.90, 1.0], feature
interaction significantly impacts the model output. Analogous interaction
patterns are discernible in <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>E,G.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>C illustrates
the interaction between Eigen_PC_phred_coding and esm1b_909. Within
the (0, 35) of Eigen_PC_phred_coding, MAX_AF feature values mostly
concentrate between 2 and 4, signifying that Eigen_PC_phred_coding
and esm1b_909 interaction wield greater influence on EvoIndMM’s
output in such range. Similar interaction patterns can be observed
in <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>D–H.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>F illustrates
the interaction of MAX_AF and BayesDel_addAF_rankscore. When MAX_AF
is in the range [0, 1], BayesDel_addAF_rankscore values predominantly
concentrate in the range (−1.0, −0.4). Within such a
range, the negative SHAP values of MAX_AF indicate a significant influence
of this interaction on EnoIndMM’s prediction of benign variants.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>I elucidates
the interaction between prott5_32 and prott5_410. When prott5_32 values
lie within [−0.4, 0.15] and prott5_410 within [-0.2, 0.4],
the positive SHAP values for prott5_32 signify their substantial contribution
to EvoIndMM’s prediction of pathogenic variants. Conversely,
as prott5_32 shifts from 0.15 to 0.6 and prott5_410 moves from −0.2
to −0.6, the majority of data points exhibit a blue hue, emphasizing
their influence on EvoIndMM to predict benign variants. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S4</ext-link> showcases the interactions of 12 additional
features for the EvoIndMM model.</p>
      </sec>
    </sec>
    <sec id="sec4.3">
      <label>4.3</label>
      <title>Assessing
the Performance of ConsMM, EvoIndMM
with Four Individual and Seven Meta-Predictors On Blind Test Set</title>
      <p>In this section, we conducted a comprehensive comparison of ConsMM
and EvoIndMM with four individual and seven meta-predictors, including
VEST4,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> PROVEAN,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> LIST-S2,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> gMVP,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> MetaSVM,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> MetaLR,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> M-CAP,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> DEOGEN2,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> InMeRF,<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> VARITY,<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> MetaRNN,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> MVP.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> Detailed information about these predictors
can be found in <xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref> (detailed descriptions), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S6</ext-link> (features
predictor used), and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S12</ext-link> (predictor
description, score range, and threshold setting).</p>
      <table-wrap id="tbl4" position="float">
        <label>Table 4</label>
        <caption>
          <title>Detailed Descriptions of the Compared
Predictors<xref rid="t4fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">name</th>
              <th style="border:none;" align="center">integrated</th>
              <th style="border:none;" align="center">pub-year</th>
              <th style="border:none;" align="center">prediction
technology</th>
              <th style="border:none;" align="center">webserver or web site of predictors</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2013</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://karchinlab.org/apps/appVest.html">http://karchinlab.org/apps/appVest.html</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2015</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://provean.jcvi.org/index.php">http://provean.jcvi.org/index.php</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2020</td>
              <td style="border:none;" align="left">Bayes rule</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://precomputed.list-s2.msl.ubc.ca/">https://precomputed.list-s2.msl.ubc.ca/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">graph attention neural network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/ShenLab/gMVP/">https://github.com/ShenLab/gMVP/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2014</td>
              <td style="border:none;" align="left">support vector machine</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ghttps://doi.org/10.1093/hmg/ddu733">https://doi.org/10.1093/hmg/ddu733</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2014</td>
              <td style="border:none;" align="left">logistic regression</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ghttps://doi.org/10.1093/hmg/ddu733">https://doi.org/10.1093/hmg/ddu733</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2016</td>
              <td style="border:none;" align="left">gradient boosting tree</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://bejerano.stanford.edu/MCAP/">http://bejerano.stanford.edu/MCAP/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2017</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://deogen2.mutaframe.com/">https://deogen2.mutaframe.com/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2020</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/">https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2021</td>
              <td style="border:none;" align="left">gradient boosted trees</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://varity.varianteffect.org/">http://varity.varianteffect.org/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">recurrent neural network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.liulab.science/metarnn.html">http://www.liulab.science/metarnn.html</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">deep residual network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/ShenLab/missense">https://github.com/ShenLab/missense</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2023</td>
              <td style="border:none;" align="left">consensus and XGBoost</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2023</td>
              <td style="border:none;" align="left">consensus and XGBoost</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t4fn1">
            <label>a</label>
            <p>Note: EvoIndMM evaluated 4969 mutations
(please refer to the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S13</ext-link> for reasons),
while others evaluated 5958 mutations. MetaSVM uses MetaSVM_rankscore,
MetaRNN uses MetaRNN_rankscore, gMVP uses gMVP_rankscore, VARITY uses
VARITY_R_rankscore, VEST4 uses VEST4_rankscore, DEOGEN2 uses DEOGEN2_rankscore,
LIST_S2 uses LIST_S2_rankscore, M_CAP uses M_CAP_rankscore, MVP uses
MVP_rankscore, MetaLR uses MetaLR_rankscore, PROVEAN uses PROVEAN_converted_rankscore.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Before embarking upon a formal
comparison, we conducted meticulous
checks at two levels as follows. (1) Variation level: We rigorously
examined the variants in the blind test data set and those in the
model training data set, identifying no instances of overlap; (2)
Protein level: our analysis identified that 448 proteins, identified
by ENSP_id, from the blind test data set were also present in the
training data set. Taking into consideration the presence of overlapping
ENSP_ids, we partitioned our findings into two distinct categories
to facilitate a more meticulous comparison. These categories included
comparison results that only encompassed recurring protein ENSP_ids
(depicted in <xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref> and discussed in <xref rid="sec4.3.1" ref-type="other">Section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>), and those devoid of recurring protein ENSP_ids (illustrated
in <xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref> and delineated
in <xref rid="sec4.3.2" ref-type="other">Section <xref rid="sec4.3.2" ref-type="other">4.3.2</xref></xref>). These findings are also cataloged comprehensively in <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>.</p>
      <table-wrap id="tbl5" position="float">
        <label>Table 5</label>
        <caption>
          <title>Performance
Comparison of ConsMM,
EvoIndMM, and Existing Predictors on the Blind Test Set</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">repeated</th>
              <th style="border:none;" align="center">predictor name</th>
              <th style="border:none;" align="center" char=".">recall/sen</th>
              <th style="border:none;" align="center" char=".">Spe</th>
              <th style="border:none;" align="center" char=".">Pre</th>
              <th style="border:none;" align="center" char=".">NPV</th>
              <th style="border:none;" align="center" char=".">F<sub>1</sub></th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">MCC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="14" style="border:none;" align="left">repeated protein (consisting
of 488 proteins
with 2593 variants)</td>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="char" char=".">0.9407</td>
              <td style="border:none;" align="char" char=".">0.7541</td>
              <td style="border:none;" align="char" char=".">0.8256</td>
              <td style="border:none;" align="char" char=".">0.9114</td>
              <td style="border:none;" align="char" char=".">0.8794</td>
              <td style="border:none;" align="char" char=".">0.8573</td>
              <td style="border:none;" align="char" char=".">0.7156</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="char" char=".">0.8159</td>
              <td style="border:none;" align="char" char=".">0.7368</td>
              <td style="border:none;" align="char" char=".">0.7932</td>
              <td style="border:none;" align="char" char=".">0.7639</td>
              <td style="border:none;" align="char" char=".">0.8044</td>
              <td style="border:none;" align="char" char=".">0.7806</td>
              <td style="border:none;" align="char" char=".">0.5549</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="char" char=".">0.8173</td>
              <td style="border:none;" align="char" char=".">0.7170</td>
              <td style="border:none;" align="char" char=".">0.7813</td>
              <td style="border:none;" align="char" char=".">0.7603</td>
              <td style="border:none;" align="char" char=".">0.7989</td>
              <td style="border:none;" align="char" char=".">0.7725</td>
              <td style="border:none;" align="char" char=".">0.5379</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="char" char=".">0.9135</td>
              <td style="border:none;" align="char" char=".">0.6471</td>
              <td style="border:none;" align="char" char=".">0.7621</td>
              <td style="border:none;" align="char" char=".">0.8581</td>
              <td style="border:none;" align="char" char=".">0.8310</td>
              <td style="border:none;" align="char" char=".">0.7944</td>
              <td style="border:none;" align="char" char=".">0.5897</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="char" char=".">0.9407</td>
              <td style="border:none;" align="char" char=".">0.6264</td>
              <td style="border:none;" align="char" char=".">0.7570</td>
              <td style="border:none;" align="char" char=".">0.8952</td>
              <td style="border:none;" align="char" char=".">0.8389</td>
              <td style="border:none;" align="char" char=".">0.8002</td>
              <td style="border:none;" align="char" char=".">0.6082</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="char" char=".">0.9268</td>
              <td style="border:none;" align="char" char=".">0.6264</td>
              <td style="border:none;" align="char" char=".">0.7543</td>
              <td style="border:none;" align="char" char=".">0.8736</td>
              <td style="border:none;" align="char" char=".">0.8317</td>
              <td style="border:none;" align="char" char=".">0.7925</td>
              <td style="border:none;" align="char" char=".">0.5894</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="char" char=".">0.9596</td>
              <td style="border:none;" align="char" char=".">0.8136</td>
              <td style="border:none;" align="char" char=".">0.8643</td>
              <td style="border:none;" align="char" char=".">0.9421</td>
              <td style="border:none;" align="char" char=".">0.9095</td>
              <td style="border:none;" align="char" char=".">0.8943</td>
              <td style="border:none;" align="char" char=".">0.7896</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="char" char=".">0.9191</td>
              <td style="border:none;" align="char" char=".">0.5876</td>
              <td style="border:none;" align="char" char=".">0.7339</td>
              <td style="border:none;" align="char" char=".">0.8545</td>
              <td style="border:none;" align="char" char=".">0.8161</td>
              <td style="border:none;" align="char" char=".">0.7709</td>
              <td style="border:none;" align="char" char=".">0.5460</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="char" char=".">0.8954</td>
              <td style="border:none;" align="char" char=".">0.7843</td>
              <td style="border:none;" align="char" char=".">0.8370</td>
              <td style="border:none;" align="char" char=".">0.8584</td>
              <td style="border:none;" align="char" char=".">0.8652</td>
              <td style="border:none;" align="char" char=".">0.8457</td>
              <td style="border:none;" align="char" char=".">0.6875</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="char" char=".">0.8375</td>
              <td style="border:none;" align="char" char=".">0.7921</td>
              <td style="border:none;" align="char" char=".">0.8329</td>
              <td style="border:none;" align="char" char=".">0.7976</td>
              <td style="border:none;" align="char" char=".">0.8352</td>
              <td style="border:none;" align="char" char=".">0.8172</td>
              <td style="border:none;" align="char" char=".">0.6300</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="char" char=".">0.8961</td>
              <td style="border:none;" align="char" char=".">0.9974</td>
              <td style="border:none;" align="char" char=".">0.9977</td>
              <td style="border:none;" align="char" char=".">0.8858</td>
              <td style="border:none;" align="char" char=".">0.9442</td>
              <td style="border:none;" align="char" char=".">0.9414</td>
              <td style="border:none;" align="char" char=".">0.8885</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="char" char=".">0.9693</td>
              <td style="border:none;" align="char" char=".">0.5789</td>
              <td style="border:none;" align="char" char=".">0.7401</td>
              <td style="border:none;" align="char" char=".">0.9385</td>
              <td style="border:none;" align="char" char=".">0.8394</td>
              <td style="border:none;" align="char" char=".">0.7948</td>
              <td style="border:none;" align="char" char=".">0.6100</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="char" char=".">0.9296</td>
              <td style="border:none;" align="char" char=".">0.8878</td>
              <td style="border:none;" align="char" char=".">0.9111</td>
              <td style="border:none;" align="char" char=".">0.9106</td>
              <td style="border:none;" align="char" char=".">0.9203</td>
              <td style="border:none;" align="char" char=".">0.9109</td>
              <td style="border:none;" align="char" char=".">0.8196</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="char" char=".">0.9150</td>
              <td style="border:none;" align="char" char=".">0.9617</td>
              <td style="border:none;" align="char" char=".">0.9719</td>
              <td style="border:none;" align="char" char=".">0.8866</td>
              <td style="border:none;" align="char" char=".">0.9426</td>
              <td style="border:none;" align="char" char=".">0.9341</td>
              <td style="border:none;" align="char" char=".">0.8675</td>
            </tr>
            <tr>
              <td rowspan="14" style="border:none;" align="left">nonrepeated protein
(consisting of 420 proteins
with 3365 variants)</td>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="char" char=".">0.9539</td>
              <td style="border:none;" align="char" char=".">0.7864</td>
              <td style="border:none;" align="char" char=".">0.8028</td>
              <td style="border:none;" align="char" char=".">0.9492</td>
              <td style="border:none;" align="char" char=".">0.8719</td>
              <td style="border:none;" align="char" char=".">0.8663</td>
              <td style="border:none;" align="char" char=".">0.7461</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="char" char=".">0.8249</td>
              <td style="border:none;" align="char" char=".">0.7625</td>
              <td style="border:none;" align="char" char=".">0.7600</td>
              <td style="border:none;" align="char" char=".">0.8269</td>
              <td style="border:none;" align="char" char=".">0.7912</td>
              <td style="border:none;" align="char" char=".">0.7923</td>
              <td style="border:none;" align="char" char=".">0.5872</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="char" char=".">0.8399</td>
              <td style="border:none;" align="char" char=".">0.6909</td>
              <td style="border:none;" align="char" char=".">0.7125</td>
              <td style="border:none;" align="char" char=".">0.8255</td>
              <td style="border:none;" align="char" char=".">0.7709</td>
              <td style="border:none;" align="char" char=".">0.7620</td>
              <td style="border:none;" align="char" char=".">0.5344</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="char" char=".">0.9221</td>
              <td style="border:none;" align="char" char=".">0.6625</td>
              <td style="border:none;" align="char" char=".">0.7136</td>
              <td style="border:none;" align="char" char=".">0.9032</td>
              <td style="border:none;" align="char" char=".">0.8046</td>
              <td style="border:none;" align="char" char=".">0.7863</td>
              <td style="border:none;" align="char" char=".">0.6005</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="char" char=".">0.9402</td>
              <td style="border:none;" align="char" char=".">0.5807</td>
              <td style="border:none;" align="char" char=".">0.6716</td>
              <td style="border:none;" align="char" char=".">0.9141</td>
              <td style="border:none;" align="char" char=".">0.7835</td>
              <td style="border:none;" align="char" char=".">0.7522</td>
              <td style="border:none;" align="char" char=".">0.5523</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="char" char=".">0.9327</td>
              <td style="border:none;" align="char" char=".">0.6091</td>
              <td style="border:none;" align="char" char=".">0.6851</td>
              <td style="border:none;" align="char" char=".">0.9085</td>
              <td style="border:none;" align="char" char=".">0.7900</td>
              <td style="border:none;" align="char" char=".">0.7634</td>
              <td style="border:none;" align="char" char=".">0.5671</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="char" char=".">0.9483</td>
              <td style="border:none;" align="char" char=".">0.8540</td>
              <td style="border:none;" align="char" char=".">0.8555</td>
              <td style="border:none;" align="char" char=".">0.9477</td>
              <td style="border:none;" align="char" char=".">0.8995</td>
              <td style="border:none;" align="char" char=".">0.8990</td>
              <td style="border:none;" align="char" char=".">0.8027</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="char" char=".">0.9333</td>
              <td style="border:none;" align="char" char=".">0.5608</td>
              <td style="border:none;" align="char" char=".">0.6596</td>
              <td style="border:none;" align="char" char=".">0.9022</td>
              <td style="border:none;" align="char" char=".">0.7730</td>
              <td style="border:none;" align="char" char=".">0.7385</td>
              <td style="border:none;" align="char" char=".">0.5269</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="char" char=".">0.9115</td>
              <td style="border:none;" align="char" char=".">0.8295</td>
              <td style="border:none;" align="char" char=".">0.8298</td>
              <td style="border:none;" align="char" char=".">0.9114</td>
              <td style="border:none;" align="char" char=".">0.8688</td>
              <td style="border:none;" align="char" char=".">0.8686</td>
              <td style="border:none;" align="char" char=".">0.7411</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="char" char=".">0.8704</td>
              <td style="border:none;" align="char" char=".">0.8261</td>
              <td style="border:none;" align="char" char=".">0.8203</td>
              <td style="border:none;" align="char" char=".">0.8748</td>
              <td style="border:none;" align="char" char=".">0.8446</td>
              <td style="border:none;" align="char" char=".">0.8473</td>
              <td style="border:none;" align="char" char=".">0.6959</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="char" char=".">0.9016</td>
              <td style="border:none;" align="char" char=".">0.9972</td>
              <td style="border:none;" align="char" char=".">0.9966</td>
              <td style="border:none;" align="char" char=".">0.9174</td>
              <td style="border:none;" align="char" char=".">0.9467</td>
              <td style="border:none;" align="char" char=".">0.9516</td>
              <td style="border:none;" align="char" char=".">0.9063</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="char" char=".">0.9483</td>
              <td style="border:none;" align="char" char=".">0.5830</td>
              <td style="border:none;" align="char" char=".">0.6746</td>
              <td style="border:none;" align="char" char=".">0.9252</td>
              <td style="border:none;" align="char" char=".">0.7884</td>
              <td style="border:none;" align="char" char=".">0.7572</td>
              <td style="border:none;" align="char" char=".">0.5645</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="char" char=".">0.9283</td>
              <td style="border:none;" align="char" char=".">0.9364</td>
              <td style="border:none;" align="char" char=".">0.9301</td>
              <td style="border:none;" align="char" char=".">0.9348</td>
              <td style="border:none;" align="char" char=".">0.9292</td>
              <td style="border:none;" align="char" char=".">0.9325</td>
              <td style="border:none;" align="char" char=".">0.8648</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="char" char=".">0.9261</td>
              <td style="border:none;" align="char" char=".">0.9840</td>
              <td style="border:none;" align="char" char=".">0.9851</td>
              <td style="border:none;" align="char" char=".">0.9213</td>
              <td style="border:none;" align="char" char=".">0.9547</td>
              <td style="border:none;" align="char" char=".">0.9532</td>
              <td style="border:none;" align="char" char=".">0.9082</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="fig9" position="float">
        <label>Figure 9</label>
        <caption>
          <p>Several evaluation
values of the compared predictors on the blind
test set (with repeated protein with training data) (A) ROC curves,
(B) PR curves, (C) ACC values, (D) MCC values.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0009" id="gr9" position="float"/>
      </fig>
      <fig id="fig10" position="float">
        <label>Figure 10</label>
        <caption>
          <p>Several
evaluation values of the compared predictors on the blind
test set (with nonrepeated protein with training data) (A) ROC curves,
(B) PR curves, (C) ACC values, (D) MCC values.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0010" id="gr10" position="float"/>
      </fig>
      <sec id="sec4.3.1">
        <label>4.3.1</label>
        <title>Comparison Results of Repeated Proteins</title>
        <p>We pursued
an in-depth analysis based on the comparative results
shown in <xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>,
partial information from <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>, as follows:<list list-type="simple"><list-item><p>(1) Integrated versus individual predictors:
Among individual
predictors, VEST4 demonstrated superior performance with an MCC of
0.7156, AUROC of 0.9414, and an AUPR of 0.9484. Meanwhile, among integrated-predictors,
MetaRNN stood out with an MCC of 0.8885, an AUROC of 0.9936, and an
AUPR of 0.9955. Evidently, integrated-predictors (e.g., MetaRNN) that
utilize a combination of multiple predictive factors outperform individual
predictors. The MCC of MetaRNN IS 0.1729 higher than that of VEST4,
indicating that integrated-predictors greatly exceed individual predictors
in terms of correlation between predictions and actual values.</p></list-item><list-item><p>(2) Top predictors based on existing methods:
Based
on the evaluation metrics of MCC, AUROC, and AUPR, the most distinguished
predictor is MetaRNN (with MCC: 0.8885, AUROC: 0.9936, and AUPR: 0.9955).
Following closely, M-CAP demonstrates significant predictive power
with an MCC of 0.7983, an AUROC of 0.9529, and an AUPR of 0.9407.
InMeRF also delivers commendable results, achieving an MCC of 0.7195,
an AUROC of 0.9349, and an AUPR of 0.9289. MetaRNN<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> utilizes 16 different scoring tools such as SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Polyphen2_HDIV and Polyphen2_HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> along with eight conservation scores and allele
frequency information from 1000 Gp3,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and gnomAD.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> It
employs complex recurrent neural networks for prediction, demonstrating
high integration and learning capabilities. M-CAP<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> incorporates nine deleteriousness prediction scores and
seven conservation scores, employing gradient boosting trees for prediction.
This approach can handle diverse data types and exhibits robustness
against noise, leading to improved predictive accuracy. InMeRF<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> employs Rankscores of 34 tools available in
dbNSFP v4.0a,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> including SIFT,,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> SIFT4G,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Polyphen2_HDIV,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> etc. By integration of the strengths of these
tools, enhanced prediction accuracy. Although these predictors employ
different methodologies, they all demonstrate strong integration and
learning capabilities, robustness against noise, and improved prediction
accuracy through the combination of various tools.</p></list-item><list-item><p>(3) Comparison of ConsMM and EvoIndMM with top three
existing predictors: ConsMM has an MCC of 0.8196, AUROC of 0.9777,
and AUPR of 0.9837, while EvoIndMM has an MCC of 0.8675, AUROC of
0.9844, and AUPR of 0.9905. Both demonstrate superior performance
on all three metrics (MCC, AUROC, and AUPR) compared to InMeRF and
M-CAP in the top three predictors but slightly fall short of MetaRNN.
This suggests that ConsMM and EvoIndMM exhibit high performance in
terms of prediction accuracy and correlation with actual results.
Collectively, the three most optimal predictors are ConsMM, EvoIndMM,
and MetaRNN, among all predictors.</p></list-item><list-item><p>(4)
Reasons for superior performance of top three predictors:
Analyzing the terms of “Integrated” and “Prediction
technology” (listed in Table 4), “Features Predictor
used” (listed in Table S6), it is easily seen that MetaRNN,
ConsMM, and EvoIndMM all belong to the category of meta-predictors.
Unlike traditional individual prediction predictors, they integrate
outputs from multiple prediction methods/models to enhance the comprehensiveness
and accuracy of prediction results.</p></list-item></list></p>
        <p>The
superior performances of ConsMM and EvoIndMM can
be attributed to several key factors. First, they were trained on
a newly constructed, large-scale nonredundant data set that encompasses
all known MMs gathered from the entire Ensembl database. Second, consensus
technology bolsters the accuracy and reliability by integrating multiple
prediction methods and annotations. Third, employing the powerful
XGBoost algorithm enables the effective handling of intricate feature
relationships, increasing predictive power and robustness. Lastly,
additional data sources such as EvoIndMM’s use of VEP outputs,
ESM-1b, and ProtT5-XU embeddings further optimize the predictions.
In conclusion, the outstanding performance of ConsMM and EvoIndMM
derives from the synergy of these elements, fully exploiting the outputs
from various tools and advanced machine learning technologies. Their
approaches capture complex relationships within data, enriching information,
and thus enabling accurate and comprehensive predictions of MM pathogenicity.</p>
      </sec>
    </sec>
    <sec id="sec4.3.2">
      <label>4.3.2</label>
      <title>Comparison Results with Nonrepeated Proteins</title>
      <p>Utilizing the results portrayed in <xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref>, partial data from <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>, we executed
a thorough analysis as follows:</p>
      <sec id="sec4.3.2.1">
        <p>(1) Comparative analysis of
evaluation metrics: Similar to the
results depicted in <xref rid="sec4.3.1" ref-type="other">Section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>, VEST4 notably outperformed all other individual predictors,
achieving an MCC of 0.7461, an AUROC of 0.9544, and an AUPR of 0.9488.
Among the existing integrated predictors, MetaRNN, M-CAP, and InMeRF
emerged as the top three performers exhibiting respective MCC, AUROC,
and AUPR scores of 0.9063, 0.9905, 0.9920; 0.8027, 0.9578, 0.9464;
and 0.7411, 0.9416, 0.9303. Notwithstanding, even though ConsMM and
EvoIndMM, positing MCC, AUROC, and AUPR measures of 0.8648, 0.9836,
0.9854 and 0.9082, 0.9852, 0.9902 correspondingly, trailed behind
MetaRNN marginally, they nevertheless surpassed both M-CAP and InMeRF
in terms of performance efficacy.</p>
        <p>(2) Comparative analysis of
performance metric–repeated protein vs nonrepeated protein
group: The performance metrics of VEST4, M-CAP, InMeRF, ConsMM, and
EvoIndMM revealed marginally superior outcomes for the “nonrepeated
protein” group, as demonstrated by the average ACC, MCC, AUROC,
and AUPR scores of 0.9121, 0.8257, 0.9701, and 0.9647 respectively.
In contrast, the corresponding metrics for the “Repeated protein”
group yielded averaged ACC, MCC, AUROC, and AUPR values of 0.8957,
0.8077, 0.9660, and 0.9697. Furthermore, MetaRNN demonstrated unwavering,
top-tier performance across both categories, thereby attesting to
its inherent robustness and capacity for generalization. Within the
confines of the “nonrepeated protein” group, ConsMM
and EvoIndMM surpassed almost all competing predictors (except for
MetaRNN) on evaluated metrics.</p>
        <p>(3) Underlying factors for observed
phenomena: The disparities
in predictive efficacy observed between “Repeated protein”
and “Nonrepeated protein” groups could be attributed
to the following factors. (A) Data distribution variations: A significant
discrepancy in data distribution between these data sets could be
a key factor. It is plausible to presume that different data distributions
exist, with nonrepeated proteins possibly favoring specific predictive
models. Such distinct distributions likely influence a model’s
ability to generalize and forecast accurately. (B) Influence of the
Protein Characteristics: The novel ConsMM and EvoIndMM models leverage
feature embeddings from amino acid mutation sites, acquired via ESM1b
and ProtT5 pretraining, rather than relying on features extracted
from the entire protein sequence. Consequently, these methodologies
demonstrate minimal variation in their predictive performances when
applied to either the “Repeated protein” or “Nonrepeated
protein” group.</p>
        <p>(4) Additional experiment on unsegmented
blind test data: Beyond
the experiments detailed in <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref>, we conducted an additional set of tests. In this experiment, the
blind test data set was evaluated entirely independently, devoid of
any segmentation or group-based analysis (please refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S5 and Tables S8,S9</ext-link> for further details).
An inclusive comparison of these results (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S5 and Tables S8,S9</ext-link>) with those from <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref> indicates that this new performance metrics set typically lies between <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref> results. Across all experiment sets, most
performance metrics of the predictors display insignificant differences.
Herein, for meticulous result comparisons, we persist in employing
the grouped performance metrics as the principal evaluation indicators
for our predictors. This conservative methodology ensures the highest
level of validity and reliability of our experimental outcomes.</p>
      </sec>
    </sec>
  </sec>
  <sec id="sec4.4">
    <label>4.4</label>
    <title>Case Study</title>
    <p>In this section, we analyzed
12 pathogenic GOF or LOF variations
in nine genes (DICER1, PTEN, CDKN2A, TREM2, SCN5A, GABRA1, KCNH2,
KCNQ1, RET) that are associated with diseases. For instance, PTEN
is associated with hereditary cancer syndromes, like Cowden syndrome
and Bannayan-Riley-Ruvalcaba syndrome,<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> while TREM2 is linked to neurodegenerative diseases, such as Alzheimer’s
disease.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> Detailed information about these
variations can be found in <xref rid="tbl6" ref-type="other">Tables <xref rid="tbl6" ref-type="other">6</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S10</ext-link>, and the heatmap
of predictors for the 12 variations is presented in <xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>.</p>
    <fig id="fig11" position="float">
      <label>Figure 11</label>
      <caption>
        <p>Heatmap of predictors
for 12 variations.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0011" id="gr11" position="float"/>
    </fig>
    <table-wrap id="tbl6" position="float">
      <label>Table 6</label>
      <caption>
        <title>Detailed
Information on 12 Pathogenic
GOF/LOF Variations<xref rid="t6fn1" ref-type="table-fn">a</xref></title>
      </caption>
      <table frame="hsides" rules="groups" border="0">
        <colgroup>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
        </colgroup>
        <thead>
          <tr>
            <th style="border:none;" align="center">variations</th>
            <th style="border:none;" align="center">verdict</th>
            <th style="border:none;" align="center">symbol</th>
            <th style="border:none;" align="center">Pfam_dom</th>
            <th style="border:none;" align="center">inheritance</th>
            <th style="border:none;" align="center">cDNA_pos</th>
            <th style="border:none;" align="center">CDS_pos</th>
            <th style="border:none;" align="center">Protein_pos</th>
            <th style="border:none;" align="center">AA</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td style="border:none;" align="left">14_95598904_G/C</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">DICER1</td>
            <td style="border:none;" align="left">PF00270</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">547/10331</td>
            <td style="border:none;" align="left">255/5769</td>
            <td style="border:none;" align="left">85/1922</td>
            <td style="border:none;" align="left">I/M</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_89653846_C/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">PTEN</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1501/9027</td>
            <td style="border:none;" align="left">144/1212</td>
            <td style="border:none;" align="left">48/403</td>
            <td style="border:none;" align="left">N/K</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">9_21971152_T/C</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">CDKN2A</td>
            <td style="border:none;" align="left">PF12796</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">245/880</td>
            <td style="border:none;" align="left">206/504</td>
            <td style="border:none;" align="left">69/167</td>
            <td style="border:none;" align="left">E/G</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">3_38662376_C/T</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">SCN5A</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">763/8504</td>
            <td style="border:none;" align="left">569/6051</td>
            <td style="border:none;" align="left">190/2016</td>
            <td style="border:none;" align="left">R/Q</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">5_161309659_G/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">GABRA1</td>
            <td style="border:none;" align="left">PF02931</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1010/4273</td>
            <td style="border:none;" align="left">655/1371</td>
            <td style="border:none;" align="left">219/456</td>
            <td style="border:none;" align="left">D/N</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">3_38598763_C/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">SCN5A</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">4452/8504</td>
            <td style="border:none;" align="left">4258/6051</td>
            <td style="border:none;" align="left">1420/2016</td>
            <td style="border:none;" align="left">G/R</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">7_150649683_A/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">KCNH2</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1789/4286</td>
            <td style="border:none;" align="left">1387/3480</td>
            <td style="border:none;" align="left">463/1159</td>
            <td style="border:none;" align="left">F/L</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">11_2592576_C/T</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">KCNQ1</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">734/3245</td>
            <td style="border:none;" align="left">626/2031</td>
            <td style="border:none;" align="left">209/676</td>
            <td style="border:none;" align="left">S/F</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">11_2608811_G/T</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">KCNQ1</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">1248/3245</td>
            <td style="border:none;" align="left">1140/2031</td>
            <td style="border:none;" align="left">380/676</td>
            <td style="border:none;" align="left">R/S</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43609061_A/G</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">2049/5659</td>
            <td style="border:none;" align="left">1817/3345</td>
            <td style="border:none;" align="left">606/1114</td>
            <td style="border:none;" align="left">Y/C</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43619231_A/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">PF07714</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">2922/5659</td>
            <td style="border:none;" align="left">2690/3345</td>
            <td style="border:none;" align="left">897/1114</td>
            <td style="border:none;" align="left">R/Q</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43615611_G/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">PF07714</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">3146/5659</td>
            <td style="border:none;" align="left">2914/3345</td>
            <td style="border:none;" align="left">972/1114</td>
            <td style="border:none;" align="left">R/G</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="t6fn1">
          <label>a</label>
          <p>Note: Verdict, Pfam_dom, and Inheritance
information were collected from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://itanlab.shinyapps.io/goflof/">https://itanlab.shinyapps.io/goflof/</uri>. Pfam_dom: protein domains built on sequence similarity and functional
characteristics. Inheritance information includes AD (Autosomal Dominant)
and ADAR (Adenosine Deaminases Acting on RNA). cDNA_pos: cDNA_position,
CDS_pos: CDS_position, Protein_pos: Protein_position, AA: amino acid.
cDNA_position, CDS_position, Protein_position, Amino_acids, and ENSP
information were collected from Ensembl VEP. The variant positions
indicate the amino acid’s position in the protein and the base
pair’s position in the cDNA or coding sequence. Utilizing ENSP
and the Ensembl API enables retrieval of the encoded protein sequence.
Besides, 14_95598904_G/C is in protein ENSP00000437256; 10_89653846_C/A
in ENSP00000361021; 9_21971152_T/C in ENSP00000418915; 3_38662376_C/T
and 3_38598763_C/G in ENSP00000410257; 5_161309659_G/A in ENSP00000393097;
7_150649683_A/G in ENSP00000262186; 11_2592576_C/T and 11_2608811_G/T
in ENSP00000155840; 10_43609061_A/G, 10_43619231_A/G, and 10_43615611_G/A
in ENSP00000347942.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>Among
the variations shown in <xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>, our developed models (ConsMM and EvoIndMM)
generally exhibited superior performance compared to other predictors,
except for the 14_95598904_G/C variation in the DICER1 gene, which
is linked to tumors like childhood multicystic nephroma and pulmonary
cystic lung lesions.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> As indicated in <xref rid="tbl6" ref-type="other">Tables <xref rid="tbl6" ref-type="other">6</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S10</ext-link>, this MM (I to M at the 85th site in ENSP00000437256)
could potentially lead to a loss of function in DICER1. The Essentiality
score<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> for DICER1 is 0.924045225, signifying
its significant role in biological processes and its RVIS score<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> is −1.52, indicating heightened vulnerability
to variations.</p>
    <p>ConsMM and EvoIndMM are developed through extensive
predictions
and annotations derived from multiple individual predictors. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S10</ext-link> provides several indicators suggesting
the benign nature of 14_95598904_G/C. According to these tools, this
variant is predicted as tolerated (0.14, SIFT<sup><xref ref-type="bibr" rid="ref10">10</xref></sup>), benign (0.053, PolyPhen<sup><xref ref-type="bibr" rid="ref2">2</xref></sup>), and neutral
(0.253, Condel<sup><xref ref-type="bibr" rid="ref66">66</xref></sup>), indicating a lack of
significant pathogenic effects. Furthermore, CADD (18.84),<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> REVEL<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> (0.656), LoFtool<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> (0.233), and ExACpLI<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> (1.0) scores suggest a minor impact on pathogenicity and a lower
probability of causing loss of gene function.</p>
    <p>EvoIndMM, incorporates
embeddings from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> capturing
physicochemical properties and evolutionary conservation. Analyzing
the scores in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S10</ext-link>, multiple indicators
point toward minimal alterations in the protein sequence. The IUPRED2<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> score (0.1731) indicates a low tendency for
disorder, while the ANCHOR2<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> score (0.277)
suggests limited binding regions. Besides, the RSA score (0.247) implies
no significant impact on solvent accessibility, and the Zfit score
(−1.063) signifies a minor effect on protein structure and
function. The RSA_class is categorized as “B”, indicating
a minor effect on protein solvent accessibility. Additionally, the
“helix_prob” (0.694), “beta_prob” (0.003),
and “coil_prob” (0.303) values suggest no significant
disruption to the protein’s secondary structure.</p>
  </sec>
  <sec id="sec5">
    <label>5</label>
    <title>Conclusions</title>
    <p>Our study contributes to the understanding of
MM pathogenicity.
In this work, we first constructed a nonredundant MM benchmark data
set and a blind test set that specifically focused on pathogenic GOF/LOF
MM. Then, by utilizing Ensembl VEP v104 and plugins (e.g., dbNSFP
v4.1a), we extracted variant-level, AA-level, individuals’
outputs, and genome-level features for each variation. Additionally,
we collected encoded protein sequences using ENSP identifiers and
Ensembl API, and generated embeddings from ESM-1b and ProtT5-XL-U50
for each mutant site AA. Based on the newly constructed data and extracted
features, we developed the interpretable model group MMPatho, consisting
of ConsMM and EvoIndMM. ConsMM utilized individuals’ outputs
and employed XGBoost with SHAP analyses, achieving outstanding prediction
performance, while EvoIndMM enhanced the model’s predictive
capacity by incorporating evolutionary characteristics derived from
ESM-1b and ProtT5-XL-U50. Extensive comparative experiments demonstrated
the remarkable efficacy of ConsMM and EvoIndMM. Our findings can give
certain contribution to the advancement of MM research and provide
valuable tools and data resources for understanding the functional
implications of variations in genetic disease.</p>
  </sec>
</body>
<back>
  <notes notes-type="data-availability" id="notes-1">
    <title>Data Availability Statement</title>
    <p>For easy access,
we implemented a Web server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>) for MM pathogenicity prediction with reliability index score. Additionally,
we uploaded our newly constructed benchmark data set and blind test
set are available at the data page of our Web server. Also, the source
python code used in this paper is available at MMPatho server and
on GitHub.</p>
  </notes>
  <notes id="notes-3" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jcim.3c00950?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.3c00950</ext-link>.<list id="silist" list-type="simple"><list-item><p>Text S1: The versions
of the databases used in Ensembl
VEP v104; Text S2: The detailed plugins information installed in Ensembl
VEP v104; Text S3: Powerful classification using XGBoost and SHAP-based
feature importance analysis; Text S4: Performance evaluation measures;
Text S5: The detailed introduction and parameter settings of LightGBM;
Text S6: The detailed introduction and parameter settings of XGBoost;
Text S7: The detailed introduction and parameter settings of CatBoost;
Text S8: Performance of ConsMM on the test set of benchmark data set
(not using protein ID as the criteria for training and test data splitting);
Text S9: The 80 features importance in ConsMM; Text S10: Assessing
the contribution of different feature sets (not using protein ID as
the criteria for training and test data splitting); Text S11: The
one hundred-60 features importance in EvoIndMM; Text S12: Output description
for state-of-the-art methods in variant pathogenicity prediction on
blind test set; Text S13: The variation number changes during data
procedure in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A of the manuscript; Figure S1: Comparison of CatBoost, XGBoost,
and LightGBM on the test set of the benchmark data set (not using
protein ID as the criteria for training and test data splitting);
Figure S2: Twelve feature interactions for ConsMM; Figure S3: The
ROC and PR curves of EvoIndMM on the test set of the benchmark data
set (not using protein ID as the criteria for training and test data
splitting); Figure S4: Twelve feature interactions for EvoIndMM; Figure
S5: The ROC and PR curves of the compared predictors on the blind
test set (without splitting the blind test data into “repeated
protein” and “non-repeated protein” groups);
Table S1: The detailed descriptions of the features extracted from
Ensembl VEP and dbNSFP; Table S2: Confusion matrix and three types
of errors of CatBoost, XGBoost, and LightGBM on the test set of benchmark
data set (not using protein ID as the criteria for training and test
data splitting); Table S3: Feature importance in the ConsMM model;
Table S4: Performance comparison of EvoIndMM with different features
on the test set of benchmark data set (not using protein ID as the
criteria for training and test data splitting); Table S5: Top 160
feature importance in the EvoIndMM model; Table S6. Detailed descriptions
of the compared predictors; Table S7: The confusion matrix and three
types of ConsMM, EvoIndMM, and existing predictors on the blind test
set; Table S8: Performance comparison of ConsMM, EvoIndMM, and existing
predictors on the blind test set (without splitting the blind test
data into “repeated protein” and “nonrepeated
protein” groups); Table S9: The confusion matrix and three
types of ConsMM, EvoIndMM, and existing predictors on the blind test
set (without splitting the blind test data into “repeated protein”
and “nonrepeated protein” groups); Table S10: Detailed
information on the 12 variants for case study (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_si_001.pdf">
        <caption>
          <p>ci3c00950_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="COI-statement" id="notes-2">
    <p>The authors
declare no competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work
was supported by the Natural Science Research Start-up
Foundation of Recruiting Talents of Nanjing University of Posts and
Telecommunications (Grant No. NY223062), the National Natural Science
Foundation of China (62372234 and 62072243), the Natural Science Foundation
of Jiangsu (BK20201304), the National Research Council of Thailand
and Mahidol University (N42A660380), and the Specific League Funds
from Mahidol University.</p>
  </ack>
  <glossary id="dl1">
    <def-list>
      <title>Abbreviations</title>
      <def-item>
        <term>CADD</term>
        <def>
          <p>combined annotation-dependent depletion;</p>
        </def>
      </def-item>
      <def-item>
        <term>CatBoost</term>
        <def>
          <p>categorical
boosting;</p>
        </def>
      </def-item>
      <def-item>
        <term>ClinVar</term>
        <def>
          <p>clinical variants;</p>
        </def>
      </def-item>
      <def-item>
        <term>COSMIC</term>
        <def>
          <p>catalogue of somatic mutations
in cancer;</p>
        </def>
      </def-item>
      <def-item>
        <term>ConsMM</term>
        <def>
          <p>consensus MM pathogenic prediction;</p>
        </def>
      </def-item>
      <def-item>
        <term>dbNSFP</term>
        <def>
          <p>database for nonsynonymous SNPs’
functional predictions;</p>
        </def>
      </def-item>
      <def-item>
        <term>dbSNP</term>
        <def>
          <p>single nucleotide polymorphism
database;</p>
        </def>
      </def-item>
      <def-item>
        <term>ENSP</term>
        <def>
          <p>Ensembl
protein;</p>
        </def>
      </def-item>
      <def-item>
        <term>Ensembl VEP</term>
        <def>
          <p>Ensembl variant effect predictor;</p>
        </def>
      </def-item>
      <def-item>
        <term>ESM</term>
        <def>
          <p>evolutionary scale modeling;</p>
        </def>
      </def-item>
      <def-item>
        <term>ExAC</term>
        <def>
          <p>exome aggregation consortium;</p>
        </def>
      </def-item>
      <def-item>
        <term>EvoIndMM</term>
        <def>
          <p>evolutionary
information and
individual outputs for MM pathogenic prediction;</p>
        </def>
      </def-item>
      <def-item>
        <term>GOF/LOF</term>
        <def>
          <p>gain of function, loss of function;</p>
        </def>
      </def-item>
      <def-item>
        <term>gnomAD</term>
        <def>
          <p>genome aggregation
database;</p>
        </def>
      </def-item>
      <def-item>
        <term>HGMD</term>
        <def>
          <p>human
gene mutation database;</p>
        </def>
      </def-item>
      <def-item>
        <term>LightGBM</term>
        <def>
          <p>light gradient boosting machine;</p>
        </def>
      </def-item>
      <def-item>
        <term>PolyPhen-2</term>
        <def>
          <p>polymorphism phenotyping
v2;</p>
        </def>
      </def-item>
      <def-item>
        <term>PROVEAN</term>
        <def>
          <p>protein
variation effect analyzer;</p>
        </def>
      </def-item>
      <def-item>
        <term>ProtTrans</term>
        <def>
          <p>protein transformer;</p>
        </def>
      </def-item>
      <def-item>
        <term>REVEL</term>
        <def>
          <p>rare exome variant ensemble learner;</p>
        </def>
      </def-item>
      <def-item>
        <term>SHAP</term>
        <def>
          <p>Shapley additive explanations;</p>
        </def>
      </def-item>
      <def-item>
        <term>SIFT</term>
        <def>
          <p>sorting intolerant
from tolerant;</p>
        </def>
      </def-item>
      <def-item>
        <term>SwissVar</term>
        <def>
          <p>variants in UniProtKB/Swiss-Prot;</p>
        </def>
      </def-item>
      <def-item>
        <term>VEST4</term>
        <def>
          <p>variant effect scoring tool v4;</p>
        </def>
      </def-item>
      <def-item>
        <term>XGBoost</term>
        <def>
          <p>eXtreme gradient
boosting.</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Tavtigian</surname><given-names>S. V.</given-names></name>; <name><surname>Byrnes</surname><given-names>G. B.</given-names></name>; <name><surname>Goldgar</surname><given-names>D. E.</given-names></name>; <name><surname>Thomas</surname><given-names>A.</given-names></name><article-title>Classification of Rare
Missense Substitutions, using Risk Surfaces, with Genetic-and Molecular-epidemiology
Applications</article-title>. <source>Hum. Mutat.</source><year>2008</year>, <volume>29</volume>, <fpage>1342</fpage>–<lpage>1354</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20896</pub-id>.<pub-id pub-id-type="pmid">18951461</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Adzhubei</surname><given-names>I. A.</given-names></name>; <name><surname>Schmidt</surname><given-names>S.</given-names></name>; <name><surname>Peshkin</surname><given-names>L.</given-names></name>; <name><surname>Ramensky</surname><given-names>V. E.</given-names></name>; <name><surname>Gerasimova</surname><given-names>A.</given-names></name>; <name><surname>Bork</surname><given-names>P.</given-names></name>; <name><surname>Kondrashov</surname><given-names>A. S.</given-names></name>; <name><surname>Sunyaev</surname><given-names>S. R.</given-names></name><article-title>A Method and Server
for Predicting Damaging Missense Mutations</article-title>. <source>Nat. Methods</source><year>2010</year>, <volume>7</volume>, <fpage>248</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Choi</surname><given-names>Y.</given-names></name>; <name><surname>Chan</surname><given-names>A. P.</given-names></name><article-title>PROVEAN
Web Server: a Tool to Predict the Functional
Effect of Amino Acid Substitutions and Indels</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>2745</fpage>–<lpage>2747</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv195</pub-id>.<pub-id pub-id-type="pmid">25851949</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Rentzsch</surname><given-names>P.</given-names></name>; <name><surname>Witten</surname><given-names>D.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Shendure</surname><given-names>J.</given-names></name>; <name><surname>Kircher</surname><given-names>M.</given-names></name><article-title>CADD: Predicting
the Deleteriousness of Variants Throughout the Human Genome</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>, <volume>47</volume>, <fpage>D886</fpage>–<lpage>D894</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1016</pub-id>.<pub-id pub-id-type="pmid">30371827</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Kircher</surname><given-names>M.</given-names></name>; <name><surname>Witten</surname><given-names>D. M.</given-names></name>; <name><surname>Jain</surname><given-names>P.</given-names></name>; <name><surname>O’roak</surname><given-names>B. J.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Shendure</surname><given-names>J.</given-names></name><article-title>A General Framework for Estimating
the Relative Pathogenicity of Human Genetic Variants</article-title>. <source>Nat. Genet.</source><year>2014</year>, <volume>46</volume>, <fpage>310</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2892</pub-id>.<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Carter</surname><given-names>H.</given-names></name>; <name><surname>Douville</surname><given-names>C.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Karchin</surname><given-names>R.</given-names></name><article-title>Identifying
Mendelian Disease Genes with the Variant Effect Scoring Tool</article-title>. <source>BMC Genomics</source><year>2013</year>, <volume>14</volume>, <fpage>S3</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-14-S3-S3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Quan</surname><given-names>L.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Lyu</surname><given-names>Q.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name><article-title>DAMpred: Recognizing Disease-associated
nsSNPs through Bayes-guided Neural-network Model Built on Low-resolution
Structure Prediction of Proteins and Protein-protein Interactions</article-title>. <source>J. Mol. Biol.</source><year>2019</year>, <volume>431</volume>, <fpage>2449</fpage>–<lpage>2459</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2019.02.017</pub-id>.<pub-id pub-id-type="pmid">30796987</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Capriotti</surname><given-names>E.</given-names></name>; <name><surname>Ozturk</surname><given-names>K.</given-names></name>; <name><surname>Carter</surname><given-names>H.</given-names></name><article-title>Integrating Molecular
Networks with
Genetic Variant Interpretation for Precision Medicine</article-title>. <source>Wiley Interdiscip. Rev. Syst. Biol. Med.</source><year>2019</year>, <volume>11</volume>, <elocation-id>e1443</elocation-id><pub-id pub-id-type="doi">10.1002/wsbm.1443</pub-id>.<pub-id pub-id-type="pmid">30548534</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Hassan</surname><given-names>M. S.</given-names></name>; <name><surname>Shaalan</surname><given-names>A. A.</given-names></name>; <name><surname>Dessouky</surname><given-names>M. I.</given-names></name>; <name><surname>Abdelnaiem</surname><given-names>A. E.</given-names></name>; <name><surname>ElHefnawi</surname><given-names>M.</given-names></name><article-title>A Review Study: Computational Techniques for Expecting
the Impact of Non-synonymous Single Nucleotide Variants in Human Diseases</article-title>. <source>Gene</source><year>2019</year>, <volume>680</volume>, <fpage>20</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2018.09.028</pub-id>.<pub-id pub-id-type="pmid">30240882</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Ng</surname><given-names>P. C.</given-names></name>; <name><surname>Henikoff</surname><given-names>S.</given-names></name><article-title>SIFT: Predicting
Amino Acid Changes that Affect Protein
Function</article-title>. <source>Nucleic Acids Res.</source><year>2003</year>, <volume>31</volume>, <fpage>3812</fpage>–<lpage>3814</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Quang</surname><given-names>D.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>DanQ: a Hybrid Convolutional
and Recurrent Deep Neural Network for
Quantifying the Function of DNA Sequences</article-title>. <source>Nucleic
Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>e107</fpage><pub-id pub-id-type="doi">10.1093/nar/gkw226</pub-id>.<pub-id pub-id-type="pmid">27084946</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Jagadeesh</surname><given-names>K. A.</given-names></name>; <name><surname>Wenger</surname><given-names>A. M.</given-names></name>; <name><surname>Berger</surname><given-names>M. J.</given-names></name>; <name><surname>Guturu</surname><given-names>H.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Bernstein</surname><given-names>J. A.</given-names></name>; <name><surname>Bejerano</surname><given-names>G.</given-names></name><article-title>M-CAP Eliminates a
Majority of Variants of Uncertain Significance in Clinical Exomes
at High Sensitivity</article-title>. <source>Nat. Genet.</source><year>2016</year>, <volume>48</volume>, <fpage>1581</fpage>–<lpage>1586</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3703</pub-id>.<pub-id pub-id-type="pmid">27776117</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Bendl</surname><given-names>J.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Salanda</surname><given-names>O.</given-names></name>; <name><surname>Pavelka</surname><given-names>A.</given-names></name>; <name><surname>Wieben</surname><given-names>E. D.</given-names></name>; <name><surname>Zendulka</surname><given-names>J.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>PredictSNP:
Robust and Accurate Consensus Classifier for Prediction of Disease-related
Mutations</article-title>. <source>PLoS Comput. Biol.</source><year>2014</year>, <volume>10</volume>, <elocation-id>e1003440</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003440</pub-id>.<pub-id pub-id-type="pmid">24453961</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Landrum</surname><given-names>M. J.</given-names></name>; <name><surname>Lee</surname><given-names>J. M.</given-names></name>; <name><surname>Riley</surname><given-names>G. R.</given-names></name>; <name><surname>Jang</surname><given-names>W.</given-names></name>; <name><surname>Rubinstein</surname><given-names>W. S.</given-names></name>; <name><surname>Church</surname><given-names>D. M.</given-names></name>; <name><surname>Maglott</surname><given-names>D. R.</given-names></name><article-title>ClinVar:
Public Archive of Relationships
among Sequence Variation and Human Phenotype</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>, <volume>42</volume>, <fpage>D980</fpage>–<lpage>D985</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1113</pub-id>.<pub-id pub-id-type="pmid">24234437</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Sherry</surname><given-names>S. T.</given-names></name>; <name><surname>Ward</surname><given-names>M.-H.</given-names></name>; <name><surname>Kholodov</surname><given-names>M.</given-names></name>; <name><surname>Baker</surname><given-names>J.</given-names></name>; <name><surname>Phan</surname><given-names>L.</given-names></name>; <name><surname>Smigielski</surname><given-names>E. M.</given-names></name>; <name><surname>Sirotkin</surname><given-names>K.</given-names></name><article-title>dbSNP: the NCBI Database of Genetic
Variation</article-title>. <source>Nucleic Acids Res.</source><year>2001</year>, <volume>29</volume>, <fpage>308</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id>.<pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Rives</surname><given-names>A.</given-names></name>; <name><surname>Meier</surname><given-names>J.</given-names></name>; <name><surname>Sercu</surname><given-names>T.</given-names></name>; <name><surname>Goyal</surname><given-names>S.</given-names></name>; <name><surname>Lin</surname><given-names>Z.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>D.</given-names></name>; <name><surname>Ott</surname><given-names>M.</given-names></name>; <name><surname>Zitnick</surname><given-names>C. L.</given-names></name>; <name><surname>Ma</surname><given-names>J.</given-names></name>; <name><surname>Fergus</surname><given-names>R.</given-names></name><article-title>Biological Structure
and Function Emerge from Scaling
Unsupervised Learning to 250 Million Protein Sequences</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2021</year>, <volume>118</volume>, <elocation-id>e2016239118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2016239118</pub-id>.<pub-id pub-id-type="pmid">33876751</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Elnaggar</surname><given-names>A.</given-names></name>; <name><surname>Heinzinger</surname><given-names>M.</given-names></name>; <name><surname>Dallago</surname><given-names>C.</given-names></name>; <name><surname>Rehawi</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Jones</surname><given-names>L.</given-names></name>; <name><surname>Gibbs</surname><given-names>T.</given-names></name>; <name><surname>Feher</surname><given-names>T.</given-names></name>; <name><surname>Angerer</surname><given-names>C.</given-names></name>; <name><surname>Steinegger</surname><given-names>M.</given-names></name><article-title>Prottrans: Toward Understanding the Language of Life
through Self-supervised Learning</article-title>. <source>ITPAM</source><year>2021</year>, <volume>44</volume>, <fpage>7112</fpage>–<lpage>7127</lpage>.</mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Mou</surname><given-names>C.</given-names></name>; <name><surname>Dong</surname><given-names>Y.</given-names></name>; <name><surname>Tu</surname><given-names>Y.</given-names></name><article-title>dbNSFP v4: a Comprehensive
Database of Transcript-specific Functional Predictions and Annotations
for Human Nonsynonymous and Splice-site SNVs</article-title>. <source>Genome Med.</source><year>2020</year>, <volume>12</volume>, <fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1186/s13073-020-00803-9</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Jian</surname><given-names>X.</given-names></name>; <name><surname>Boerwinkle</surname><given-names>E.</given-names></name><article-title>dbNSFP: a
Lightweight Database of
Human Nonsynonymous SNPs and Their Functional Predictions</article-title>. <source>Hum. Mutat.</source><year>2011</year>, <volume>32</volume>, <fpage>894</fpage>–<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21517</pub-id>.<pub-id pub-id-type="pmid">21520341</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Dallago</surname><given-names>C.</given-names></name>; <name><surname>Schütze</surname><given-names>K.</given-names></name>; <name><surname>Heinzinger</surname><given-names>M.</given-names></name>; <name><surname>Olenyi</surname><given-names>T.</given-names></name>; <name><surname>Littmann</surname><given-names>M.</given-names></name>; <name><surname>Lu</surname><given-names>A. X.</given-names></name>; <name><surname>Yang</surname><given-names>K. K.</given-names></name>; <name><surname>Min</surname><given-names>S.</given-names></name>; <name><surname>Yoon</surname><given-names>S.</given-names></name>; <name><surname>Morton</surname><given-names>J. T.</given-names></name>; <name><surname>Rost</surname><given-names>B.</given-names></name><article-title>Learned Embeddings from Deep Learning
to Visualize and Predict Protein Sets</article-title>. <source>Curr.
Protoc.</source><year>2021</year>, <volume>1</volume>, <elocation-id>e113</elocation-id><pub-id pub-id-type="doi">10.1002/cpz1.113</pub-id>.<pub-id pub-id-type="pmid">33961736</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>Francioli</surname><given-names>L. C.</given-names></name>; <name><surname>Tiao</surname><given-names>G.</given-names></name>; <name><surname>Cummings</surname><given-names>B. B.</given-names></name>; <name><surname>Alföldi</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Collins</surname><given-names>R. L.</given-names></name>; <name><surname>Laricchia</surname><given-names>K. M.</given-names></name>; <name><surname>Ganna</surname><given-names>A.</given-names></name>; <name><surname>Birnbaum</surname><given-names>D. P.</given-names></name>; et al. <article-title>The Mutational Constraint
Spectrum Quantified from Variation in 141,456 Humans</article-title>. <source>Nature</source><year>2020</year>, <volume>581</volume>, <fpage>434</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id>.<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><article-title>UniProt: the Universal
Protein Knowledgebase in 2023</article-title>. <source>Nucleic Acids
Res.</source><year>2023</year>, <volume>51</volume>, <fpage>D523</fpage>–<lpage>D531</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac1052</pub-id>.<pub-id pub-id-type="pmid">36408920</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Lek</surname><given-names>M.</given-names></name>; <name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>Minikel</surname><given-names>E. V.</given-names></name>; <name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Banks</surname><given-names>E.</given-names></name>; <name><surname>Fennell</surname><given-names>T.</given-names></name>; <name><surname>O’Donnell-Luria</surname><given-names>A. H.</given-names></name>; <name><surname>Ware</surname><given-names>J. S.</given-names></name>; <name><surname>Hill</surname><given-names>A. J.</given-names></name>; <name><surname>Cummings</surname><given-names>B. B.</given-names></name>; et al. <article-title>Analysis of Protein-coding
Genetic Variation in 60,706 Humans</article-title>. <source>Nature</source><year>2016</year>, <volume>536</volume>, <fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nature19057</pub-id>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Forbes</surname><given-names>S. A.</given-names></name>; <name><surname>Bindal</surname><given-names>N.</given-names></name>; <name><surname>Bamford</surname><given-names>S.</given-names></name>; <name><surname>Cole</surname><given-names>C.</given-names></name>; <name><surname>Kok</surname><given-names>C. Y.</given-names></name>; <name><surname>Beare</surname><given-names>D.</given-names></name>; <name><surname>Jia</surname><given-names>M.</given-names></name>; <name><surname>Shepherd</surname><given-names>R.</given-names></name>; <name><surname>Leung</surname><given-names>K.</given-names></name>; <name><surname>Menzies</surname><given-names>A.</given-names></name>; et al. <article-title>COSMIC: Mining Complete
Cancer Genomes in the Catalogue
of Somatic Mutations in Cancer</article-title>. <source>Nucleic Acids
Res.</source><year>2011</year>, <volume>39</volume>, <fpage>D945</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq929</pub-id>.<pub-id pub-id-type="pmid">20952405</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Sevim
Bayrak</surname><given-names>C.</given-names></name>; <name><surname>Stein</surname><given-names>D.</given-names></name>; <name><surname>Jain</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Nadkarni</surname><given-names>G. N.</given-names></name>; <name><surname>Van Vleck</surname><given-names>T. T.</given-names></name>; <name><surname>Puel</surname><given-names>A.</given-names></name>; <name><surname>Boisson-Dupuis</surname><given-names>S.</given-names></name>; <name><surname>Okada</surname><given-names>S.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; et al. <article-title>Identification of Discriminative
Gene-level and Protein-level Features Associated with Pathogenic Gain-of-function
and Loss-of-function Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2021</year>, <volume>108</volume>, <fpage>2301</fpage>–<lpage>2318</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2021.10.007</pub-id>.<pub-id pub-id-type="pmid">34762822</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>McLaren</surname><given-names>W.</given-names></name>; <name><surname>Gil</surname><given-names>L.</given-names></name>; <name><surname>Hunt</surname><given-names>S. E.</given-names></name>; <name><surname>Riat</surname><given-names>H. S.</given-names></name>; <name><surname>Ritchie</surname><given-names>G. R.</given-names></name>; <name><surname>Thormann</surname><given-names>A.</given-names></name>; <name><surname>Flicek</surname><given-names>P.</given-names></name>; <name><surname>Cunningham</surname><given-names>F.</given-names></name><article-title>The Ensembl Variant Effect Predictor</article-title>. <source>Genome Biol.</source><year>2016</year>, <volume>17</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id>.<pub-id pub-id-type="pmid">26753840</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Henikoff</surname><given-names>S.</given-names></name>; <name><surname>Henikoff</surname><given-names>J. G.</given-names></name><article-title>Amino Acid Substitution
Matrices from Protein Blocks</article-title>. <source>Proc. Natl. Acad.
Sci. U.S.A.</source><year>1992</year>, <volume>89</volume>, <fpage>10915</fpage>–<lpage>10919</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.22.10915</pub-id>.<pub-id pub-id-type="pmid">1438297</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Barker</surname><given-names>G. L.</given-names></name>; <name><surname>Edwards</surname><given-names>K. J.</given-names></name>; <name><surname>Day</surname><given-names>I. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name><article-title>Predicting the Functional,
Molecular, and Phenotypic Consequences of Amino Acid Substitutions
using Hidden Markov Models</article-title>. <source>Hum. Mutat.</source><year>2013</year>, <volume>34</volume>, <fpage>57</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22225</pub-id>.<pub-id pub-id-type="pmid">23033316</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Quang</surname><given-names>D.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>DANN: a Deep
Learning Approach for
Annotating the Pathogenicity of Genetic Variants</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>761</fpage>–<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu703</pub-id>.<pub-id pub-id-type="pmid">25338716</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Ionita-Laza</surname><given-names>I.</given-names></name>; <name><surname>McCallum</surname><given-names>K.</given-names></name>; <name><surname>Xu</surname><given-names>B.</given-names></name>; <name><surname>Buxbaum</surname><given-names>J. D.</given-names></name><article-title>A Spectral
Approach
Integrating Functional Genomic Annotations for Coding and Noncoding
Variants</article-title>. <source>Nat. Genet.</source><year>2016</year>, <volume>48</volume>, <fpage>214</fpage><pub-id pub-id-type="doi">10.1038/ng.3477</pub-id>.<pub-id pub-id-type="pmid">26727659</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Ioannidis</surname><given-names>N. M.</given-names></name>; <name><surname>Rothstein</surname><given-names>J. H.</given-names></name>; <name><surname>Pejaver</surname><given-names>V.</given-names></name>; <name><surname>Middha</surname><given-names>S.</given-names></name>; <name><surname>McDonnell</surname><given-names>S. K.</given-names></name>; <name><surname>Baheti</surname><given-names>S.</given-names></name>; <name><surname>Musolf</surname><given-names>A.</given-names></name>; <name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>Holzinger</surname><given-names>E.</given-names></name>; <name><surname>Karyadi</surname><given-names>D.</given-names></name>; et al. <article-title>REVEL: An Ensemble Method for Predicting the Pathogenicity
of Rare Missense Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2016</year>, <volume>99</volume>, <fpage>877</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.08.016</pub-id>.<pub-id pub-id-type="pmid">27666373</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Sundaram</surname><given-names>L.</given-names></name>; <name><surname>Gao</surname><given-names>H.</given-names></name>; <name><surname>Padigepati</surname><given-names>S. R.</given-names></name>; <name><surname>McRae</surname><given-names>J. F.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Kosmicki</surname><given-names>J. A.</given-names></name>; <name><surname>Fritzilas</surname><given-names>N.</given-names></name>; <name><surname>Hakenberg</surname><given-names>J.</given-names></name>; <name><surname>Dutta</surname><given-names>A.</given-names></name>; <name><surname>Shon</surname><given-names>J.</given-names></name>; et al. <article-title>Predicting
the Clinical
Impact of Human Mutation with Deep Neural Networks</article-title>. <source>Nat. Genet.</source><year>2018</year>, <volume>50</volume>, <fpage>1161</fpage>–<lpage>1170</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0167-z</pub-id>.<pub-id pub-id-type="pmid">30038395</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Feng</surname><given-names>B. J.</given-names></name><article-title>PERCH:
a Unified Framework for Disease Gene Prioritization</article-title>. <source>Hum. Mutat.</source><year>2017</year>, <volume>38</volume>, <fpage>243</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23158</pub-id>.<pub-id pub-id-type="pmid">27995669</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Alirezaie</surname><given-names>N.</given-names></name>; <name><surname>Kernohan</surname><given-names>K. D.</given-names></name>; <name><surname>Hartley</surname><given-names>T.</given-names></name>; <name><surname>Majewski</surname><given-names>J.</given-names></name>; <name><surname>Hocking</surname><given-names>T. D.</given-names></name><article-title>ClinPred:
Prediction Tool to Identify Disease-relevant Nonsynonymous Single-nucleotide
Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2018</year>, <volume>103</volume>, <fpage>474</fpage>–<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2018.08.005</pub-id>.<pub-id pub-id-type="pmid">30220433</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Davydov</surname><given-names>E. V.</given-names></name>; <name><surname>Goode</surname><given-names>D. L.</given-names></name>; <name><surname>Sirota</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Sidow</surname><given-names>A.</given-names></name>; <name><surname>Batzoglou</surname><given-names>S.</given-names></name><article-title>Identifying
a High Fraction of the Human Genome to
be Under Selective Constraint using GERP++</article-title>. <source>PLoS Comput. Biol.</source><year>2010</year>, <volume>6</volume>, <elocation-id>e1001025</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1001025</pub-id>.<pub-id pub-id-type="pmid">21152010</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Chen</surname><given-names>Y.-C.</given-names></name><article-title>A Tutorial
on Kernel Density Estimation and Recent Advances</article-title>. <source>Biostatistics Epidemiol.</source><year>2017</year>, <volume>1</volume>, <fpage>161</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1080/24709360.2017.1396742</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Rogers</surname><given-names>M. F.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Day</surname><given-names>I. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name>; <name><surname>Campbell</surname><given-names>C.</given-names></name><article-title>An Integrative
Approach
to Predicting the Functional Effects of Non-coding and Coding Sequence
Variation</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>1536</fpage>–<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv009</pub-id>.<pub-id pub-id-type="pmid">25583119</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Rogers</surname><given-names>M. F.</given-names></name>; <name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name>; <name><surname>Campbell</surname><given-names>C.</given-names></name><article-title>FATHMM-XF: Accurate
Prediction of Pathogenic Point
Mutations via Extended Features</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>511</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx536</pub-id>.<pub-id pub-id-type="pmid">28968714</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Gulko</surname><given-names>B.</given-names></name>; <name><surname>Hubisz</surname><given-names>M. J.</given-names></name>; <name><surname>Gronau</surname><given-names>I.</given-names></name>; <name><surname>Siepel</surname><given-names>A.</given-names></name><article-title>A Method for Calculating
Probabilities of Fitness Consequences for Point Mutations Across the
Human Genome</article-title>. <source>Nat. Genet.</source><year>2015</year>, <volume>47</volume>, <fpage>276</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3196</pub-id>.<pub-id pub-id-type="pmid">25599402</pub-id></mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Lu</surname><given-names>Q.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Sun</surname><given-names>J.</given-names></name>; <name><surname>Cheng</surname><given-names>Y.</given-names></name>; <name><surname>Cheung</surname><given-names>K.-H.</given-names></name>; <name><surname>Zhao</surname><given-names>H.</given-names></name><article-title>A Statistical
Framework to Predict Functional Non-coding Regions in the Human Genome
through Integrated Analysis of Annotation Data</article-title>. <source>Sci. Rep.</source><year>2015</year>, <volume>5</volume>, <elocation-id>10576</elocation-id><pub-id pub-id-type="doi">10.1038/srep10576</pub-id>.<pub-id pub-id-type="pmid">26015273</pub-id></mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Chun</surname><given-names>S.</given-names></name>; <name><surname>Fay</surname><given-names>J. C.</given-names></name><article-title>Identification of
Deleterious Mutations within Three
Human Genomes</article-title>. <source>Genome Res.</source><year>2009</year>, <volume>19</volume>, <fpage>1553</fpage>–<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.1101/gr.092619.109</pub-id>.<pub-id pub-id-type="pmid">19602639</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Kosmicki</surname><given-names>J. A.</given-names></name>; <name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>O’Donnell-Luria</surname><given-names>A. H.</given-names></name>; <name><surname>Pierce-Hoffman</surname><given-names>E.</given-names></name>; <name><surname>MacArthur</surname><given-names>D. G.</given-names></name>; <name><surname>Neale</surname><given-names>B. M.</given-names></name>; <name><surname>Daly</surname><given-names>M. J.</given-names></name><article-title>Regional
Missense Constraint Improves Variant Deleteriousness Prediction</article-title>. <source>BioRxiv.</source><year>2017</year>, <elocation-id>148353</elocation-id><pub-id pub-id-type="doi">10.1101/148353</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Pejaver</surname><given-names>V.</given-names></name>; <name><surname>Urresti</surname><given-names>J.</given-names></name>; <name><surname>Lugo-Martinez</surname><given-names>J.</given-names></name>; <name><surname>Pagel</surname><given-names>K. A.</given-names></name>; <name><surname>Lin</surname><given-names>G. N.</given-names></name>; <name><surname>Nam</surname><given-names>H.-J.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Sebat</surname><given-names>J.</given-names></name>; <name><surname>Iakoucheva</surname><given-names>L. M.</given-names></name>; et al. <article-title>Inferring the Molecular and Phenotypic Impact
of Amino Acid Variants with MutPred2</article-title>. <source>Nat. Commun.</source><year>2020</year>, <volume>11</volume>, <elocation-id>5918</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19669-x</pub-id>.<pub-id pub-id-type="pmid">33219223</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Schwarz</surname><given-names>J. M.</given-names></name>; <name><surname>Rödelsperger</surname><given-names>C.</given-names></name>; <name><surname>Schuelke</surname><given-names>M.</given-names></name>; <name><surname>Seelow</surname><given-names>D.</given-names></name><article-title>MutationTaster Evaluates
Disease-causing Potential of Sequence Alterations</article-title>. <source>Nat. Methods</source><year>2010</year>, <volume>7</volume>, <fpage>575</fpage><pub-id pub-id-type="doi">10.1038/nmeth0810-575</pub-id>.<pub-id pub-id-type="pmid">20676075</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Reva</surname><given-names>B.</given-names></name>; <name><surname>Antipin</surname><given-names>Y.</given-names></name>; <name><surname>Sander</surname><given-names>C.</given-names></name><article-title>Predicting
the Functional Impact
of Protein Mutations: Application to Cancer Genomics</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>, <volume>39</volume>, <fpage>e118</fpage><pub-id pub-id-type="doi">10.1093/nar/gkr407</pub-id>.<pub-id pub-id-type="pmid">21727090</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Vaser</surname><given-names>R.</given-names></name>; <name><surname>Adusumalli</surname><given-names>S.</given-names></name>; <name><surname>Leng</surname><given-names>S. N.</given-names></name>; <name><surname>Sikic</surname><given-names>M.</given-names></name>; <name><surname>Ng</surname><given-names>P. C.</given-names></name><article-title>SIFT Missense
Predictions for Genomes</article-title>. <source>Nat. Protoc.</source><year>2016</year>, <volume>11</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.1038/nprot.2015.123</pub-id>.<pub-id pub-id-type="pmid">26633127</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Pollard</surname><given-names>K. S.</given-names></name>; <name><surname>Hubisz</surname><given-names>M. J.</given-names></name>; <name><surname>Rosenbloom</surname><given-names>K. R.</given-names></name>; <name><surname>Siepel</surname><given-names>A.</given-names></name><article-title>Detection of Nonneutral
Substitution Rates on Mammalian Phylogenies</article-title>. <source>Genome Res.</source><year>2010</year>, <volume>20</volume>, <fpage>110</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1101/gr.097857.109</pub-id>.<pub-id pub-id-type="pmid">19858363</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Garber</surname><given-names>M.</given-names></name>; <name><surname>Guttman</surname><given-names>M.</given-names></name>; <name><surname>Clamp</surname><given-names>M.</given-names></name>; <name><surname>Zody</surname><given-names>M. C.</given-names></name>; <name><surname>Friedman</surname><given-names>N.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>Identifying Novel Constrained Elements by Exploiting biased Substitution
Patterns</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>i54</fpage>–<lpage>i62</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp190</pub-id>.<pub-id pub-id-type="pmid">19478016</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Consortium</surname><given-names>G. P.</given-names></name><article-title>A Map of
Human Genome Variation from Population Scale Sequencing</article-title>. <source>Nature</source><year>2010</year>, <volume>467</volume>, <fpage>1061</fpage><pub-id pub-id-type="doi">10.1038/nature09534</pub-id>.<pub-id pub-id-type="pmid">20981092</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="conf-proc" id="cit50"><person-group person-group-type="allauthors"><name><surname>Lundberg</surname><given-names>S. M.</given-names></name>; <name><surname>Lee</surname><given-names>S.-I.</given-names></name></person-group><article-title>A Unified Approach
to Interpreting Model Predictions</article-title>. In <source>Advances
in Neural Information Processing Systems</source><year>2017</year>30 p <fpage>4765</fpage>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Grimm</surname><given-names>D. G.</given-names></name>; <name><surname>Azencott</surname><given-names>C. A.</given-names></name>; <name><surname>Aicheler</surname><given-names>F.</given-names></name>; <name><surname>Gieraths</surname><given-names>U.</given-names></name>; <name><surname>MacArthur</surname><given-names>D. G.</given-names></name>; <name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Daly</surname><given-names>M. J.</given-names></name>; <name><surname>Smoller</surname><given-names>J. W.</given-names></name>; et al. <article-title>The
Evaluation of Tools used to Predict the
Impact of Missense Variants is Hindered by Two Types of Circularity</article-title>. <source>Hum. Mutat.</source><year>2015</year>, <volume>36</volume>, <fpage>513</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22768</pub-id>.<pub-id pub-id-type="pmid">25684150</pub-id></mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Pedregosa</surname><given-names>F.</given-names></name>; <name><surname>Varoquaux</surname><given-names>G.</given-names></name>; <name><surname>Gramfort</surname><given-names>A.</given-names></name>; <name><surname>Michel</surname><given-names>V.</given-names></name>; <name><surname>Thirion</surname><given-names>B.</given-names></name>; <name><surname>Grisel</surname><given-names>O.</given-names></name>; <name><surname>Blondel</surname><given-names>M.</given-names></name>; <name><surname>Prettenhofer</surname><given-names>P.</given-names></name>; <name><surname>Weiss</surname><given-names>R.</given-names></name>; <name><surname>Dubourg</surname><given-names>V.</given-names></name><article-title>Scikit-learn:
Machine Learning in
Python</article-title>. <source>J. Mach. Learn. Res.</source><year>2011</year>, <volume>12</volume>, <fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Malhis</surname><given-names>N.</given-names></name>; <name><surname>Jacobson</surname><given-names>M.</given-names></name>; <name><surname>Jones</surname><given-names>S. J.</given-names></name>; <name><surname>Gsponer</surname><given-names>J.</given-names></name><article-title>LIST-S2: Taxonomy
based
Sorting of Deleterious Missense Mutations across Species</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>, <volume>48</volume>, <fpage>W154</fpage>–<lpage>W161</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa288</pub-id>.<pub-id pub-id-type="pmid">32352516</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>M. S.</given-names></name>; <name><surname>Fan</surname><given-names>X.</given-names></name>; <name><surname>Chung</surname><given-names>W. K.</given-names></name>; <name><surname>Shen</surname><given-names>Y.</given-names></name><article-title>Predicting
Functional Effect of Missense Variants using Graph Attention Neural
Networks</article-title>. <source>Nat. Mach. Intell.</source><year>2022</year>, <volume>4</volume>, <fpage>1017</fpage>–<lpage>1028</lpage>. <pub-id pub-id-type="doi">10.1038/s42256-022-00561-w</pub-id>.<pub-id pub-id-type="pmid">37484202</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Dong</surname><given-names>C.</given-names></name>; <name><surname>Wei</surname><given-names>P.</given-names></name>; <name><surname>Jian</surname><given-names>X.</given-names></name>; <name><surname>Gibbs</surname><given-names>R.</given-names></name>; <name><surname>Boerwinkle</surname><given-names>E.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name><article-title>Comparison
and Integration of Deleteriousness
Prediction Methods for Nonsynonymous SNVs in Whole Exome Sequencing
Studies</article-title>. <source>Hum. Mol. Genet.</source><year>2015</year>, <volume>24</volume>, <fpage>2125</fpage>–<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu733</pub-id>.<pub-id pub-id-type="pmid">25552646</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Raimondi</surname><given-names>D.</given-names></name>; <name><surname>Tanyalcin</surname><given-names>I.</given-names></name>; <name><surname>Ferté</surname><given-names>J.</given-names></name>; <name><surname>Gazzo</surname><given-names>A.</given-names></name>; <name><surname>Orlando</surname><given-names>G.</given-names></name>; <name><surname>Lenaerts</surname><given-names>T.</given-names></name>; <name><surname>Rooman</surname><given-names>M.</given-names></name>; <name><surname>Vranken</surname><given-names>W.</given-names></name><article-title>DEOGEN2: Prediction
and Interactive Visualization of Single Amino Acid Variant Deleteriousness
in Human Proteins</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>W201</fpage>–<lpage>W206</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx390</pub-id>.<pub-id pub-id-type="pmid">28498993</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Takeda</surname><given-names>J.-i.</given-names></name>; <name><surname>Nanatsue</surname><given-names>K.</given-names></name>; <name><surname>Yamagishi</surname><given-names>R.</given-names></name>; <name><surname>Ito</surname><given-names>M.</given-names></name>; <name><surname>Haga</surname><given-names>N.</given-names></name>; <name><surname>Hirata</surname><given-names>H.</given-names></name>; <name><surname>Ogi</surname><given-names>T.</given-names></name>; <name><surname>Ohno</surname><given-names>K.</given-names></name><article-title>InMeRF: Prediction
of Pathogenicity of Missense Variants by Individual Modeling for Each
Amino Acid Substitution</article-title>. <source>NAR Genomics Bioinf.</source><year>2020</year>, <volume>2</volume>, <elocation-id>lqaa038</elocation-id><pub-id pub-id-type="doi">10.1093/nargab/lqaa038</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Sun</surname><given-names>S.</given-names></name>; <name><surname>Weile</surname><given-names>J.</given-names></name>; <name><surname>Roth</surname><given-names>F. P.</given-names></name><article-title>Improved
Pathogenicity Prediction for Rare Human Missense Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2021</year>, <volume>108</volume>, <fpage>1891</fpage>–<lpage>1906</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2021.08.012</pub-id>.<pub-id pub-id-type="pmid">34551312</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Zhi</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name><article-title>MetaRNN: Differentiating
Rare Pathogenic
and Rare Benign Missense SNVs and InDels using Deep Learning</article-title>. <source>Genome Med.</source><year>2022</year>, <volume>14</volume>, <fpage>115</fpage><pub-id pub-id-type="doi">10.1186/s13073-022-01120-z</pub-id>.<pub-id pub-id-type="pmid">36209109</pub-id></mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Qi</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>C.</given-names></name>; <name><surname>Long</surname><given-names>J. J.</given-names></name>; <name><surname>Chung</surname><given-names>W. K.</given-names></name>; <name><surname>Guan</surname><given-names>Y.</given-names></name>; <name><surname>Shen</surname><given-names>Y.</given-names></name><article-title>MVP Predicts the Pathogenicity
of Missense Variants by Deep Learning</article-title>. <source>Nat.
Commun.</source><year>2021</year>, <volume>12</volume>, <elocation-id>510</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20847-0</pub-id>.<pub-id pub-id-type="pmid">33479230</pub-id></mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Ngeow</surname><given-names>J.</given-names></name>; <name><surname>Sesock</surname><given-names>K.</given-names></name>; <name><surname>Eng</surname><given-names>C.</given-names></name><article-title>Clinical Implications
for Germline
PTEN Spectrum Disorders</article-title>. <source>Endocrinol. Metab.
Clin. North Am.</source><year>2017</year>, <volume>46</volume>, <fpage>503</fpage>–<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecl.2017.01.013</pub-id>.<pub-id pub-id-type="pmid">28476234</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Colonna</surname><given-names>M.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name><article-title>TREM2 Variants: New Keys to Decipher
Alzheimer Disease Pathogenesis</article-title>. <source>Nat. Rev. Neurosci.</source><year>2016</year>, <volume>17</volume>, <fpage>201</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.7</pub-id>.<pub-id pub-id-type="pmid">26911435</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Foulkes</surname><given-names>W. D.</given-names></name>; <name><surname>Priest</surname><given-names>J. R.</given-names></name>; <name><surname>Duchaine</surname><given-names>T. F.</given-names></name><article-title>DICER1:
Mutations, microRNAs and
Mechanisms</article-title>. <source>Nat. Rev. Cancer</source><year>2014</year>, <volume>14</volume>, <fpage>662</fpage>–<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3802</pub-id>.<pub-id pub-id-type="pmid">25176334</pub-id></mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Jia</surname><given-names>P.</given-names></name>; <name><surname>Zhao</surname><given-names>Z.</given-names></name><article-title>VarWalker: Personalized
Mutation Network Analysis of Putative Cancer
Genes from Next-generation Sequencing Data</article-title>. <source>PLoS Comput. Biol.</source><year>2014</year>, <volume>10</volume>, <elocation-id>e1003460</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003460</pub-id>.<pub-id pub-id-type="pmid">24516372</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Petrovski</surname><given-names>S.</given-names></name>; <name><surname>Gussow</surname><given-names>A. B.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Halvorsen</surname><given-names>M.</given-names></name>; <name><surname>Han</surname><given-names>Y.</given-names></name>; <name><surname>Weir</surname><given-names>W. H.</given-names></name>; <name><surname>Allen</surname><given-names>A. S.</given-names></name>; <name><surname>Goldstein</surname><given-names>D. B.</given-names></name><article-title>The Intolerance
of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity</article-title>. <source>PLoS Genet.</source><year>2015</year>, <volume>11</volume>, <elocation-id>e1005492</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005492</pub-id>.<pub-id pub-id-type="pmid">26332131</pub-id></mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>González-Pérez</surname><given-names>A.</given-names></name>; <name><surname>López-Bigas</surname><given-names>N.</given-names></name><article-title>Improving
the Assessment of the Outcome of Nonsynonymous
SNVs with a Consensus Deleteriousness Score, Condel</article-title>. <source>Am. J. Hum. Genet.</source><year>2011</year>, <volume>88</volume>, <fpage>440</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.03.004</pub-id>.<pub-id pub-id-type="pmid">21457909</pub-id></mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Fadista</surname><given-names>J.</given-names></name>; <name><surname>Oskolkov</surname><given-names>N.</given-names></name>; <name><surname>Hansson</surname><given-names>O.</given-names></name>; <name><surname>Groop</surname><given-names>L.</given-names></name><article-title>LoFtool: a
Gene Intolerance
Score based on Loss-of-function Variants in 60706 Individuals</article-title>. <source>Bioinformatics</source><year>2017</year>, <volume>33</volume>, <fpage>471</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv602</pub-id>.<pub-id pub-id-type="pmid">27563026</pub-id></mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="conf-proc" id="cit68"><person-group person-group-type="allauthors"><name><surname>Khan</surname><given-names>M. E.</given-names></name>; <name><surname>Dutt</surname><given-names>D. N.</given-names></name></person-group> In <source>Expectation-maximization
(EM) Algorithm for Instantaneous Frequency Estimation with Kalman
Smoother</source>, 12th European Signal Processing Conference, <year>2004</year>; pp <fpage>1797</fpage>–<lpage>1800</lpage>.</mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>Mészáros</surname><given-names>B.</given-names></name>; <name><surname>Erdős</surname><given-names>G.</given-names></name>; <name><surname>Dosztányi</surname><given-names>Z.</given-names></name><article-title>IUPred2A: Context-dependent Prediction
of Protein Disorder as a Function of Redox State and Protein Binding</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>W329</fpage>–<lpage>W337</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky384</pub-id>.<pub-id pub-id-type="pmid">29860432</pub-id></mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Dosztányi</surname><given-names>Z.</given-names></name>; <name><surname>Mészáros</surname><given-names>B.</given-names></name>; <name><surname>Simon</surname><given-names>I.</given-names></name><article-title>ANCHOR: Web Server
for Predicting Protein Binding Regions in Disordered Proteins</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>2745</fpage>–<lpage>2746</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp518</pub-id>.<pub-id pub-id-type="pmid">19717576</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="publisher-id">ci</journal-id>
    <journal-id journal-id-type="coden">jcisd8</journal-id>
    <journal-title-group>
      <journal-title>Journal of Chemical Information and Modeling</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1549-9596</issn>
    <issn pub-type="epub">1549-960X</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10685454</article-id>
    <article-id pub-id-type="pmid">37947586</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jcim.3c00950</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MMPatho: Leveraging Multilevel Consensus and Evolutionary
Information for Enhanced Missense Mutation Pathogenic Prediction</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Ge</surname>
          <given-names>Fang</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Arif</surname>
          <given-names>Muhammad</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">∥</xref>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>Yan</surname>
          <given-names>Zihao</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <name>
          <surname>Alahmadi</surname>
          <given-names>Hanin</given-names>
        </name>
        <xref rid="aff6" ref-type="aff">#</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <name>
          <surname>Worachartcheewan</surname>
          <given-names>Apilak</given-names>
        </name>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath6">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6786-8053</contrib-id>
        <name>
          <surname>Yu</surname>
          <given-names>Dong-Jun</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath7">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3394-8709</contrib-id>
        <name>
          <surname>Shoombuatong</surname>
          <given-names>Watshara</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <aff id="aff1"><label>†</label>School
of Geographic and Biologic Information, <institution>Nanjing University of Posts and Telecommunications</institution>, 9 Wenyuanlu, Nanjing 210023, <country>China</country></aff>
      <aff id="aff2"><label>‡</label>Center
for Research Innovation and Biomedical Informatics, Faculty of Medical
Technology, <institution>Mahidol University</institution>, Bangkok 10700, <country>Thailand</country></aff>
      <aff id="aff3"><label>§</label>School
of Computer Science and Engineering, <institution>Nanjing
University of Science and Technology</institution>, 200 Xiaolingwei, Nanjing 210094, <country>China</country></aff>
      <aff id="aff4"><label>∥</label>College
of Science and Engineering, <institution>Hamad Bin Khalifa
University</institution>, Doha 34110, <country>Qatar</country></aff>
      <aff id="aff5"><label>⊥</label>Department
of Community Medical Technology, Faculty of Medical Technology, <institution>Mahidol University</institution>, Bangkok 10700, <country>Thailand</country></aff>
      <aff id="aff6"><label>#</label>College of
Computer Science and Engineering, <institution>Taibah
University</institution>, Madinah 344, <country>Saudi Arabia</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label> Email: <email>njyudj@njust.edu.cn</email>.</corresp>
      <corresp id="cor2"><label>*</label> Email: <email>watshara.sho@mahidol.ac.th</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>10</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>27</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <volume>63</volume>
    <issue>22</issue>
    <fpage>7239</fpage>
    <lpage>7257</lpage>
    <history>
      <date date-type="received">
        <day>22</day>
        <month>06</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>23</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>21</day>
        <month>10</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0012" id="ab-tgr1"/>
      </p>
      <p>Understanding the
pathogenicity of missense mutation (MM) is essential
for shed light on genetic diseases, gene functions, and individual
variations. In this study, we propose a novel computational approach,
called MMPatho, for enhancing missense mutation pathogenic prediction.
First, we established a large-scale nonredundant MM benchmark data
set based on the entire Ensembl database, complemented by a focused
blind test set specifically for pathogenic GOF/LOF MM. Based on this
data set, for each mutation, we utilized Ensembl VEP v104 and dbNSFP
v4.1a to extract variant-level, amino acid-level, individuals’
outputs, and genome-level features. Additionally, protein sequences
were generated using ENSP identifiers with the Ensembl API, and then
encoded. The mutant sites’ ESM-1b and ProtTrans-T5 embeddings
were subsequently extracted. Then, our model group (MMPatho) was developed
by leveraging upon these efforts, which comprised ConsMM and EvoIndMM.
To be specific, ConsMM employs individuals’ outputs and XGBoost
with SHAP explanation analysis, while EvoIndMM investigates the potential
enhancement of predictive capability by incorporating evolutionary
information from ESM-1b and ProtT5-XL-U50, large protein language
embeddings. Through rigorous comparative experiments, both ConsMM
and EvoIndMM were capable of achieving remarkable AUROC (0.9836 and
0.9854) and AUPR (0.9852 and 0.9902) values on the blind test set
devoid of overlapping variations and proteins from the training data,
thus highlighting the superiority of our computational approach in
the prediction of MM pathogenicity. Our Web server, available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>, allows researchers to predict the pathogenicity (alongside the
reliability index score) of MMs using the ConsMM and EvoIndMM models
and provides extensive annotations for user input. Additionally, the
newly constructed benchmark data set and blind test set can be accessed
via the data page of our web server.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="doi">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61772273</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Nanjing University of Posts and Telecommunications</institution>
            <institution-id institution-id-type="doi">10.13039/501100005374</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NY223062</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Research Council of Thailand</institution>
            <institution-id institution-id-type="doi">10.13039/501100004704</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>N42A660380</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Natural Science Foundation of Jiangsu Province</institution>
            <institution-id institution-id-type="doi">10.13039/501100004608</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>BK20201304</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Mahidol University</institution>
            <institution-id institution-id-type="doi">10.13039/501100004156</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>N42A660380</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="doi">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>62072243</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ci3c00950</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ci3c00950</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <label>1</label>
    <title>Introduction</title>
    <p>The investigation of genetic variations, including MM, insertion,
deletion, and other genetic alteration, profoundly influences an individual’s
physiology, susceptibility to diseases, and response to medications.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Specially, studying these variations offers insights into genetic
diversity and its associations with disease onset, progression, and
treatment response.<sup><xref ref-type="bibr" rid="ref3">3</xref>−<xref ref-type="bibr" rid="ref5">5</xref></sup> This comprehension of genetic factors facilitates
the identification of specific alterations that contribute to disease
development and enables the advancement of targeted therapies and
personalized medicine approaches.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p>
    <p>MMs are common genetic variations associated with human diseases.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Till now, various computational methods have
been developed to predict MM pathogenicity.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Traditional machine learning techniques (e.g., SVM and RF) have
laid foundations for advanced methodologies<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> (like SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> PolyPhen,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> PROVEAN,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> CADD<sup><xref ref-type="bibr" rid="ref4">4</xref></sup>). These methodologies utilize sophisticated feature extraction
techniques from diverse data sources (e.g., sequence, structure, and
evolution) to differentiate between pathogenic and benign variations.
Deep learning technologies (e.g., Transformer) have emerged in variation
pathogenicity prediction, autonomously learning complex patterns and
features from extensive genomic and proteomic data sets.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Consensus methods integrate individual predictions
to improve accuracy and reliability, addressing biases and providing
comprehensive pathogenicity assessments.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref></sup> Benchmark data (e.g., ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> dbSNP<sup><xref ref-type="bibr" rid="ref15">15</xref></sup>) have been established for performance comparisons
of prediction methods.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> More specifically,
deep learning excels at capturing complex relationships in data, but
requires larger training sets and computational resources.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Consensus methods enhance reliability by integrating
multiple predictions,<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> while traditional methods offers
interpretable models for biological insights.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p>
    <p>ESM<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtTrans<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> are prominent models in protein sequence analysis
and interpretation,
trained on extensive protein sequence databases. ESM models (e.g.,
ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup>) capture evolutionary information
using self-attention mechanisms, accounting for long-range dependencies
in protein sequences. ProtTrans models (e.g, ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup>) leverage NLP transformers to capture relationships
between amino acids (AA) and structural, functional, and evolutionary
characteristics of proteins.</p>
    <p>Despite considerable efforts, there
are several critical issues
that need to be addressed. First, it is crucial to establish a comprehensive
and nonredundant data set on a large-scale, which incorporates known
effects. In-depth discussions regarding data quality, integration
methods, and potential biases are necessary. Second, it is essential
to develop computational models and perform analyses on feature importance,
interactions, and contributions. Lastly, it holds significant importance
to compare the classification abilities of individual outputs and
embeddings derived from large-scale protein language models.</p>
    <p>In this work, we focused on the following key aspects. (1) Construction
of benchmark data sets: We constructed one nonredundant MM benchmark
data set and one blind test set (focusing especially on pathogenic
GOF/LOF MM). (2) Feature generation: By utilizing the Ensembl VEP
v104 and its plugins (e.g., dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup>), we generated variant-level, AA-level, individuals’ outputs,
and genome-level features. (3) Protein sequence retrieval: By leveraging
ENSP identifiers and the Ensembl API, we retrieved encoded protein
sequences corresponding to query variations. (4) Embedding generation:
We used bio_embeddings<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> to generate ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> embeddings for each mutant site, which captured essential characteristics
and features of mutant AAs. (5) Model development: We developed an
interpretable model group, MMPatho, which consisted of ConsMM and
EvoIndMM. ConsMM utilized individuals’ outputs and employed
XGBoost with SHAP analyses. On the other hand, EvoIndMM incorporated
evolutionary information from ESM-1b and ProtT5-XL-U50 to enhance
the predictive capability.</p>
  </sec>
  <sec id="sec2">
    <label>2</label>
    <title>Materials and Methods</title>
    <sec id="sec2.1">
      <label>2.1</label>
      <title>Construction of the Benchmark Data Set and
Blind Test Set</title>
      <sec id="sec2.1.1">
        <label>2.1.1</label>
        <title>Benchmark Data Set Construction</title>
        <p>We downloaded the entire Ensembl database (6.18GB) from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://web.expasy.org/swissvar.html">https://web.expasy.org/swissvar.html</uri>, which includes variants from various sources (e.g., ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> gnomAD,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> UniProt,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> COSMIC<sup><xref ref-type="bibr" rid="ref24">24</xref></sup>) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A). To select related MMs, we applied two filters: variant
type (setting as MM or missense) and clinical significance (setting
as benign/likely benign or pathogenic/likely pathogenic), getting
622,270 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). We then applied five additional filters to remove unwanted
mutations: (1) those with conflicting interpretations of pathogenicity,
(2) uncertain significance, (3) repetitive and inconsistent MMs from
different sources, (4) variants classified as benign and pathogenic/likely
pathogenic, and (5) variants being likely benign and pathogenic/likely
pathogenic (obtaining 91,072 variants, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C). Using the Ensembl variant effect predictor,
we mapped the mutations to GRCh38, excluding inconsistent chromosome/position
and unmatched mutations, getting 77,700 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D). Following the processing
illustrated in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, the benchmark data set consists of 37,317 benign and 40,383 pathogenic
in 2,595 and 3,294 proteins, respectively. However, a subset of variants
lacked annotations when processed with Ensembl VEP. Consequently,
we excluded these variants/proteins. Eventually, we obtained a large-scale
nonredundant MM benchmark data set (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p>
        <fig id="fig1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Workflow of benchmark data set and blind test
set construction.
(A) Variations in the Ensembl Database, (B) Selecting, (C) Filtering,
and (D) Mapping: the procedures for benchmark data forming. (E) GOF/LOF
Variations and (F) gnomAD Database (v2.1.1): pathogenic GOF/LOF and
benign variants sources.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0001" id="gr1" position="float"/>
        </fig>
        <table-wrap id="tbl1" position="float">
          <label>Table 1</label>
          <caption>
            <title>Statistical
Summary of Missense Mutations
and Proteins in the Benchmark Data Set and Blind Test Set</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center"> </th>
                <th colspan="2" align="center" char=".">number
of variant<hr/></th>
                <th colspan="2" align="center" char=".">number
of protein<hr/></th>
              </tr>
              <tr>
                <th style="border:none;" align="center">data type</th>
                <th style="border:none;" align="center" char=".">benign/likely benign</th>
                <th style="border:none;" align="center" char=".">pathogenic/likely pathogenic</th>
                <th style="border:none;" align="center" char=".">benign/likely benign</th>
                <th style="border:none;" align="center" char=".">pathogenic/likely pathogenic</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">Benchmark data
set</td>
                <td style="border:none;" align="char" char=".">34,602</td>
                <td style="border:none;" align="char" char=".">38,476</td>
                <td style="border:none;" align="char" char=".">2439</td>
                <td style="border:none;" align="char" char=".">3115</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">blind test set</td>
                <td style="border:none;" align="char" char=".">2919</td>
                <td style="border:none;" align="char" char=".">3039</td>
                <td style="border:none;" align="char" char=".">675</td>
                <td style="border:none;" align="char" char=".">703</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="sec2.1.2">
        <label>2.1.2</label>
        <title>Blind
Test Set Construction</title>
        <p>We
downloaded pathogenic GOF/LOF variants<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> (HGMD_based), which contains 9,619 variants. From this set, we selected
single nucleotide variants occurring in protein coding regions, excluded
variants overlapped with in the benchmark data set (getting 3039 variants, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E). Subsequently,
for the gene set within the GOF/LOF data, we searched each gene in
gnomAD and applied the following filters to get benign variants: (1)
remove variants stored in ClinVar; (2) retained MMs with an allele
frequency &gt;0.1%; (3) kept MMs with clinical significance being
as
benign or likely benign; (4) remove MMs overlapped with the benchmark
data set. This process yielded 2919 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>F). Finally, we merged the pathogenic and
benign variants, removing redundant ones to construct a blind test
set (presented in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p>
      </sec>
    </sec>
    <sec id="sec2.2">
      <label>2.2</label>
      <title>Feature Extraction</title>
      <sec id="sec2.2.1">
        <label>2.2.1</label>
        <title>Ensembl
VEP Outputs and Individual Predictions/Annotations</title>
        <p>On a CentOS
v6.10 computer with 32 CPU kernels, we installed Ensembl
VEP v140<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> along with the formatted and
well-indexed human GRCh37 assembly data. Additionally, we incorporated
various plugins (e.g., dbNSFP v4.1a,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> Blosum62,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> ExAC<sup><xref ref-type="bibr" rid="ref23">23</xref></sup>) (please refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Texts S1 and S2</ext-link> detailed information about database versions and
plugins). These tools offer comprehensive features for each variant,
categorizing into four groups: variant-level, AA-level, individuals’
outputs, and genome-level features.</p>
        <p>(1) Variant-level features.
Location: variant’s coordinates for annotation extraction.
Allele: variant allele used for consequence calculation. Consequence:
type of consequence associated with the variant. Position: cDNA_position,
CDS_position, and Protein_position indicate relative base pair positions
in cDNA sequence, coding sequence, and protein AAs, respectively.
IMPACT: subjective impact classification of consequence type (e.g.,
moderate, modifier, low). CANONICAL: indicates whether the transcript
is canonical for the gene. ENSP: Protein identifier. GENE_PHENO: indicates
whether the gene is associated with a phenotype, disease, or trait.
CLIN_SIG: ClinVar clinical significance of the dbSNP variant.</p>
        <p>(2) AA-level features. Wildtype and mutant AAs were obtained from
Ensembl VEP v104.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Additional features
(including molecular weight, hydrophobicity, isoelectric point, residue
volume) were extracted for wild-type and mutant AAs. Furthermore,
the differences between two type AAs were also calculated, namely,
damino_frq_diff, V_residue_diff, Hydrophobicity_diff, Isoelectric_point_diff,
etc.</p>
        <p>(3) Individuals’ outputs. Ensembl VEP v104<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> and dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> offer an extensive
range of MM effect predictions and annotations using multiple methods.
This encompasses thirty-one prediction algorithms, such as (SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Polyphen2-HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> FATHMM,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> DANN,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Eigen,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> REVEL,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> PrimateAI,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> ClinPred<sup><xref ref-type="bibr" rid="ref34">34</xref></sup>). Additionally,
nine conservation scores (e.g., bStatistic, phyloP30way_mammal, GERP++<sup><xref ref-type="bibr" rid="ref35">35</xref></sup>) and other functional annotations are also provided.</p>
        <p>(4) Genome-level features. We acquired genome-level features from
multiple databases, including gnomAD_exomes, ESP6500, and ExAC. For
example, 1000Gp3_AFR_AF represents the alternative allele frequency
in 1000Gp3 African descendant samples. ESP6500_EA_AF denotes the alternative
allele frequency in European American samples from ESP6500 (Please
refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S1</ext-link> for more information
about the extracted features).</p>
      </sec>
    </sec>
    <sec id="sec2.2.2">
      <label>2.2.2</label>
      <title>Amino
acid embeddings</title>
      <p>For each
MM, we calculated AA-level embedding features from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtTransT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> These features originated from protein sequences acquired by using
the ENSP ID and API functions. During protein sequence retrieval,
some variants returned empty information. To maintain the embedding
quality, we filtered out such variants with empty returns.</p>
      <p>(1)
ESM-1b embeddings. We utilized the bio_embeddings<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> to obtain ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> embeddings
for each AA at the mutant site. These 1280-dimensional vectors effectively
encode crucial AA properties, including physicochemical properties,
and evolutionary conservations.</p>
      <p>(2) ProtTransT5-XL-U50 embeddings.
By employing the ProtTransT5XLU5<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> embedder
from bio_embeddings,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> we leveraged the
potential of the 1024-dimensional vector
for each mutant AA. This approach facilitated the extraction of valuable
insights from protein sequences, capturing AA’s properties
such as hydrophobicity, charge, and size.</p>
    </sec>
  </sec>
  <sec id="sec2.2.3">
    <label>2.2.3</label>
    <title>Distribution of Features</title>
    <p>We executed an elaborate investigation
into the disparities in
distribution of features utilized for classifying genome variations
as either pathogenic or benign, with a particular emphasis on the
annotated “benchmark data set” missense mutations (listed
in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). We applied
Kernel Density Estimation (KDE)<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> to portray
efficiently the intricate dynamism of these distributions in a continuous,
and unbiased manner.</p>
    <p>We opted to showcase a subset of 12 distinct
features out of the
total 884 features extracted in <xref rid="sec2.2.1" ref-type="other">Sections 2.2.1–2.2.2</xref>. The features selected for presentation exhibited remarkable differences
in their distributions. For instance, as depicted in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A, the gnomAD_exomes_ASJ_AF
feature demonstrated a highly significant distribution contrast (<italic>p</italic>-value: 1.622517e-274). Similarly, <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>E highlighted the distribution disparity
of the Hydrophobicity_diff feature (<italic>p</italic>-value: 1.587287e-48),
while <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>K revealed
the distinct distribution pattern of esm1b_90 (<italic>p</italic>-value:
2.531859e-235). <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>L illustrated the pronounced distribution discrepancy of prott5_570
(<italic>p</italic>-value: 4.379378e-220). These exemplary features
were chosen to exemplify the analytical power of feature distributions
in discerning the classification potential of the extracted attributes.</p>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Analyses
of the extracted features with <italic>p</italic>-values
using the KDE function. (A) gnomAD_exomes_ASJ_AF (<italic>p</italic>-value = 1.622817e-274), (B) Isoelectric_point_diff (<italic>p</italic>-value = 2.627391e-21), (C) Molecular_weight_diff (<italic>p</italic>-value = 0.00074061), (D) Molecular_weight_wt (<italic>p</italic>-value = 1.560005e-11), (E) Hydrophobicity_diff (<italic>p</italic>-value = 1.587287e-48), (F) codeToVal_diff (<italic>p</italic>-value
= 0.00102270), (G) V_residue_wt (<italic>p</italic>-value = 1.286094e-16),
(H) V_residue_diff (<italic>p</italic>-value = 4.680308e-12), (I)
CADD_raw_rankscore_gh19 (<italic>p</italic>-value = 0.0), (J) GERP++_NR
(<italic>p</italic>-value = 1.118603e-46), (K) esm1b_90 (<italic>p</italic>-value = 2.531859e-235), and (L) prott5_570 (<italic>p</italic>-value
= 4.379378e-220). Note: “Label 0” and “Label
1” represent the benign and pathogenic variation class, respectively.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0002" id="gr2" position="float"/>
    </fig>
    <p>In conclusion, our comprehensive analysis effectively
demonstrates
how feature distributions, aided by KDE and selective visualization,
aid in distinguishing different classes of genome variations, thereby
enhancing the understanding of genome variation impacts.</p>
  </sec>
  <sec id="sec3">
    <label>3</label>
    <title>Workflow of ConsMM and EvoIndMM</title>
    <p>In this work, we developed
an integrated model group of models
termed MMPatho, consisting of two distinct models: ConsMM (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>) and EvoIndMM (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). Importantly, ConsMM
solely employs individual outputs as inputs, whereas EvoIndMM integrates
Ensembl VEP outputs along with embeddings generated from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p>
    <fig id="fig3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Workflow
of the ConsMM model. (A) Feature Extraction, (B) Pathogenic
Mutation Identification using LightGBM, XGBoost, and CatBoost, (C)
Utilizing the Optimal Model for Prediction and Model Explanation,
(D) Analysis of Feature Dependence, and (E) Analysis of Feature Importance.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0003" id="gr3" position="float"/>
    </fig>
    <fig id="fig4" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Architecture of the EvoIndMM model. (A) Protein Sequence
Generation
and Inputs Creation for ProtT5-XL-U50 and ESM-1b embedders, embedding
Generation from ProtT5-XL-U50 and ESM-1b, (B) Feature Extraction via
Ensembl VEP and its Plugins, (C) Feature Selection through PCA, and
(D) XGBoost Model Training.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0004" id="gr4" position="float"/>
    </fig>
    <p>Within ConsMM, we e exclusively implemented 34 individuals’
predictions or conservation scores procured from Ensembl VEP and dbNSFP,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> which include SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> ClinPred,<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> DANN,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Eigen,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> FATHMM<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> (fathmm-MKL,<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> fathmm-XF<sup><xref ref-type="bibr" rid="ref38">38</xref></sup>), FitCons<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> (GM12878, H1_hESC, HUVEC), GenoCanyon,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> LRT,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> MPC,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> MutPred2,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> MutationTaster,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> MutationAssessor,<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> Polyphen2_HDIV and Polyphen2_HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> REVEL,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> SIFT4G,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> PrimateAI.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> Also
include nine conservation scores, e.g., bStatistic, phyloP100way_vertebrate,
phastCons17way_primate,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> GERP++,<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> SiPhy,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> and others.</p>
    <p>Conversely, for EvoIndMM, we broadened the feature set beyond mere
predictions/annotations, integrating additional variant-level, amino
acid-level, and genome-level features sourced from dbSNP,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> UniProt,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> gnomAD,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> 1000Gp3,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> ESP<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and others. Additionally, we also generated
variant characteristic from ESM-1b,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and
ProtT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Please refer to the Readme
page of our Web server for viewing feature contributions in the ConsMM
or EvoIndMM model.</p>
    <sec id="sec3.1">
      <label>3.1</label>
      <title>ConsMM</title>
      <p>The ConsMM
workflow (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>)
comprises three
key components: feature extraction (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A), prediction (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B), feature importance analysis, and model
explanation (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C–<xref rid="fig3" ref-type="fig">3</xref>E). In <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A, Ensembl VEP v104 and dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> were used to obtain predictions and annotations for multiple individuals(e.g.,
SIFT<sup><xref ref-type="bibr" rid="ref10">10</xref></sup>). In <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B, the extracted features were input into
LightGBM, XGBoost, and CatBoost to derive the optimal model. Finally,
in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C–E,
the feature importance and interaction dependencies were analyzed
using SHAP<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S3</ext-link> introduced SHAP and XGBoost), aiming to provide a comprehensive
explanation for the prediction model (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S4</ext-link> listed the evaluation indices).</p>
    </sec>
    <sec id="sec3.2">
      <label>3.2</label>
      <title>EvoIndMM</title>
      <p><xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref> depicts
the stepwise construction process
of EvoIndMM, involving the following key steps: (1) Retrieval of Encoded
Protein Sequences: Protein sequences in FASTA format are retrieved
for ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> and ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> embedders using the Ensembl API and ENSP identifiers.
Filter options are applied to exclude specific mutations (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). (2) Feature Extraction
through the Ensembl VEP: Ensembl VEP v104 is employed to extract feature
vectors, including variant-level, AA-level, individual outputs, and
genome-level features. Additionally, for each mutant site AA, ESM-1b
and ProtT5-XL-U50 embedders generate 1120 and 1280-dimensional feature
vectors, respectively (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A, <xref rid="fig4" ref-type="fig">4</xref>B). (3) Benchmark Data Splitting
and Model Training: The benchmark data is partitioned into training
data and test set. PCA is then utilized to select features from VEP,
ESM-1b, and ProtT5-XL-U50, using a threshold of &gt;0.1 or 0.05. Subsequently,
the XGBoost model is trained using the training data (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref><bold>C-</bold><xref rid="fig4" ref-type="fig">4</xref><bold>D</bold>). By following this systematic approach, EvoIndMM
ensures the accurate prediction of MM pathogenicity by integrating
diverse features and embedding techniques.</p>
    </sec>
    <sec id="sec3.3">
      <label>3.3</label>
      <title>Avoiding
Protein Overlap for Model Fairness</title>
      <p>The study by Grimm et
al. highlights a potential flaw in the modeling
process: the inclusion of different variations of a single protein
in both the training and testing sets may lead to artificially inflated
model performance during testing.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Such
inflation can occur if the model merely mimics specific variation
patterns from the training data without genuinely learning to apply
these patterns to novel variations. To ensure validity and prevent
data leakage, it is critical to maintain separate training and testing
sets that do not concurrently include different variations of the
same protein.</p>
      <p>To this end, we employed protein IDs as sorting
criteria when distributing distinct protein variations between the
training (80%) and testing (20%) sets of the benchmark data set (training:
58786 and testing: 14292 for ConsMM), utilizing “train_test_split”
from sklearn.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> This allocation strategy
ensures that proteins and their variations are exclusively assigned
to either the training or the testing set, thereby boosting the reliability
of the model’s performance assessment.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <label>4</label>
    <title>Results and Discussions</title>
    <sec id="sec4.1">
      <label>4.1</label>
      <title>Performance Comparison
of ConsMM and EvoIndMM</title>
      <sec id="sec4.1.1">
        <label>4.1.1</label>
        <title>Performance of ConsMM
on the Test Set of
Benchmark Data Set</title>
        <p>To optimize parameter settings and experimental
design, the following steps were taken. (1) Grid Search Cross-Validation
and Model Selection: in GridSearchCV, we conducted 5-fold cross-validation
with 3 repetitions to thoroughly explore a predefined grid of hyperparameters
and determine the best-performing model. (2) Parameter Settings: For
XGBoost, the chosen settings were a “learning rate”
of 0.01, a binary logistic regression objective, a subsample ratio
of 0.5, the “base_score” as the mean of “y_train”,
the “eval_metric” as “log_loss”, “max_depth”
of 4, and “n_estimators” of 300. In contrast, CatBoost
and LightGBM underwent extensive grid searches for iterations, learning
rates, and tree depths. The best parameter configurations were identified
as follows: CatBoost (“iterations”=400, “learning_rate”=0.1,
“depth”=4) and LightGBM (“iterations”=400,
“learning_rate”=0.01, “depth”=4). The
CatBoost, XGBoost, and LightGBM models were meticulously fine-tuned
and evaluated, and the comparison results are documented in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> (further details for LightGBM,
XGBoost, and CatBoost can be found in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Texts S5–S7</ext-link>).</p>
        <fig id="fig5" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Comparison of CatBoost, XGBoost, and LightGBM on the test set of
the benchmark data set. (A) ROC curves of CatBoost, XGBoost, and LightGBM.
(B) PR curves of CatBoost, XGBoost, and LightGBM. (C) <italic>Pre</italic>, <italic>NPV</italic>, <italic>Recall</italic>, <italic>Spe</italic>, <italic>ACC</italic>, <italic>MCC</italic>, and <italic>F</italic><sub>1</sub> values of CatBoost, XGBoost, and LightGBM.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0005" id="gr5" position="float"/>
        </fig>
        <table-wrap id="tbl2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Confusion Matrix and Three Types of
Errors of CatBoost, XGBoost, and LightGBM on the Test Set of Benchmark
Data Set</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">model name</th>
                <th style="border:none;" align="center">TP</th>
                <th style="border:none;" align="center">TN</th>
                <th style="border:none;" align="center">FP</th>
                <th style="border:none;" align="center">FN</th>
                <th style="border:none;" align="center" char=".">ER</th>
                <th style="border:none;" align="center" char=".">FPR</th>
                <th style="border:none;" align="center" char=".">FNR</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">CatBoost</td>
                <td style="border:none;" align="left">7339 (51.35%)</td>
                <td style="border:none;" align="left">5516 (38.60%)</td>
                <td style="border:none;" align="left">839 (5.87%)</td>
                <td style="border:none;" align="left">598 (4.18%)</td>
                <td style="border:none;" align="char" char=".">0.0587</td>
                <td style="border:none;" align="char" char=".">0.1320</td>
                <td style="border:none;" align="char" char=".">0.0753</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">XGBoost</td>
                <td style="border:none;" align="left">7242 (50.67%)</td>
                <td style="border:none;" align="left">5675 (39.71%)</td>
                <td style="border:none;" align="left">680 (4.76%)</td>
                <td style="border:none;" align="left">695 (4.86%)</td>
                <td style="border:none;" align="char" char=".">0.0476</td>
                <td style="border:none;" align="char" char=".">0.1070</td>
                <td style="border:none;" align="char" char=".">0.0876</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">LightGBM</td>
                <td style="border:none;" align="left">7302 (51.09%)</td>
                <td style="border:none;" align="left">5513 (38.57%)</td>
                <td style="border:none;" align="left">842 (5.89%)</td>
                <td style="border:none;" align="left">635 (4.44%)</td>
                <td style="border:none;" align="char" char=".">0.0589</td>
                <td style="border:none;" align="char" char=".">0.1325</td>
                <td style="border:none;" align="char" char=".">0.0800</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>When comparing the performance of CatBoost,
XGBoost, and LightGBM,
we evaluated multiple metrics (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>) to assess their effectiveness; analyses are given below:
(1) XGBoost outperformed CatBoost and LightGBM with MCC of 0.8052,
compared to 0.7961 and 0.7904, respectively. MCC can capture the overall
model performance, by considering TP, TN, FP, and FN. (2) XGBoost
achieved an ACC score of 0.9038, surpassing CatBoost (0.8995) and
LightGBM (0.8967), indicating better pathogenic variant classification
ability. (3) XGBoost demonstrated a Spe value of 0.8930, outperforming
CatBoost (0.8680) and LightGBM (0.8675), indicating better identification
of negative cases. (4) XGBoost achieved a Pre score of 0.9142, higher
than CatBoost (0.8974) and LightGBM (0.8966), indicating a higher
proportion of correctly predicted positive cases. (5) XGBoost obtained
the highest F<sub>1</sub> score of 0.9133, which combines precision
and recall to represent the balance between them. Considering the
comparisons, XGBoost consistently demonstrated a competitive performance
across multiple metrics. Therefore, we selected XGBoost as the preferred
model for subsequent comparisons and referred to the entire model
as ConsMM for further analyses.</p>
      </sec>
      <sec id="sec4.1.2">
        <label>4.1.2</label>
        <title>Assessing
ConsMM Efficacy: Protein ID-Based
Splitting Vs Nonprotein ID-Based splitting</title>
        <p>To ensure a robust
evaluation of ConsMM, we conducted supplementary testing using data
that did not split based on protein ID. Detailed results from these
tests are provided in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S8, Figure S1, and Table S2</ext-link>.</p>
        <p>Comparative analysis between findings detailed
in <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> and those outlined in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S8, Figure S1, and Table S2</ext-link> reveals subtly lower metrics in the former. For instance,
with reference to the XGBoost classifier, its AUROC value in <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> stands at 0.9650
(Protein ID-Based Separation), which is marginally below that depicted
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S1</ext-link> (0.9764, Non-Protein ID-Based
Separation), marking a decrease of approximately 0.0114. A similar
trend is observed in XGBoost’s AUPR, where <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> displays a score of 0.9715,
slightly under the corresponding value in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S1</ext-link> (0.9802), indicating a decline of roughly 0.0093. This suggests
that employing a protein ID for data segregation provides a more conservative
appraisal of model performance. The ACC and MCC values of XGBoost
in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> (0.9038
and 0.8052 respectively) are fractionally under those given in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S2</ext-link> (0.9208 and 0.8416 respectively), demonstrating
marginal decreases of 0.017 and 0.0364, implying a reduced capacity
of the models to handle imbalanced data and produce balanced predictions
when protein ID separation is used.</p>
        <p>In summary, the results
from the Supporting Information show superior
AUROC, AUPR, ACC, and MCC scores, suggesting improved overall model
performance. Nonetheless, the experiments delineated in <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> utilizing
protein ID for data splitting provide a more conservative and reliable
evaluation, taking into account potential data leakage and model overfitting.
The selection between these two methodologies should be guided by
the specific demands of the task at hand with a preference for <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> when a
dependable estimation of model generalizability is required.</p>
      </sec>
      <sec id="sec4.1.3">
        <label>4.1.3</label>
        <title>Feature Importance in ConsMM</title>
        <p>To
gain comprehensive insight into the key features of ConsMM, we plotted
the top 35 features with the highest SHAP values (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A). The findings can be summarized
as follows: (1) The ClinPred_rankscore demonstrates that a higher
value significantly contributes ConsMM to predicting pathogenic variants,
whereas a lower value has a greater impact on predicting benign variants.
Similar contribution patterns can be observed on BayesDel_addAF_score.
(2) Furthermore, the prevalence of red color in features (e.g., BayesDel_addAF_rcore,
BayesDel_addAF_rankscore, MutPred_rankscore, MPC_rankscore, REVEL_rankscore,
ClinPred_score, and CADD_raw_rankscore) indicates feature higher values
strong correlation with classes and their crucial predictive capabilities
in accurately identifying pathogenic variants. (3) Additionally, the
lower values of features (e.g., FATHMM_converted_rankscore, Reliability_index,
SIFT_converted_rankscore, PrimateAI_rankscore, GERP++_NR) highlight
their significant impact on predicting pathogenic variants. (SHAP
values of all features for ConsMM and feature analyses were documented
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S3 and Text S9</ext-link>).</p>
        <fig id="fig6" position="float">
          <label>Figure 6</label>
          <caption>
            <p>SHAP summary plot and
feature interactions for ConsMM. (A) SHAP
summary plot, (B) ClinPred_rankscore with phyloP100way_vertebrate_rankscore,
(C) BayesDel_addAF_rankscore with ClinPred_score, (D) MutPred_rankscore
with ClinPred_rankscore, (E) Eigen_phred_coding with BayesDel_addAF_score,
(F) GERP++_RS with ClinPred_score, (G) Polyphen2_HVAR_rankscore with
BayesDel_addAF_rankscore, (H) bStatistic_converted_rankscore with
GERP++_NR, and <bold>(I)</bold> phastCons100way_vertebrate with CADD_phred.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0006" id="gr6" position="float"/>
        </fig>
        <p>The feature interactions depicted in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B–<xref rid="fig6" ref-type="fig">6</xref>I offer
valuable insights into the joint effects of various features on the
output of ConsMM’s output. Detailed analyses are as follows:<list list-type="simple"><list-item><label>(1)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B, <xref rid="fig6" ref-type="fig">6</xref>C display analogous patterns.
Feature interaction plots exhibit regions of red and blue overlap,
signifying that when both features possess higher values, they synergistically
amplify each other’s impact on ConsMM’s output. In essence,
evaluating these two features collectively augments ConsMM’s
predictive capacity and exerts a positive influence on its predictions.</p></list-item><list-item><label>(2)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>E,<xref rid="fig6" ref-type="fig">6</xref>G, and I reveal
similar patterns.
The aggregate effect of these feature interactions on predictions
deviates from their individual impacts, alluding to the presence of
intricate interactions between features. When one feature exhibits
high while another displays low values, they mutually reinforce each
other, culminating in enhanced predictive prowess for pathogenic variants.</p></list-item><list-item><label>(3)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>D,<xref rid="fig6" ref-type="fig">6</xref>F, and <xref rid="fig6" ref-type="fig">6</xref>H exhibit similar influence. The observed concave
shape indicates
a complex interplay between feature pairs. Within a specific range,
the feature interaction significantly influences prediction outcomes
and combined effect becomes more potent, resulting in a striking aggregation
of red areas. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S2</ext-link> displays the interactions
of other 12 features for ConsMM.</p></list-item></list></p>
      </sec>
    </sec>
    <sec id="sec4.2">
      <label>4.2</label>
      <title>Performance of EvoIndMM with VEP Outputs,
ESM-1b and ProtT5-XL-U50 Embeddings</title>
      <sec id="sec4.2.1">
        <label>4.2.1</label>
        <title>Assessing
the Contribution of Different
Feature Sets</title>
        <p>To assess the impact of different feature sets
on EvoIndMM predictions, ablation experiments were conducted. Experiments
results (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>) provide insights
into feature contributions. <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>A highlights that EvoIndMM with the “Combined”
feature set achieves the highest TN (5515, 47.47%) and lowest FP (416,
3.58%), indicating superior classification performance compared to
EvoIndMM with other feature sets. Additionally, the “Combined”
feature set exhibits the lowest ER (0.0358) among all feature sets.
EvoIndMM with “VEP” demonstrates the lowest FPR (0.0701),
revealing its proficiency in accurately identifying benign variants.
Conversely, EvoIndMM with the “VEP” feature set exhibits
the highest FNR (0.0895), indicating challenges in correctly identifying
pathogenic variants.</p>
        <fig id="fig7" position="float">
          <label>Figure 7</label>
          <caption>
            <p>ROC and PR curves of EvoIndMM on the test set of the benchmark
data set. (A) Confusion matrix of EvoIndMM with VEP outputs, ESM-1b,
ProtT5-XL-U50, or combined feature set, (B) ROC curves, and (C) PR
curves.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0007" id="gr7" position="float"/>
        </fig>
        <table-wrap id="tbl3" position="float">
          <label>Table 3</label>
          <caption>
            <title>Performance Comparison
of EvoIndMM
with Different Features on the Test Set of Benchmark Data Set<xref rid="t3fn1" ref-type="table-fn">a</xref></title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">features</th>
                <th style="border:none;" align="center" char=".">MCC</th>
                <th style="border:none;" align="center" char=".">ACC</th>
                <th style="border:none;" align="center" char=".">recall/sen</th>
                <th style="border:none;" align="center" char=".">Spe</th>
                <th style="border:none;" align="center" char=".">Pre</th>
                <th style="border:none;" align="center" char=".">NPV</th>
                <th style="border:none;" align="center" char=".">F<sub>1</sub></th>
                <th style="border:none;" align="center" char=".">ER</th>
                <th style="border:none;" align="center" char=".">FPR</th>
                <th style="border:none;" align="center" char=".">FNR</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">VEP<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.8348</td>
                <td style="border:none;" align="char" char=".">0.9175</td>
                <td style="border:none;" align="char" char=".">0.9105</td>
                <td style="border:none;" align="char" char=".">0.9241</td>
                <td style="border:none;" align="char" char=".">0.9200</td>
                <td style="border:none;" align="char" char=".">0.9150</td>
                <td style="border:none;" align="char" char=".">0.9152</td>
                <td style="border:none;" align="char" char=".">0.0387</td>
                <td style="border:none;" align="char" char=".">0.0759</td>
                <td style="border:none;" align="char" char=".">0.0895</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">ESM-1b<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.5801</td>
                <td style="border:none;" align="char" char=".">0.7901</td>
                <td style="border:none;" align="char" char=".">0.7633</td>
                <td style="border:none;" align="char" char=".">0.8157</td>
                <td style="border:none;" align="char" char=".">0.7989</td>
                <td style="border:none;" align="char" char=".">0.7823</td>
                <td style="border:none;" align="char" char=".">0.7807</td>
                <td style="border:none;" align="char" char=".">0.0941</td>
                <td style="border:none;" align="char" char=".">0.1843</td>
                <td style="border:none;" align="char" char=".">0.2367</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">ProtT5-XL-U50<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.6137</td>
                <td style="border:none;" align="char" char=".">0.8068</td>
                <td style="border:none;" align="char" char=".">0.7772</td>
                <td style="border:none;" align="char" char=".">0.8351</td>
                <td style="border:none;" align="char" char=".">0.8188</td>
                <td style="border:none;" align="char" char=".">0.7963</td>
                <td style="border:none;" align="char" char=".">0.7975</td>
                <td style="border:none;" align="char" char=".">0.0842</td>
                <td style="border:none;" align="char" char=".">0.1649</td>
                <td style="border:none;" align="char" char=".">0.2228</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">combined<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.8390</td>
                <td style="border:none;" align="char" char=".">0.9195</td>
                <td style="border:none;" align="char" char=".">0.9087</td>
                <td style="border:none;" align="char" char=".">0.9299</td>
                <td style="border:none;" align="char" char=".">0.9255</td>
                <td style="border:none;" align="char" char=".">0.9140</td>
                <td style="border:none;" align="char" char=".">0.9170</td>
                <td style="border:none;" align="char" char=".">0.0358</td>
                <td style="border:none;" align="char" char=".">0.0701</td>
                <td style="border:none;" align="char" char=".">0.0913</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t3fn1">
              <label>a</label>
              <p>Note: VEP<sup>#</sup>, ESM-1b<sup>#</sup>, ProtT5-XL-U50<sup>#</sup> mean EvoIndMM only with VEP outputs,
or ESM-1b embeddings, or ProtT5-XL-U50 embeddings. Combined<sup>#</sup> represents the concatenation of VEP outputs, ESM-1b and ProtT5-XL-U50
embeddings.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Analyzing the
results presented in <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>, it is evident that EvoIndMM with the “Combined”
feature set achieves outstanding performance, as reflected by its
highest AUROC (0.9736) and AUPR (0.9738) values. Additionally, EvoIndMM
demonstrates robust agreement between predicted and true classes with
the highest MCC (0.8390) and ACC (0.9195) values, indicating accurate
classification. Besides, EvoIndMM with “VEP” exhibits
superior Recall/Sen (0.9105), showcasing its ability to identify positive
variants effectively. In contrast, EvoIndMM with “ESM-1b″
shows a lower Spe (0.8157), suggesting a higher rate of false positives.
Notably, EvoIndMM with “Combined” achieves the highest
Pre score (0.9255) and F<sub>1</sub> score (0.9170), indicating a
favorable balance between precision and recall.</p>
        <p>In summary,
the “Combined” feature set consistently
outperforms other feature sets across various metrics. The limited
effectiveness of ESM-1b and ProtT5-XL-U50 embeddings in predicting
MM pathogenicity can be attributed to their insufficient individual
pathogenic predictions and annotations, limited coverage of mutation
features, and inadequate representation of functional impacts. In
contrast, the “Combined” feature set outperforms each
single set, indicating the combination provides complementary information
that can enhance predictive performance. The inclusion of the “VEP”
feature set in “Combined”, with its extensive individual-level
predictions and annotations, likely compensates for any limitations
in ESM-1b and ProtT5-XL-U50 embeddings, resulting in improved accuracy
in predicting MM pathogenicity.</p>
      </sec>
      <sec id="sec4.2.2">
        <label>4.2.2</label>
        <title>Assessing
EvoIndMM Efficacy: Protein ID-Based
Splitting vs Nonprotein ID-Based Splitting</title>
        <p>To robustly evaluate
the differential attributes of EvoIndMM, we performed additional analyses
on data that did not split based on protein ID. Detailed results from
these tests are encapsulated in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S10, Table S4, and Figure S3</ext-link>. The “Combined<sup>#</sup>″
feature set of EvoIndMM is employed for a detailed comparative assessment
of performance metrics.</p>
        <p>With respect to the MCC Value, a subtle
decrease of approximately 0.0828 is observed from <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S4</ext-link> (0.8390) to <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> (0.9218), indicating a modest reduction in proficiency
of sample classification. In terms of ACC, a minor decrement of about
0.0416 is noted upon comparison of <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S4</ext-link> with <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>, signaling
a slight decline in the model’s ability to classify samples
correctly. Considering the AUROC Value, a marginal fall of roughly
0.0173 is seen transitioning from <xref rid="fig7" ref-type="fig">Figures <xref rid="fig7" ref-type="fig">7</xref></xref> to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S3</ext-link>, suggesting
a minimal decrease in the model’s competence in distinguishing
positive from negative samples. Regarding the AUPR value, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S3</ext-link> demonstrates a decrease of nearly 0.0185
relative to <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>, denotes a slight deterioration in the equilibrium between precision
and recall. In summation, notwithstanding the apparent reductions
in performance metrics in <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> for EvoIndMM with the “Combined<sup>#</sup>″ feature set, these decreases remain relatively trivial.
This indicates that the model preserves its robust performance even
when adopting protein ID for data partitioning, thereby emphasizing
its dependability in real-world scenarios.</p>
        <p>In light of the experimental
data associated with the data splitting
strategy in <xref rid="sec3.3" ref-type="other">Section <xref rid="sec3.3" ref-type="other">3.3</xref></xref>, along with the comparative evaluations of <xref rid="sec4.2.2" ref-type="other">sections <xref rid="sec4.2.2" ref-type="other">4.2.2</xref></xref> and <xref rid="sec4.1.2" ref-type="other">4.1.2</xref>, it can be deduced that the slight performance decline
noted in the predictive model, attributable to the strategy detailed
in <xref rid="sec3.3" ref-type="other">Section <xref rid="sec3.3" ref-type="other">3.3</xref></xref>, is
an acceptable trade-off. This approach ensures more reliable performance
appraisals and fosters superior generalizability, thereby endorsing
the corresponding marginal decreases in performance.</p>
      </sec>
      <sec id="sec4.2.3">
        <label>4.2.3</label>
        <title>Feature Importance in EvoIndMM</title>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>A presents
the top 35 features for EvoIndMM, ranked by their SHAP values. These
features demonstrate unique impact patterns, summarized as follows:
(1) Features (e.g., ClinPred_rankscore, BayesDel_addAF_rankscore,
REVEL_rankscore, bStatistic_converted_rankscore, VEST4_rankscore,
MutPred_rankscore, MVP_rankscore, CADD_raw_rankscore) enhance significant
the EvoIndMM’s ability to predict pathogenic variants. (2)
Conversely, features like MAX_AF, Reliability_index, gnomAD_exomes_AF,
FATHMM_converted_rankscore, and Molecular_weight_diff have a notable
impact on predicting pathogenic variants when their values are lower.
These observed impact patterns validate the relevance and crucial
predictive capabilities of these features in EvoIndMM (SHAP values
of the top 160 features and feature analyses were documented in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S5 and Text S11</ext-link>).</p>
        <fig id="fig8" position="float">
          <label>Figure 8</label>
          <caption>
            <p>SHAP summary plot and
feature interactions for EvoIndMM. (A) SHAP
summary plot, (B) ClinPred_score interacting with phyloP100way_vertebrate_rankscore,
(C) Eigen_PC_phred_coding with esm1b_909, (D) esm1b_781 with ClinPred_Score,
(E) MPC_rankscore with esm1b_909, (F) MAX_AF with BayesDel_addAF_rankscore,
(G) MutPred_rankscore with ClinPred_rankscore, (H) phyloP100way_vertebrate
with ClinPred_Score, and <bold>(I)</bold> prott5_32 with prott5_410.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0008" id="gr8" position="float"/>
        </fig>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>B–<xref rid="fig8" ref-type="fig">8</xref>I depicts eight feature interactions
that effect
EvoIndMM, with detailed analyses provided below: (1) In <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>B, within the ClinPred_rankscore
range of [0, 0.80], the ClinPred_rankscore and phyloP100way_vertebrate
interaction exerts minimal influence on EvoIndMM’s output.
However, when ClinPred_rankscore values fall within [0.90, 1.0], feature
interaction significantly impacts the model output. Analogous interaction
patterns are discernible in <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>E,G.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>C illustrates
the interaction between Eigen_PC_phred_coding and esm1b_909. Within
the (0, 35) of Eigen_PC_phred_coding, MAX_AF feature values mostly
concentrate between 2 and 4, signifying that Eigen_PC_phred_coding
and esm1b_909 interaction wield greater influence on EvoIndMM’s
output in such range. Similar interaction patterns can be observed
in <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>D–H.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>F illustrates
the interaction of MAX_AF and BayesDel_addAF_rankscore. When MAX_AF
is in the range [0, 1], BayesDel_addAF_rankscore values predominantly
concentrate in the range (−1.0, −0.4). Within such a
range, the negative SHAP values of MAX_AF indicate a significant influence
of this interaction on EnoIndMM’s prediction of benign variants.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>I elucidates
the interaction between prott5_32 and prott5_410. When prott5_32 values
lie within [−0.4, 0.15] and prott5_410 within [-0.2, 0.4],
the positive SHAP values for prott5_32 signify their substantial contribution
to EvoIndMM’s prediction of pathogenic variants. Conversely,
as prott5_32 shifts from 0.15 to 0.6 and prott5_410 moves from −0.2
to −0.6, the majority of data points exhibit a blue hue, emphasizing
their influence on EvoIndMM to predict benign variants. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S4</ext-link> showcases the interactions of 12 additional
features for the EvoIndMM model.</p>
      </sec>
    </sec>
    <sec id="sec4.3">
      <label>4.3</label>
      <title>Assessing
the Performance of ConsMM, EvoIndMM
with Four Individual and Seven Meta-Predictors On Blind Test Set</title>
      <p>In this section, we conducted a comprehensive comparison of ConsMM
and EvoIndMM with four individual and seven meta-predictors, including
VEST4,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> PROVEAN,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> LIST-S2,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> gMVP,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> MetaSVM,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> MetaLR,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> M-CAP,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> DEOGEN2,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> InMeRF,<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> VARITY,<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> MetaRNN,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> MVP.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> Detailed information about these predictors
can be found in <xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref> (detailed descriptions), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S6</ext-link> (features
predictor used), and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S12</ext-link> (predictor
description, score range, and threshold setting).</p>
      <table-wrap id="tbl4" position="float">
        <label>Table 4</label>
        <caption>
          <title>Detailed Descriptions of the Compared
Predictors<xref rid="t4fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">name</th>
              <th style="border:none;" align="center">integrated</th>
              <th style="border:none;" align="center">pub-year</th>
              <th style="border:none;" align="center">prediction
technology</th>
              <th style="border:none;" align="center">webserver or web site of predictors</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2013</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://karchinlab.org/apps/appVest.html">http://karchinlab.org/apps/appVest.html</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2015</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://provean.jcvi.org/index.php">http://provean.jcvi.org/index.php</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2020</td>
              <td style="border:none;" align="left">Bayes rule</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://precomputed.list-s2.msl.ubc.ca/">https://precomputed.list-s2.msl.ubc.ca/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">graph attention neural network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/ShenLab/gMVP/">https://github.com/ShenLab/gMVP/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2014</td>
              <td style="border:none;" align="left">support vector machine</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ghttps://doi.org/10.1093/hmg/ddu733">https://doi.org/10.1093/hmg/ddu733</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2014</td>
              <td style="border:none;" align="left">logistic regression</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ghttps://doi.org/10.1093/hmg/ddu733">https://doi.org/10.1093/hmg/ddu733</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2016</td>
              <td style="border:none;" align="left">gradient boosting tree</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://bejerano.stanford.edu/MCAP/">http://bejerano.stanford.edu/MCAP/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2017</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://deogen2.mutaframe.com/">https://deogen2.mutaframe.com/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2020</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/">https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2021</td>
              <td style="border:none;" align="left">gradient boosted trees</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://varity.varianteffect.org/">http://varity.varianteffect.org/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">recurrent neural network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.liulab.science/metarnn.html">http://www.liulab.science/metarnn.html</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">deep residual network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/ShenLab/missense">https://github.com/ShenLab/missense</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2023</td>
              <td style="border:none;" align="left">consensus and XGBoost</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2023</td>
              <td style="border:none;" align="left">consensus and XGBoost</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t4fn1">
            <label>a</label>
            <p>Note: EvoIndMM evaluated 4969 mutations
(please refer to the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S13</ext-link> for reasons),
while others evaluated 5958 mutations. MetaSVM uses MetaSVM_rankscore,
MetaRNN uses MetaRNN_rankscore, gMVP uses gMVP_rankscore, VARITY uses
VARITY_R_rankscore, VEST4 uses VEST4_rankscore, DEOGEN2 uses DEOGEN2_rankscore,
LIST_S2 uses LIST_S2_rankscore, M_CAP uses M_CAP_rankscore, MVP uses
MVP_rankscore, MetaLR uses MetaLR_rankscore, PROVEAN uses PROVEAN_converted_rankscore.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Before embarking upon a formal
comparison, we conducted meticulous
checks at two levels as follows. (1) Variation level: We rigorously
examined the variants in the blind test data set and those in the
model training data set, identifying no instances of overlap; (2)
Protein level: our analysis identified that 448 proteins, identified
by ENSP_id, from the blind test data set were also present in the
training data set. Taking into consideration the presence of overlapping
ENSP_ids, we partitioned our findings into two distinct categories
to facilitate a more meticulous comparison. These categories included
comparison results that only encompassed recurring protein ENSP_ids
(depicted in <xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref> and discussed in <xref rid="sec4.3.1" ref-type="other">Section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>), and those devoid of recurring protein ENSP_ids (illustrated
in <xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref> and delineated
in <xref rid="sec4.3.2" ref-type="other">Section <xref rid="sec4.3.2" ref-type="other">4.3.2</xref></xref>). These findings are also cataloged comprehensively in <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>.</p>
      <table-wrap id="tbl5" position="float">
        <label>Table 5</label>
        <caption>
          <title>Performance
Comparison of ConsMM,
EvoIndMM, and Existing Predictors on the Blind Test Set</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">repeated</th>
              <th style="border:none;" align="center">predictor name</th>
              <th style="border:none;" align="center" char=".">recall/sen</th>
              <th style="border:none;" align="center" char=".">Spe</th>
              <th style="border:none;" align="center" char=".">Pre</th>
              <th style="border:none;" align="center" char=".">NPV</th>
              <th style="border:none;" align="center" char=".">F<sub>1</sub></th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">MCC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="14" style="border:none;" align="left">repeated protein (consisting
of 488 proteins
with 2593 variants)</td>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="char" char=".">0.9407</td>
              <td style="border:none;" align="char" char=".">0.7541</td>
              <td style="border:none;" align="char" char=".">0.8256</td>
              <td style="border:none;" align="char" char=".">0.9114</td>
              <td style="border:none;" align="char" char=".">0.8794</td>
              <td style="border:none;" align="char" char=".">0.8573</td>
              <td style="border:none;" align="char" char=".">0.7156</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="char" char=".">0.8159</td>
              <td style="border:none;" align="char" char=".">0.7368</td>
              <td style="border:none;" align="char" char=".">0.7932</td>
              <td style="border:none;" align="char" char=".">0.7639</td>
              <td style="border:none;" align="char" char=".">0.8044</td>
              <td style="border:none;" align="char" char=".">0.7806</td>
              <td style="border:none;" align="char" char=".">0.5549</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="char" char=".">0.8173</td>
              <td style="border:none;" align="char" char=".">0.7170</td>
              <td style="border:none;" align="char" char=".">0.7813</td>
              <td style="border:none;" align="char" char=".">0.7603</td>
              <td style="border:none;" align="char" char=".">0.7989</td>
              <td style="border:none;" align="char" char=".">0.7725</td>
              <td style="border:none;" align="char" char=".">0.5379</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="char" char=".">0.9135</td>
              <td style="border:none;" align="char" char=".">0.6471</td>
              <td style="border:none;" align="char" char=".">0.7621</td>
              <td style="border:none;" align="char" char=".">0.8581</td>
              <td style="border:none;" align="char" char=".">0.8310</td>
              <td style="border:none;" align="char" char=".">0.7944</td>
              <td style="border:none;" align="char" char=".">0.5897</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="char" char=".">0.9407</td>
              <td style="border:none;" align="char" char=".">0.6264</td>
              <td style="border:none;" align="char" char=".">0.7570</td>
              <td style="border:none;" align="char" char=".">0.8952</td>
              <td style="border:none;" align="char" char=".">0.8389</td>
              <td style="border:none;" align="char" char=".">0.8002</td>
              <td style="border:none;" align="char" char=".">0.6082</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="char" char=".">0.9268</td>
              <td style="border:none;" align="char" char=".">0.6264</td>
              <td style="border:none;" align="char" char=".">0.7543</td>
              <td style="border:none;" align="char" char=".">0.8736</td>
              <td style="border:none;" align="char" char=".">0.8317</td>
              <td style="border:none;" align="char" char=".">0.7925</td>
              <td style="border:none;" align="char" char=".">0.5894</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="char" char=".">0.9596</td>
              <td style="border:none;" align="char" char=".">0.8136</td>
              <td style="border:none;" align="char" char=".">0.8643</td>
              <td style="border:none;" align="char" char=".">0.9421</td>
              <td style="border:none;" align="char" char=".">0.9095</td>
              <td style="border:none;" align="char" char=".">0.8943</td>
              <td style="border:none;" align="char" char=".">0.7896</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="char" char=".">0.9191</td>
              <td style="border:none;" align="char" char=".">0.5876</td>
              <td style="border:none;" align="char" char=".">0.7339</td>
              <td style="border:none;" align="char" char=".">0.8545</td>
              <td style="border:none;" align="char" char=".">0.8161</td>
              <td style="border:none;" align="char" char=".">0.7709</td>
              <td style="border:none;" align="char" char=".">0.5460</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="char" char=".">0.8954</td>
              <td style="border:none;" align="char" char=".">0.7843</td>
              <td style="border:none;" align="char" char=".">0.8370</td>
              <td style="border:none;" align="char" char=".">0.8584</td>
              <td style="border:none;" align="char" char=".">0.8652</td>
              <td style="border:none;" align="char" char=".">0.8457</td>
              <td style="border:none;" align="char" char=".">0.6875</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="char" char=".">0.8375</td>
              <td style="border:none;" align="char" char=".">0.7921</td>
              <td style="border:none;" align="char" char=".">0.8329</td>
              <td style="border:none;" align="char" char=".">0.7976</td>
              <td style="border:none;" align="char" char=".">0.8352</td>
              <td style="border:none;" align="char" char=".">0.8172</td>
              <td style="border:none;" align="char" char=".">0.6300</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="char" char=".">0.8961</td>
              <td style="border:none;" align="char" char=".">0.9974</td>
              <td style="border:none;" align="char" char=".">0.9977</td>
              <td style="border:none;" align="char" char=".">0.8858</td>
              <td style="border:none;" align="char" char=".">0.9442</td>
              <td style="border:none;" align="char" char=".">0.9414</td>
              <td style="border:none;" align="char" char=".">0.8885</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="char" char=".">0.9693</td>
              <td style="border:none;" align="char" char=".">0.5789</td>
              <td style="border:none;" align="char" char=".">0.7401</td>
              <td style="border:none;" align="char" char=".">0.9385</td>
              <td style="border:none;" align="char" char=".">0.8394</td>
              <td style="border:none;" align="char" char=".">0.7948</td>
              <td style="border:none;" align="char" char=".">0.6100</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="char" char=".">0.9296</td>
              <td style="border:none;" align="char" char=".">0.8878</td>
              <td style="border:none;" align="char" char=".">0.9111</td>
              <td style="border:none;" align="char" char=".">0.9106</td>
              <td style="border:none;" align="char" char=".">0.9203</td>
              <td style="border:none;" align="char" char=".">0.9109</td>
              <td style="border:none;" align="char" char=".">0.8196</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="char" char=".">0.9150</td>
              <td style="border:none;" align="char" char=".">0.9617</td>
              <td style="border:none;" align="char" char=".">0.9719</td>
              <td style="border:none;" align="char" char=".">0.8866</td>
              <td style="border:none;" align="char" char=".">0.9426</td>
              <td style="border:none;" align="char" char=".">0.9341</td>
              <td style="border:none;" align="char" char=".">0.8675</td>
            </tr>
            <tr>
              <td rowspan="14" style="border:none;" align="left">nonrepeated protein
(consisting of 420 proteins
with 3365 variants)</td>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="char" char=".">0.9539</td>
              <td style="border:none;" align="char" char=".">0.7864</td>
              <td style="border:none;" align="char" char=".">0.8028</td>
              <td style="border:none;" align="char" char=".">0.9492</td>
              <td style="border:none;" align="char" char=".">0.8719</td>
              <td style="border:none;" align="char" char=".">0.8663</td>
              <td style="border:none;" align="char" char=".">0.7461</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="char" char=".">0.8249</td>
              <td style="border:none;" align="char" char=".">0.7625</td>
              <td style="border:none;" align="char" char=".">0.7600</td>
              <td style="border:none;" align="char" char=".">0.8269</td>
              <td style="border:none;" align="char" char=".">0.7912</td>
              <td style="border:none;" align="char" char=".">0.7923</td>
              <td style="border:none;" align="char" char=".">0.5872</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="char" char=".">0.8399</td>
              <td style="border:none;" align="char" char=".">0.6909</td>
              <td style="border:none;" align="char" char=".">0.7125</td>
              <td style="border:none;" align="char" char=".">0.8255</td>
              <td style="border:none;" align="char" char=".">0.7709</td>
              <td style="border:none;" align="char" char=".">0.7620</td>
              <td style="border:none;" align="char" char=".">0.5344</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="char" char=".">0.9221</td>
              <td style="border:none;" align="char" char=".">0.6625</td>
              <td style="border:none;" align="char" char=".">0.7136</td>
              <td style="border:none;" align="char" char=".">0.9032</td>
              <td style="border:none;" align="char" char=".">0.8046</td>
              <td style="border:none;" align="char" char=".">0.7863</td>
              <td style="border:none;" align="char" char=".">0.6005</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="char" char=".">0.9402</td>
              <td style="border:none;" align="char" char=".">0.5807</td>
              <td style="border:none;" align="char" char=".">0.6716</td>
              <td style="border:none;" align="char" char=".">0.9141</td>
              <td style="border:none;" align="char" char=".">0.7835</td>
              <td style="border:none;" align="char" char=".">0.7522</td>
              <td style="border:none;" align="char" char=".">0.5523</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="char" char=".">0.9327</td>
              <td style="border:none;" align="char" char=".">0.6091</td>
              <td style="border:none;" align="char" char=".">0.6851</td>
              <td style="border:none;" align="char" char=".">0.9085</td>
              <td style="border:none;" align="char" char=".">0.7900</td>
              <td style="border:none;" align="char" char=".">0.7634</td>
              <td style="border:none;" align="char" char=".">0.5671</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="char" char=".">0.9483</td>
              <td style="border:none;" align="char" char=".">0.8540</td>
              <td style="border:none;" align="char" char=".">0.8555</td>
              <td style="border:none;" align="char" char=".">0.9477</td>
              <td style="border:none;" align="char" char=".">0.8995</td>
              <td style="border:none;" align="char" char=".">0.8990</td>
              <td style="border:none;" align="char" char=".">0.8027</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="char" char=".">0.9333</td>
              <td style="border:none;" align="char" char=".">0.5608</td>
              <td style="border:none;" align="char" char=".">0.6596</td>
              <td style="border:none;" align="char" char=".">0.9022</td>
              <td style="border:none;" align="char" char=".">0.7730</td>
              <td style="border:none;" align="char" char=".">0.7385</td>
              <td style="border:none;" align="char" char=".">0.5269</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="char" char=".">0.9115</td>
              <td style="border:none;" align="char" char=".">0.8295</td>
              <td style="border:none;" align="char" char=".">0.8298</td>
              <td style="border:none;" align="char" char=".">0.9114</td>
              <td style="border:none;" align="char" char=".">0.8688</td>
              <td style="border:none;" align="char" char=".">0.8686</td>
              <td style="border:none;" align="char" char=".">0.7411</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="char" char=".">0.8704</td>
              <td style="border:none;" align="char" char=".">0.8261</td>
              <td style="border:none;" align="char" char=".">0.8203</td>
              <td style="border:none;" align="char" char=".">0.8748</td>
              <td style="border:none;" align="char" char=".">0.8446</td>
              <td style="border:none;" align="char" char=".">0.8473</td>
              <td style="border:none;" align="char" char=".">0.6959</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="char" char=".">0.9016</td>
              <td style="border:none;" align="char" char=".">0.9972</td>
              <td style="border:none;" align="char" char=".">0.9966</td>
              <td style="border:none;" align="char" char=".">0.9174</td>
              <td style="border:none;" align="char" char=".">0.9467</td>
              <td style="border:none;" align="char" char=".">0.9516</td>
              <td style="border:none;" align="char" char=".">0.9063</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="char" char=".">0.9483</td>
              <td style="border:none;" align="char" char=".">0.5830</td>
              <td style="border:none;" align="char" char=".">0.6746</td>
              <td style="border:none;" align="char" char=".">0.9252</td>
              <td style="border:none;" align="char" char=".">0.7884</td>
              <td style="border:none;" align="char" char=".">0.7572</td>
              <td style="border:none;" align="char" char=".">0.5645</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="char" char=".">0.9283</td>
              <td style="border:none;" align="char" char=".">0.9364</td>
              <td style="border:none;" align="char" char=".">0.9301</td>
              <td style="border:none;" align="char" char=".">0.9348</td>
              <td style="border:none;" align="char" char=".">0.9292</td>
              <td style="border:none;" align="char" char=".">0.9325</td>
              <td style="border:none;" align="char" char=".">0.8648</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="char" char=".">0.9261</td>
              <td style="border:none;" align="char" char=".">0.9840</td>
              <td style="border:none;" align="char" char=".">0.9851</td>
              <td style="border:none;" align="char" char=".">0.9213</td>
              <td style="border:none;" align="char" char=".">0.9547</td>
              <td style="border:none;" align="char" char=".">0.9532</td>
              <td style="border:none;" align="char" char=".">0.9082</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="fig9" position="float">
        <label>Figure 9</label>
        <caption>
          <p>Several evaluation
values of the compared predictors on the blind
test set (with repeated protein with training data) (A) ROC curves,
(B) PR curves, (C) ACC values, (D) MCC values.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0009" id="gr9" position="float"/>
      </fig>
      <fig id="fig10" position="float">
        <label>Figure 10</label>
        <caption>
          <p>Several
evaluation values of the compared predictors on the blind
test set (with nonrepeated protein with training data) (A) ROC curves,
(B) PR curves, (C) ACC values, (D) MCC values.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0010" id="gr10" position="float"/>
      </fig>
      <sec id="sec4.3.1">
        <label>4.3.1</label>
        <title>Comparison Results of Repeated Proteins</title>
        <p>We pursued
an in-depth analysis based on the comparative results
shown in <xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>,
partial information from <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>, as follows:<list list-type="simple"><list-item><p>(1) Integrated versus individual predictors:
Among individual
predictors, VEST4 demonstrated superior performance with an MCC of
0.7156, AUROC of 0.9414, and an AUPR of 0.9484. Meanwhile, among integrated-predictors,
MetaRNN stood out with an MCC of 0.8885, an AUROC of 0.9936, and an
AUPR of 0.9955. Evidently, integrated-predictors (e.g., MetaRNN) that
utilize a combination of multiple predictive factors outperform individual
predictors. The MCC of MetaRNN IS 0.1729 higher than that of VEST4,
indicating that integrated-predictors greatly exceed individual predictors
in terms of correlation between predictions and actual values.</p></list-item><list-item><p>(2) Top predictors based on existing methods:
Based
on the evaluation metrics of MCC, AUROC, and AUPR, the most distinguished
predictor is MetaRNN (with MCC: 0.8885, AUROC: 0.9936, and AUPR: 0.9955).
Following closely, M-CAP demonstrates significant predictive power
with an MCC of 0.7983, an AUROC of 0.9529, and an AUPR of 0.9407.
InMeRF also delivers commendable results, achieving an MCC of 0.7195,
an AUROC of 0.9349, and an AUPR of 0.9289. MetaRNN<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> utilizes 16 different scoring tools such as SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Polyphen2_HDIV and Polyphen2_HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> along with eight conservation scores and allele
frequency information from 1000 Gp3,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and gnomAD.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> It
employs complex recurrent neural networks for prediction, demonstrating
high integration and learning capabilities. M-CAP<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> incorporates nine deleteriousness prediction scores and
seven conservation scores, employing gradient boosting trees for prediction.
This approach can handle diverse data types and exhibits robustness
against noise, leading to improved predictive accuracy. InMeRF<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> employs Rankscores of 34 tools available in
dbNSFP v4.0a,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> including SIFT,,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> SIFT4G,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Polyphen2_HDIV,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> etc. By integration of the strengths of these
tools, enhanced prediction accuracy. Although these predictors employ
different methodologies, they all demonstrate strong integration and
learning capabilities, robustness against noise, and improved prediction
accuracy through the combination of various tools.</p></list-item><list-item><p>(3) Comparison of ConsMM and EvoIndMM with top three
existing predictors: ConsMM has an MCC of 0.8196, AUROC of 0.9777,
and AUPR of 0.9837, while EvoIndMM has an MCC of 0.8675, AUROC of
0.9844, and AUPR of 0.9905. Both demonstrate superior performance
on all three metrics (MCC, AUROC, and AUPR) compared to InMeRF and
M-CAP in the top three predictors but slightly fall short of MetaRNN.
This suggests that ConsMM and EvoIndMM exhibit high performance in
terms of prediction accuracy and correlation with actual results.
Collectively, the three most optimal predictors are ConsMM, EvoIndMM,
and MetaRNN, among all predictors.</p></list-item><list-item><p>(4)
Reasons for superior performance of top three predictors:
Analyzing the terms of “Integrated” and “Prediction
technology” (listed in Table 4), “Features Predictor
used” (listed in Table S6), it is easily seen that MetaRNN,
ConsMM, and EvoIndMM all belong to the category of meta-predictors.
Unlike traditional individual prediction predictors, they integrate
outputs from multiple prediction methods/models to enhance the comprehensiveness
and accuracy of prediction results.</p></list-item></list></p>
        <p>The
superior performances of ConsMM and EvoIndMM can
be attributed to several key factors. First, they were trained on
a newly constructed, large-scale nonredundant data set that encompasses
all known MMs gathered from the entire Ensembl database. Second, consensus
technology bolsters the accuracy and reliability by integrating multiple
prediction methods and annotations. Third, employing the powerful
XGBoost algorithm enables the effective handling of intricate feature
relationships, increasing predictive power and robustness. Lastly,
additional data sources such as EvoIndMM’s use of VEP outputs,
ESM-1b, and ProtT5-XU embeddings further optimize the predictions.
In conclusion, the outstanding performance of ConsMM and EvoIndMM
derives from the synergy of these elements, fully exploiting the outputs
from various tools and advanced machine learning technologies. Their
approaches capture complex relationships within data, enriching information,
and thus enabling accurate and comprehensive predictions of MM pathogenicity.</p>
      </sec>
    </sec>
    <sec id="sec4.3.2">
      <label>4.3.2</label>
      <title>Comparison Results with Nonrepeated Proteins</title>
      <p>Utilizing the results portrayed in <xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref>, partial data from <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>, we executed
a thorough analysis as follows:</p>
      <sec id="sec4.3.2.1">
        <p>(1) Comparative analysis of
evaluation metrics: Similar to the
results depicted in <xref rid="sec4.3.1" ref-type="other">Section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>, VEST4 notably outperformed all other individual predictors,
achieving an MCC of 0.7461, an AUROC of 0.9544, and an AUPR of 0.9488.
Among the existing integrated predictors, MetaRNN, M-CAP, and InMeRF
emerged as the top three performers exhibiting respective MCC, AUROC,
and AUPR scores of 0.9063, 0.9905, 0.9920; 0.8027, 0.9578, 0.9464;
and 0.7411, 0.9416, 0.9303. Notwithstanding, even though ConsMM and
EvoIndMM, positing MCC, AUROC, and AUPR measures of 0.8648, 0.9836,
0.9854 and 0.9082, 0.9852, 0.9902 correspondingly, trailed behind
MetaRNN marginally, they nevertheless surpassed both M-CAP and InMeRF
in terms of performance efficacy.</p>
        <p>(2) Comparative analysis of
performance metric–repeated protein vs nonrepeated protein
group: The performance metrics of VEST4, M-CAP, InMeRF, ConsMM, and
EvoIndMM revealed marginally superior outcomes for the “nonrepeated
protein” group, as demonstrated by the average ACC, MCC, AUROC,
and AUPR scores of 0.9121, 0.8257, 0.9701, and 0.9647 respectively.
In contrast, the corresponding metrics for the “Repeated protein”
group yielded averaged ACC, MCC, AUROC, and AUPR values of 0.8957,
0.8077, 0.9660, and 0.9697. Furthermore, MetaRNN demonstrated unwavering,
top-tier performance across both categories, thereby attesting to
its inherent robustness and capacity for generalization. Within the
confines of the “nonrepeated protein” group, ConsMM
and EvoIndMM surpassed almost all competing predictors (except for
MetaRNN) on evaluated metrics.</p>
        <p>(3) Underlying factors for observed
phenomena: The disparities
in predictive efficacy observed between “Repeated protein”
and “Nonrepeated protein” groups could be attributed
to the following factors. (A) Data distribution variations: A significant
discrepancy in data distribution between these data sets could be
a key factor. It is plausible to presume that different data distributions
exist, with nonrepeated proteins possibly favoring specific predictive
models. Such distinct distributions likely influence a model’s
ability to generalize and forecast accurately. (B) Influence of the
Protein Characteristics: The novel ConsMM and EvoIndMM models leverage
feature embeddings from amino acid mutation sites, acquired via ESM1b
and ProtT5 pretraining, rather than relying on features extracted
from the entire protein sequence. Consequently, these methodologies
demonstrate minimal variation in their predictive performances when
applied to either the “Repeated protein” or “Nonrepeated
protein” group.</p>
        <p>(4) Additional experiment on unsegmented
blind test data: Beyond
the experiments detailed in <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref>, we conducted an additional set of tests. In this experiment, the
blind test data set was evaluated entirely independently, devoid of
any segmentation or group-based analysis (please refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S5 and Tables S8,S9</ext-link> for further details).
An inclusive comparison of these results (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S5 and Tables S8,S9</ext-link>) with those from <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref> indicates that this new performance metrics set typically lies between <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref> results. Across all experiment sets, most
performance metrics of the predictors display insignificant differences.
Herein, for meticulous result comparisons, we persist in employing
the grouped performance metrics as the principal evaluation indicators
for our predictors. This conservative methodology ensures the highest
level of validity and reliability of our experimental outcomes.</p>
      </sec>
    </sec>
  </sec>
  <sec id="sec4.4">
    <label>4.4</label>
    <title>Case Study</title>
    <p>In this section, we analyzed
12 pathogenic GOF or LOF variations
in nine genes (DICER1, PTEN, CDKN2A, TREM2, SCN5A, GABRA1, KCNH2,
KCNQ1, RET) that are associated with diseases. For instance, PTEN
is associated with hereditary cancer syndromes, like Cowden syndrome
and Bannayan-Riley-Ruvalcaba syndrome,<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> while TREM2 is linked to neurodegenerative diseases, such as Alzheimer’s
disease.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> Detailed information about these
variations can be found in <xref rid="tbl6" ref-type="other">Tables <xref rid="tbl6" ref-type="other">6</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S10</ext-link>, and the heatmap
of predictors for the 12 variations is presented in <xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>.</p>
    <fig id="fig11" position="float">
      <label>Figure 11</label>
      <caption>
        <p>Heatmap of predictors
for 12 variations.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0011" id="gr11" position="float"/>
    </fig>
    <table-wrap id="tbl6" position="float">
      <label>Table 6</label>
      <caption>
        <title>Detailed
Information on 12 Pathogenic
GOF/LOF Variations<xref rid="t6fn1" ref-type="table-fn">a</xref></title>
      </caption>
      <table frame="hsides" rules="groups" border="0">
        <colgroup>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
        </colgroup>
        <thead>
          <tr>
            <th style="border:none;" align="center">variations</th>
            <th style="border:none;" align="center">verdict</th>
            <th style="border:none;" align="center">symbol</th>
            <th style="border:none;" align="center">Pfam_dom</th>
            <th style="border:none;" align="center">inheritance</th>
            <th style="border:none;" align="center">cDNA_pos</th>
            <th style="border:none;" align="center">CDS_pos</th>
            <th style="border:none;" align="center">Protein_pos</th>
            <th style="border:none;" align="center">AA</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td style="border:none;" align="left">14_95598904_G/C</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">DICER1</td>
            <td style="border:none;" align="left">PF00270</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">547/10331</td>
            <td style="border:none;" align="left">255/5769</td>
            <td style="border:none;" align="left">85/1922</td>
            <td style="border:none;" align="left">I/M</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_89653846_C/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">PTEN</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1501/9027</td>
            <td style="border:none;" align="left">144/1212</td>
            <td style="border:none;" align="left">48/403</td>
            <td style="border:none;" align="left">N/K</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">9_21971152_T/C</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">CDKN2A</td>
            <td style="border:none;" align="left">PF12796</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">245/880</td>
            <td style="border:none;" align="left">206/504</td>
            <td style="border:none;" align="left">69/167</td>
            <td style="border:none;" align="left">E/G</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">3_38662376_C/T</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">SCN5A</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">763/8504</td>
            <td style="border:none;" align="left">569/6051</td>
            <td style="border:none;" align="left">190/2016</td>
            <td style="border:none;" align="left">R/Q</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">5_161309659_G/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">GABRA1</td>
            <td style="border:none;" align="left">PF02931</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1010/4273</td>
            <td style="border:none;" align="left">655/1371</td>
            <td style="border:none;" align="left">219/456</td>
            <td style="border:none;" align="left">D/N</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">3_38598763_C/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">SCN5A</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">4452/8504</td>
            <td style="border:none;" align="left">4258/6051</td>
            <td style="border:none;" align="left">1420/2016</td>
            <td style="border:none;" align="left">G/R</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">7_150649683_A/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">KCNH2</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1789/4286</td>
            <td style="border:none;" align="left">1387/3480</td>
            <td style="border:none;" align="left">463/1159</td>
            <td style="border:none;" align="left">F/L</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">11_2592576_C/T</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">KCNQ1</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">734/3245</td>
            <td style="border:none;" align="left">626/2031</td>
            <td style="border:none;" align="left">209/676</td>
            <td style="border:none;" align="left">S/F</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">11_2608811_G/T</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">KCNQ1</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">1248/3245</td>
            <td style="border:none;" align="left">1140/2031</td>
            <td style="border:none;" align="left">380/676</td>
            <td style="border:none;" align="left">R/S</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43609061_A/G</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">2049/5659</td>
            <td style="border:none;" align="left">1817/3345</td>
            <td style="border:none;" align="left">606/1114</td>
            <td style="border:none;" align="left">Y/C</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43619231_A/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">PF07714</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">2922/5659</td>
            <td style="border:none;" align="left">2690/3345</td>
            <td style="border:none;" align="left">897/1114</td>
            <td style="border:none;" align="left">R/Q</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43615611_G/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">PF07714</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">3146/5659</td>
            <td style="border:none;" align="left">2914/3345</td>
            <td style="border:none;" align="left">972/1114</td>
            <td style="border:none;" align="left">R/G</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="t6fn1">
          <label>a</label>
          <p>Note: Verdict, Pfam_dom, and Inheritance
information were collected from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://itanlab.shinyapps.io/goflof/">https://itanlab.shinyapps.io/goflof/</uri>. Pfam_dom: protein domains built on sequence similarity and functional
characteristics. Inheritance information includes AD (Autosomal Dominant)
and ADAR (Adenosine Deaminases Acting on RNA). cDNA_pos: cDNA_position,
CDS_pos: CDS_position, Protein_pos: Protein_position, AA: amino acid.
cDNA_position, CDS_position, Protein_position, Amino_acids, and ENSP
information were collected from Ensembl VEP. The variant positions
indicate the amino acid’s position in the protein and the base
pair’s position in the cDNA or coding sequence. Utilizing ENSP
and the Ensembl API enables retrieval of the encoded protein sequence.
Besides, 14_95598904_G/C is in protein ENSP00000437256; 10_89653846_C/A
in ENSP00000361021; 9_21971152_T/C in ENSP00000418915; 3_38662376_C/T
and 3_38598763_C/G in ENSP00000410257; 5_161309659_G/A in ENSP00000393097;
7_150649683_A/G in ENSP00000262186; 11_2592576_C/T and 11_2608811_G/T
in ENSP00000155840; 10_43609061_A/G, 10_43619231_A/G, and 10_43615611_G/A
in ENSP00000347942.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>Among
the variations shown in <xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>, our developed models (ConsMM and EvoIndMM)
generally exhibited superior performance compared to other predictors,
except for the 14_95598904_G/C variation in the DICER1 gene, which
is linked to tumors like childhood multicystic nephroma and pulmonary
cystic lung lesions.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> As indicated in <xref rid="tbl6" ref-type="other">Tables <xref rid="tbl6" ref-type="other">6</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S10</ext-link>, this MM (I to M at the 85th site in ENSP00000437256)
could potentially lead to a loss of function in DICER1. The Essentiality
score<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> for DICER1 is 0.924045225, signifying
its significant role in biological processes and its RVIS score<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> is −1.52, indicating heightened vulnerability
to variations.</p>
    <p>ConsMM and EvoIndMM are developed through extensive
predictions
and annotations derived from multiple individual predictors. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S10</ext-link> provides several indicators suggesting
the benign nature of 14_95598904_G/C. According to these tools, this
variant is predicted as tolerated (0.14, SIFT<sup><xref ref-type="bibr" rid="ref10">10</xref></sup>), benign (0.053, PolyPhen<sup><xref ref-type="bibr" rid="ref2">2</xref></sup>), and neutral
(0.253, Condel<sup><xref ref-type="bibr" rid="ref66">66</xref></sup>), indicating a lack of
significant pathogenic effects. Furthermore, CADD (18.84),<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> REVEL<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> (0.656), LoFtool<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> (0.233), and ExACpLI<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> (1.0) scores suggest a minor impact on pathogenicity and a lower
probability of causing loss of gene function.</p>
    <p>EvoIndMM, incorporates
embeddings from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> capturing
physicochemical properties and evolutionary conservation. Analyzing
the scores in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S10</ext-link>, multiple indicators
point toward minimal alterations in the protein sequence. The IUPRED2<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> score (0.1731) indicates a low tendency for
disorder, while the ANCHOR2<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> score (0.277)
suggests limited binding regions. Besides, the RSA score (0.247) implies
no significant impact on solvent accessibility, and the Zfit score
(−1.063) signifies a minor effect on protein structure and
function. The RSA_class is categorized as “B”, indicating
a minor effect on protein solvent accessibility. Additionally, the
“helix_prob” (0.694), “beta_prob” (0.003),
and “coil_prob” (0.303) values suggest no significant
disruption to the protein’s secondary structure.</p>
  </sec>
  <sec id="sec5">
    <label>5</label>
    <title>Conclusions</title>
    <p>Our study contributes to the understanding of
MM pathogenicity.
In this work, we first constructed a nonredundant MM benchmark data
set and a blind test set that specifically focused on pathogenic GOF/LOF
MM. Then, by utilizing Ensembl VEP v104 and plugins (e.g., dbNSFP
v4.1a), we extracted variant-level, AA-level, individuals’
outputs, and genome-level features for each variation. Additionally,
we collected encoded protein sequences using ENSP identifiers and
Ensembl API, and generated embeddings from ESM-1b and ProtT5-XL-U50
for each mutant site AA. Based on the newly constructed data and extracted
features, we developed the interpretable model group MMPatho, consisting
of ConsMM and EvoIndMM. ConsMM utilized individuals’ outputs
and employed XGBoost with SHAP analyses, achieving outstanding prediction
performance, while EvoIndMM enhanced the model’s predictive
capacity by incorporating evolutionary characteristics derived from
ESM-1b and ProtT5-XL-U50. Extensive comparative experiments demonstrated
the remarkable efficacy of ConsMM and EvoIndMM. Our findings can give
certain contribution to the advancement of MM research and provide
valuable tools and data resources for understanding the functional
implications of variations in genetic disease.</p>
  </sec>
</body>
<back>
  <notes notes-type="data-availability" id="notes-1">
    <title>Data Availability Statement</title>
    <p>For easy access,
we implemented a Web server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>) for MM pathogenicity prediction with reliability index score. Additionally,
we uploaded our newly constructed benchmark data set and blind test
set are available at the data page of our Web server. Also, the source
python code used in this paper is available at MMPatho server and
on GitHub.</p>
  </notes>
  <notes id="notes-3" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jcim.3c00950?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.3c00950</ext-link>.<list id="silist" list-type="simple"><list-item><p>Text S1: The versions
of the databases used in Ensembl
VEP v104; Text S2: The detailed plugins information installed in Ensembl
VEP v104; Text S3: Powerful classification using XGBoost and SHAP-based
feature importance analysis; Text S4: Performance evaluation measures;
Text S5: The detailed introduction and parameter settings of LightGBM;
Text S6: The detailed introduction and parameter settings of XGBoost;
Text S7: The detailed introduction and parameter settings of CatBoost;
Text S8: Performance of ConsMM on the test set of benchmark data set
(not using protein ID as the criteria for training and test data splitting);
Text S9: The 80 features importance in ConsMM; Text S10: Assessing
the contribution of different feature sets (not using protein ID as
the criteria for training and test data splitting); Text S11: The
one hundred-60 features importance in EvoIndMM; Text S12: Output description
for state-of-the-art methods in variant pathogenicity prediction on
blind test set; Text S13: The variation number changes during data
procedure in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A of the manuscript; Figure S1: Comparison of CatBoost, XGBoost,
and LightGBM on the test set of the benchmark data set (not using
protein ID as the criteria for training and test data splitting);
Figure S2: Twelve feature interactions for ConsMM; Figure S3: The
ROC and PR curves of EvoIndMM on the test set of the benchmark data
set (not using protein ID as the criteria for training and test data
splitting); Figure S4: Twelve feature interactions for EvoIndMM; Figure
S5: The ROC and PR curves of the compared predictors on the blind
test set (without splitting the blind test data into “repeated
protein” and “non-repeated protein” groups);
Table S1: The detailed descriptions of the features extracted from
Ensembl VEP and dbNSFP; Table S2: Confusion matrix and three types
of errors of CatBoost, XGBoost, and LightGBM on the test set of benchmark
data set (not using protein ID as the criteria for training and test
data splitting); Table S3: Feature importance in the ConsMM model;
Table S4: Performance comparison of EvoIndMM with different features
on the test set of benchmark data set (not using protein ID as the
criteria for training and test data splitting); Table S5: Top 160
feature importance in the EvoIndMM model; Table S6. Detailed descriptions
of the compared predictors; Table S7: The confusion matrix and three
types of ConsMM, EvoIndMM, and existing predictors on the blind test
set; Table S8: Performance comparison of ConsMM, EvoIndMM, and existing
predictors on the blind test set (without splitting the blind test
data into “repeated protein” and “nonrepeated
protein” groups); Table S9: The confusion matrix and three
types of ConsMM, EvoIndMM, and existing predictors on the blind test
set (without splitting the blind test data into “repeated protein”
and “nonrepeated protein” groups); Table S10: Detailed
information on the 12 variants for case study (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_si_001.pdf">
        <caption>
          <p>ci3c00950_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="COI-statement" id="notes-2">
    <p>The authors
declare no competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work
was supported by the Natural Science Research Start-up
Foundation of Recruiting Talents of Nanjing University of Posts and
Telecommunications (Grant No. NY223062), the National Natural Science
Foundation of China (62372234 and 62072243), the Natural Science Foundation
of Jiangsu (BK20201304), the National Research Council of Thailand
and Mahidol University (N42A660380), and the Specific League Funds
from Mahidol University.</p>
  </ack>
  <glossary id="dl1">
    <def-list>
      <title>Abbreviations</title>
      <def-item>
        <term>CADD</term>
        <def>
          <p>combined annotation-dependent depletion;</p>
        </def>
      </def-item>
      <def-item>
        <term>CatBoost</term>
        <def>
          <p>categorical
boosting;</p>
        </def>
      </def-item>
      <def-item>
        <term>ClinVar</term>
        <def>
          <p>clinical variants;</p>
        </def>
      </def-item>
      <def-item>
        <term>COSMIC</term>
        <def>
          <p>catalogue of somatic mutations
in cancer;</p>
        </def>
      </def-item>
      <def-item>
        <term>ConsMM</term>
        <def>
          <p>consensus MM pathogenic prediction;</p>
        </def>
      </def-item>
      <def-item>
        <term>dbNSFP</term>
        <def>
          <p>database for nonsynonymous SNPs’
functional predictions;</p>
        </def>
      </def-item>
      <def-item>
        <term>dbSNP</term>
        <def>
          <p>single nucleotide polymorphism
database;</p>
        </def>
      </def-item>
      <def-item>
        <term>ENSP</term>
        <def>
          <p>Ensembl
protein;</p>
        </def>
      </def-item>
      <def-item>
        <term>Ensembl VEP</term>
        <def>
          <p>Ensembl variant effect predictor;</p>
        </def>
      </def-item>
      <def-item>
        <term>ESM</term>
        <def>
          <p>evolutionary scale modeling;</p>
        </def>
      </def-item>
      <def-item>
        <term>ExAC</term>
        <def>
          <p>exome aggregation consortium;</p>
        </def>
      </def-item>
      <def-item>
        <term>EvoIndMM</term>
        <def>
          <p>evolutionary
information and
individual outputs for MM pathogenic prediction;</p>
        </def>
      </def-item>
      <def-item>
        <term>GOF/LOF</term>
        <def>
          <p>gain of function, loss of function;</p>
        </def>
      </def-item>
      <def-item>
        <term>gnomAD</term>
        <def>
          <p>genome aggregation
database;</p>
        </def>
      </def-item>
      <def-item>
        <term>HGMD</term>
        <def>
          <p>human
gene mutation database;</p>
        </def>
      </def-item>
      <def-item>
        <term>LightGBM</term>
        <def>
          <p>light gradient boosting machine;</p>
        </def>
      </def-item>
      <def-item>
        <term>PolyPhen-2</term>
        <def>
          <p>polymorphism phenotyping
v2;</p>
        </def>
      </def-item>
      <def-item>
        <term>PROVEAN</term>
        <def>
          <p>protein
variation effect analyzer;</p>
        </def>
      </def-item>
      <def-item>
        <term>ProtTrans</term>
        <def>
          <p>protein transformer;</p>
        </def>
      </def-item>
      <def-item>
        <term>REVEL</term>
        <def>
          <p>rare exome variant ensemble learner;</p>
        </def>
      </def-item>
      <def-item>
        <term>SHAP</term>
        <def>
          <p>Shapley additive explanations;</p>
        </def>
      </def-item>
      <def-item>
        <term>SIFT</term>
        <def>
          <p>sorting intolerant
from tolerant;</p>
        </def>
      </def-item>
      <def-item>
        <term>SwissVar</term>
        <def>
          <p>variants in UniProtKB/Swiss-Prot;</p>
        </def>
      </def-item>
      <def-item>
        <term>VEST4</term>
        <def>
          <p>variant effect scoring tool v4;</p>
        </def>
      </def-item>
      <def-item>
        <term>XGBoost</term>
        <def>
          <p>eXtreme gradient
boosting.</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Tavtigian</surname><given-names>S. V.</given-names></name>; <name><surname>Byrnes</surname><given-names>G. B.</given-names></name>; <name><surname>Goldgar</surname><given-names>D. E.</given-names></name>; <name><surname>Thomas</surname><given-names>A.</given-names></name><article-title>Classification of Rare
Missense Substitutions, using Risk Surfaces, with Genetic-and Molecular-epidemiology
Applications</article-title>. <source>Hum. Mutat.</source><year>2008</year>, <volume>29</volume>, <fpage>1342</fpage>–<lpage>1354</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20896</pub-id>.<pub-id pub-id-type="pmid">18951461</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Adzhubei</surname><given-names>I. A.</given-names></name>; <name><surname>Schmidt</surname><given-names>S.</given-names></name>; <name><surname>Peshkin</surname><given-names>L.</given-names></name>; <name><surname>Ramensky</surname><given-names>V. E.</given-names></name>; <name><surname>Gerasimova</surname><given-names>A.</given-names></name>; <name><surname>Bork</surname><given-names>P.</given-names></name>; <name><surname>Kondrashov</surname><given-names>A. S.</given-names></name>; <name><surname>Sunyaev</surname><given-names>S. R.</given-names></name><article-title>A Method and Server
for Predicting Damaging Missense Mutations</article-title>. <source>Nat. Methods</source><year>2010</year>, <volume>7</volume>, <fpage>248</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Choi</surname><given-names>Y.</given-names></name>; <name><surname>Chan</surname><given-names>A. P.</given-names></name><article-title>PROVEAN
Web Server: a Tool to Predict the Functional
Effect of Amino Acid Substitutions and Indels</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>2745</fpage>–<lpage>2747</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv195</pub-id>.<pub-id pub-id-type="pmid">25851949</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Rentzsch</surname><given-names>P.</given-names></name>; <name><surname>Witten</surname><given-names>D.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Shendure</surname><given-names>J.</given-names></name>; <name><surname>Kircher</surname><given-names>M.</given-names></name><article-title>CADD: Predicting
the Deleteriousness of Variants Throughout the Human Genome</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>, <volume>47</volume>, <fpage>D886</fpage>–<lpage>D894</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1016</pub-id>.<pub-id pub-id-type="pmid">30371827</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Kircher</surname><given-names>M.</given-names></name>; <name><surname>Witten</surname><given-names>D. M.</given-names></name>; <name><surname>Jain</surname><given-names>P.</given-names></name>; <name><surname>O’roak</surname><given-names>B. J.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Shendure</surname><given-names>J.</given-names></name><article-title>A General Framework for Estimating
the Relative Pathogenicity of Human Genetic Variants</article-title>. <source>Nat. Genet.</source><year>2014</year>, <volume>46</volume>, <fpage>310</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2892</pub-id>.<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Carter</surname><given-names>H.</given-names></name>; <name><surname>Douville</surname><given-names>C.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Karchin</surname><given-names>R.</given-names></name><article-title>Identifying
Mendelian Disease Genes with the Variant Effect Scoring Tool</article-title>. <source>BMC Genomics</source><year>2013</year>, <volume>14</volume>, <fpage>S3</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-14-S3-S3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Quan</surname><given-names>L.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Lyu</surname><given-names>Q.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name><article-title>DAMpred: Recognizing Disease-associated
nsSNPs through Bayes-guided Neural-network Model Built on Low-resolution
Structure Prediction of Proteins and Protein-protein Interactions</article-title>. <source>J. Mol. Biol.</source><year>2019</year>, <volume>431</volume>, <fpage>2449</fpage>–<lpage>2459</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2019.02.017</pub-id>.<pub-id pub-id-type="pmid">30796987</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Capriotti</surname><given-names>E.</given-names></name>; <name><surname>Ozturk</surname><given-names>K.</given-names></name>; <name><surname>Carter</surname><given-names>H.</given-names></name><article-title>Integrating Molecular
Networks with
Genetic Variant Interpretation for Precision Medicine</article-title>. <source>Wiley Interdiscip. Rev. Syst. Biol. Med.</source><year>2019</year>, <volume>11</volume>, <elocation-id>e1443</elocation-id><pub-id pub-id-type="doi">10.1002/wsbm.1443</pub-id>.<pub-id pub-id-type="pmid">30548534</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Hassan</surname><given-names>M. S.</given-names></name>; <name><surname>Shaalan</surname><given-names>A. A.</given-names></name>; <name><surname>Dessouky</surname><given-names>M. I.</given-names></name>; <name><surname>Abdelnaiem</surname><given-names>A. E.</given-names></name>; <name><surname>ElHefnawi</surname><given-names>M.</given-names></name><article-title>A Review Study: Computational Techniques for Expecting
the Impact of Non-synonymous Single Nucleotide Variants in Human Diseases</article-title>. <source>Gene</source><year>2019</year>, <volume>680</volume>, <fpage>20</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2018.09.028</pub-id>.<pub-id pub-id-type="pmid">30240882</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Ng</surname><given-names>P. C.</given-names></name>; <name><surname>Henikoff</surname><given-names>S.</given-names></name><article-title>SIFT: Predicting
Amino Acid Changes that Affect Protein
Function</article-title>. <source>Nucleic Acids Res.</source><year>2003</year>, <volume>31</volume>, <fpage>3812</fpage>–<lpage>3814</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Quang</surname><given-names>D.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>DanQ: a Hybrid Convolutional
and Recurrent Deep Neural Network for
Quantifying the Function of DNA Sequences</article-title>. <source>Nucleic
Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>e107</fpage><pub-id pub-id-type="doi">10.1093/nar/gkw226</pub-id>.<pub-id pub-id-type="pmid">27084946</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Jagadeesh</surname><given-names>K. A.</given-names></name>; <name><surname>Wenger</surname><given-names>A. M.</given-names></name>; <name><surname>Berger</surname><given-names>M. J.</given-names></name>; <name><surname>Guturu</surname><given-names>H.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Bernstein</surname><given-names>J. A.</given-names></name>; <name><surname>Bejerano</surname><given-names>G.</given-names></name><article-title>M-CAP Eliminates a
Majority of Variants of Uncertain Significance in Clinical Exomes
at High Sensitivity</article-title>. <source>Nat. Genet.</source><year>2016</year>, <volume>48</volume>, <fpage>1581</fpage>–<lpage>1586</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3703</pub-id>.<pub-id pub-id-type="pmid">27776117</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Bendl</surname><given-names>J.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Salanda</surname><given-names>O.</given-names></name>; <name><surname>Pavelka</surname><given-names>A.</given-names></name>; <name><surname>Wieben</surname><given-names>E. D.</given-names></name>; <name><surname>Zendulka</surname><given-names>J.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>PredictSNP:
Robust and Accurate Consensus Classifier for Prediction of Disease-related
Mutations</article-title>. <source>PLoS Comput. Biol.</source><year>2014</year>, <volume>10</volume>, <elocation-id>e1003440</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003440</pub-id>.<pub-id pub-id-type="pmid">24453961</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Landrum</surname><given-names>M. J.</given-names></name>; <name><surname>Lee</surname><given-names>J. M.</given-names></name>; <name><surname>Riley</surname><given-names>G. R.</given-names></name>; <name><surname>Jang</surname><given-names>W.</given-names></name>; <name><surname>Rubinstein</surname><given-names>W. S.</given-names></name>; <name><surname>Church</surname><given-names>D. M.</given-names></name>; <name><surname>Maglott</surname><given-names>D. R.</given-names></name><article-title>ClinVar:
Public Archive of Relationships
among Sequence Variation and Human Phenotype</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>, <volume>42</volume>, <fpage>D980</fpage>–<lpage>D985</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1113</pub-id>.<pub-id pub-id-type="pmid">24234437</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Sherry</surname><given-names>S. T.</given-names></name>; <name><surname>Ward</surname><given-names>M.-H.</given-names></name>; <name><surname>Kholodov</surname><given-names>M.</given-names></name>; <name><surname>Baker</surname><given-names>J.</given-names></name>; <name><surname>Phan</surname><given-names>L.</given-names></name>; <name><surname>Smigielski</surname><given-names>E. M.</given-names></name>; <name><surname>Sirotkin</surname><given-names>K.</given-names></name><article-title>dbSNP: the NCBI Database of Genetic
Variation</article-title>. <source>Nucleic Acids Res.</source><year>2001</year>, <volume>29</volume>, <fpage>308</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id>.<pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Rives</surname><given-names>A.</given-names></name>; <name><surname>Meier</surname><given-names>J.</given-names></name>; <name><surname>Sercu</surname><given-names>T.</given-names></name>; <name><surname>Goyal</surname><given-names>S.</given-names></name>; <name><surname>Lin</surname><given-names>Z.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>D.</given-names></name>; <name><surname>Ott</surname><given-names>M.</given-names></name>; <name><surname>Zitnick</surname><given-names>C. L.</given-names></name>; <name><surname>Ma</surname><given-names>J.</given-names></name>; <name><surname>Fergus</surname><given-names>R.</given-names></name><article-title>Biological Structure
and Function Emerge from Scaling
Unsupervised Learning to 250 Million Protein Sequences</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2021</year>, <volume>118</volume>, <elocation-id>e2016239118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2016239118</pub-id>.<pub-id pub-id-type="pmid">33876751</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Elnaggar</surname><given-names>A.</given-names></name>; <name><surname>Heinzinger</surname><given-names>M.</given-names></name>; <name><surname>Dallago</surname><given-names>C.</given-names></name>; <name><surname>Rehawi</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Jones</surname><given-names>L.</given-names></name>; <name><surname>Gibbs</surname><given-names>T.</given-names></name>; <name><surname>Feher</surname><given-names>T.</given-names></name>; <name><surname>Angerer</surname><given-names>C.</given-names></name>; <name><surname>Steinegger</surname><given-names>M.</given-names></name><article-title>Prottrans: Toward Understanding the Language of Life
through Self-supervised Learning</article-title>. <source>ITPAM</source><year>2021</year>, <volume>44</volume>, <fpage>7112</fpage>–<lpage>7127</lpage>.</mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Mou</surname><given-names>C.</given-names></name>; <name><surname>Dong</surname><given-names>Y.</given-names></name>; <name><surname>Tu</surname><given-names>Y.</given-names></name><article-title>dbNSFP v4: a Comprehensive
Database of Transcript-specific Functional Predictions and Annotations
for Human Nonsynonymous and Splice-site SNVs</article-title>. <source>Genome Med.</source><year>2020</year>, <volume>12</volume>, <fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1186/s13073-020-00803-9</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Jian</surname><given-names>X.</given-names></name>; <name><surname>Boerwinkle</surname><given-names>E.</given-names></name><article-title>dbNSFP: a
Lightweight Database of
Human Nonsynonymous SNPs and Their Functional Predictions</article-title>. <source>Hum. Mutat.</source><year>2011</year>, <volume>32</volume>, <fpage>894</fpage>–<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21517</pub-id>.<pub-id pub-id-type="pmid">21520341</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Dallago</surname><given-names>C.</given-names></name>; <name><surname>Schütze</surname><given-names>K.</given-names></name>; <name><surname>Heinzinger</surname><given-names>M.</given-names></name>; <name><surname>Olenyi</surname><given-names>T.</given-names></name>; <name><surname>Littmann</surname><given-names>M.</given-names></name>; <name><surname>Lu</surname><given-names>A. X.</given-names></name>; <name><surname>Yang</surname><given-names>K. K.</given-names></name>; <name><surname>Min</surname><given-names>S.</given-names></name>; <name><surname>Yoon</surname><given-names>S.</given-names></name>; <name><surname>Morton</surname><given-names>J. T.</given-names></name>; <name><surname>Rost</surname><given-names>B.</given-names></name><article-title>Learned Embeddings from Deep Learning
to Visualize and Predict Protein Sets</article-title>. <source>Curr.
Protoc.</source><year>2021</year>, <volume>1</volume>, <elocation-id>e113</elocation-id><pub-id pub-id-type="doi">10.1002/cpz1.113</pub-id>.<pub-id pub-id-type="pmid">33961736</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>Francioli</surname><given-names>L. C.</given-names></name>; <name><surname>Tiao</surname><given-names>G.</given-names></name>; <name><surname>Cummings</surname><given-names>B. B.</given-names></name>; <name><surname>Alföldi</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Collins</surname><given-names>R. L.</given-names></name>; <name><surname>Laricchia</surname><given-names>K. M.</given-names></name>; <name><surname>Ganna</surname><given-names>A.</given-names></name>; <name><surname>Birnbaum</surname><given-names>D. P.</given-names></name>; et al. <article-title>The Mutational Constraint
Spectrum Quantified from Variation in 141,456 Humans</article-title>. <source>Nature</source><year>2020</year>, <volume>581</volume>, <fpage>434</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id>.<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><article-title>UniProt: the Universal
Protein Knowledgebase in 2023</article-title>. <source>Nucleic Acids
Res.</source><year>2023</year>, <volume>51</volume>, <fpage>D523</fpage>–<lpage>D531</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac1052</pub-id>.<pub-id pub-id-type="pmid">36408920</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Lek</surname><given-names>M.</given-names></name>; <name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>Minikel</surname><given-names>E. V.</given-names></name>; <name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Banks</surname><given-names>E.</given-names></name>; <name><surname>Fennell</surname><given-names>T.</given-names></name>; <name><surname>O’Donnell-Luria</surname><given-names>A. H.</given-names></name>; <name><surname>Ware</surname><given-names>J. S.</given-names></name>; <name><surname>Hill</surname><given-names>A. J.</given-names></name>; <name><surname>Cummings</surname><given-names>B. B.</given-names></name>; et al. <article-title>Analysis of Protein-coding
Genetic Variation in 60,706 Humans</article-title>. <source>Nature</source><year>2016</year>, <volume>536</volume>, <fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nature19057</pub-id>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Forbes</surname><given-names>S. A.</given-names></name>; <name><surname>Bindal</surname><given-names>N.</given-names></name>; <name><surname>Bamford</surname><given-names>S.</given-names></name>; <name><surname>Cole</surname><given-names>C.</given-names></name>; <name><surname>Kok</surname><given-names>C. Y.</given-names></name>; <name><surname>Beare</surname><given-names>D.</given-names></name>; <name><surname>Jia</surname><given-names>M.</given-names></name>; <name><surname>Shepherd</surname><given-names>R.</given-names></name>; <name><surname>Leung</surname><given-names>K.</given-names></name>; <name><surname>Menzies</surname><given-names>A.</given-names></name>; et al. <article-title>COSMIC: Mining Complete
Cancer Genomes in the Catalogue
of Somatic Mutations in Cancer</article-title>. <source>Nucleic Acids
Res.</source><year>2011</year>, <volume>39</volume>, <fpage>D945</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq929</pub-id>.<pub-id pub-id-type="pmid">20952405</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Sevim
Bayrak</surname><given-names>C.</given-names></name>; <name><surname>Stein</surname><given-names>D.</given-names></name>; <name><surname>Jain</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Nadkarni</surname><given-names>G. N.</given-names></name>; <name><surname>Van Vleck</surname><given-names>T. T.</given-names></name>; <name><surname>Puel</surname><given-names>A.</given-names></name>; <name><surname>Boisson-Dupuis</surname><given-names>S.</given-names></name>; <name><surname>Okada</surname><given-names>S.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; et al. <article-title>Identification of Discriminative
Gene-level and Protein-level Features Associated with Pathogenic Gain-of-function
and Loss-of-function Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2021</year>, <volume>108</volume>, <fpage>2301</fpage>–<lpage>2318</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2021.10.007</pub-id>.<pub-id pub-id-type="pmid">34762822</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>McLaren</surname><given-names>W.</given-names></name>; <name><surname>Gil</surname><given-names>L.</given-names></name>; <name><surname>Hunt</surname><given-names>S. E.</given-names></name>; <name><surname>Riat</surname><given-names>H. S.</given-names></name>; <name><surname>Ritchie</surname><given-names>G. R.</given-names></name>; <name><surname>Thormann</surname><given-names>A.</given-names></name>; <name><surname>Flicek</surname><given-names>P.</given-names></name>; <name><surname>Cunningham</surname><given-names>F.</given-names></name><article-title>The Ensembl Variant Effect Predictor</article-title>. <source>Genome Biol.</source><year>2016</year>, <volume>17</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id>.<pub-id pub-id-type="pmid">26753840</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Henikoff</surname><given-names>S.</given-names></name>; <name><surname>Henikoff</surname><given-names>J. G.</given-names></name><article-title>Amino Acid Substitution
Matrices from Protein Blocks</article-title>. <source>Proc. Natl. Acad.
Sci. U.S.A.</source><year>1992</year>, <volume>89</volume>, <fpage>10915</fpage>–<lpage>10919</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.22.10915</pub-id>.<pub-id pub-id-type="pmid">1438297</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Barker</surname><given-names>G. L.</given-names></name>; <name><surname>Edwards</surname><given-names>K. J.</given-names></name>; <name><surname>Day</surname><given-names>I. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name><article-title>Predicting the Functional,
Molecular, and Phenotypic Consequences of Amino Acid Substitutions
using Hidden Markov Models</article-title>. <source>Hum. Mutat.</source><year>2013</year>, <volume>34</volume>, <fpage>57</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22225</pub-id>.<pub-id pub-id-type="pmid">23033316</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Quang</surname><given-names>D.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>DANN: a Deep
Learning Approach for
Annotating the Pathogenicity of Genetic Variants</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>761</fpage>–<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu703</pub-id>.<pub-id pub-id-type="pmid">25338716</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Ionita-Laza</surname><given-names>I.</given-names></name>; <name><surname>McCallum</surname><given-names>K.</given-names></name>; <name><surname>Xu</surname><given-names>B.</given-names></name>; <name><surname>Buxbaum</surname><given-names>J. D.</given-names></name><article-title>A Spectral
Approach
Integrating Functional Genomic Annotations for Coding and Noncoding
Variants</article-title>. <source>Nat. Genet.</source><year>2016</year>, <volume>48</volume>, <fpage>214</fpage><pub-id pub-id-type="doi">10.1038/ng.3477</pub-id>.<pub-id pub-id-type="pmid">26727659</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Ioannidis</surname><given-names>N. M.</given-names></name>; <name><surname>Rothstein</surname><given-names>J. H.</given-names></name>; <name><surname>Pejaver</surname><given-names>V.</given-names></name>; <name><surname>Middha</surname><given-names>S.</given-names></name>; <name><surname>McDonnell</surname><given-names>S. K.</given-names></name>; <name><surname>Baheti</surname><given-names>S.</given-names></name>; <name><surname>Musolf</surname><given-names>A.</given-names></name>; <name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>Holzinger</surname><given-names>E.</given-names></name>; <name><surname>Karyadi</surname><given-names>D.</given-names></name>; et al. <article-title>REVEL: An Ensemble Method for Predicting the Pathogenicity
of Rare Missense Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2016</year>, <volume>99</volume>, <fpage>877</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.08.016</pub-id>.<pub-id pub-id-type="pmid">27666373</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Sundaram</surname><given-names>L.</given-names></name>; <name><surname>Gao</surname><given-names>H.</given-names></name>; <name><surname>Padigepati</surname><given-names>S. R.</given-names></name>; <name><surname>McRae</surname><given-names>J. F.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Kosmicki</surname><given-names>J. A.</given-names></name>; <name><surname>Fritzilas</surname><given-names>N.</given-names></name>; <name><surname>Hakenberg</surname><given-names>J.</given-names></name>; <name><surname>Dutta</surname><given-names>A.</given-names></name>; <name><surname>Shon</surname><given-names>J.</given-names></name>; et al. <article-title>Predicting
the Clinical
Impact of Human Mutation with Deep Neural Networks</article-title>. <source>Nat. Genet.</source><year>2018</year>, <volume>50</volume>, <fpage>1161</fpage>–<lpage>1170</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0167-z</pub-id>.<pub-id pub-id-type="pmid">30038395</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Feng</surname><given-names>B. J.</given-names></name><article-title>PERCH:
a Unified Framework for Disease Gene Prioritization</article-title>. <source>Hum. Mutat.</source><year>2017</year>, <volume>38</volume>, <fpage>243</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23158</pub-id>.<pub-id pub-id-type="pmid">27995669</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Alirezaie</surname><given-names>N.</given-names></name>; <name><surname>Kernohan</surname><given-names>K. D.</given-names></name>; <name><surname>Hartley</surname><given-names>T.</given-names></name>; <name><surname>Majewski</surname><given-names>J.</given-names></name>; <name><surname>Hocking</surname><given-names>T. D.</given-names></name><article-title>ClinPred:
Prediction Tool to Identify Disease-relevant Nonsynonymous Single-nucleotide
Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2018</year>, <volume>103</volume>, <fpage>474</fpage>–<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2018.08.005</pub-id>.<pub-id pub-id-type="pmid">30220433</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Davydov</surname><given-names>E. V.</given-names></name>; <name><surname>Goode</surname><given-names>D. L.</given-names></name>; <name><surname>Sirota</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Sidow</surname><given-names>A.</given-names></name>; <name><surname>Batzoglou</surname><given-names>S.</given-names></name><article-title>Identifying
a High Fraction of the Human Genome to
be Under Selective Constraint using GERP++</article-title>. <source>PLoS Comput. Biol.</source><year>2010</year>, <volume>6</volume>, <elocation-id>e1001025</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1001025</pub-id>.<pub-id pub-id-type="pmid">21152010</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Chen</surname><given-names>Y.-C.</given-names></name><article-title>A Tutorial
on Kernel Density Estimation and Recent Advances</article-title>. <source>Biostatistics Epidemiol.</source><year>2017</year>, <volume>1</volume>, <fpage>161</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1080/24709360.2017.1396742</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Rogers</surname><given-names>M. F.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Day</surname><given-names>I. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name>; <name><surname>Campbell</surname><given-names>C.</given-names></name><article-title>An Integrative
Approach
to Predicting the Functional Effects of Non-coding and Coding Sequence
Variation</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>1536</fpage>–<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv009</pub-id>.<pub-id pub-id-type="pmid">25583119</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Rogers</surname><given-names>M. F.</given-names></name>; <name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name>; <name><surname>Campbell</surname><given-names>C.</given-names></name><article-title>FATHMM-XF: Accurate
Prediction of Pathogenic Point
Mutations via Extended Features</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>511</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx536</pub-id>.<pub-id pub-id-type="pmid">28968714</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Gulko</surname><given-names>B.</given-names></name>; <name><surname>Hubisz</surname><given-names>M. J.</given-names></name>; <name><surname>Gronau</surname><given-names>I.</given-names></name>; <name><surname>Siepel</surname><given-names>A.</given-names></name><article-title>A Method for Calculating
Probabilities of Fitness Consequences for Point Mutations Across the
Human Genome</article-title>. <source>Nat. Genet.</source><year>2015</year>, <volume>47</volume>, <fpage>276</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3196</pub-id>.<pub-id pub-id-type="pmid">25599402</pub-id></mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Lu</surname><given-names>Q.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Sun</surname><given-names>J.</given-names></name>; <name><surname>Cheng</surname><given-names>Y.</given-names></name>; <name><surname>Cheung</surname><given-names>K.-H.</given-names></name>; <name><surname>Zhao</surname><given-names>H.</given-names></name><article-title>A Statistical
Framework to Predict Functional Non-coding Regions in the Human Genome
through Integrated Analysis of Annotation Data</article-title>. <source>Sci. Rep.</source><year>2015</year>, <volume>5</volume>, <elocation-id>10576</elocation-id><pub-id pub-id-type="doi">10.1038/srep10576</pub-id>.<pub-id pub-id-type="pmid">26015273</pub-id></mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Chun</surname><given-names>S.</given-names></name>; <name><surname>Fay</surname><given-names>J. C.</given-names></name><article-title>Identification of
Deleterious Mutations within Three
Human Genomes</article-title>. <source>Genome Res.</source><year>2009</year>, <volume>19</volume>, <fpage>1553</fpage>–<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.1101/gr.092619.109</pub-id>.<pub-id pub-id-type="pmid">19602639</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Kosmicki</surname><given-names>J. A.</given-names></name>; <name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>O’Donnell-Luria</surname><given-names>A. H.</given-names></name>; <name><surname>Pierce-Hoffman</surname><given-names>E.</given-names></name>; <name><surname>MacArthur</surname><given-names>D. G.</given-names></name>; <name><surname>Neale</surname><given-names>B. M.</given-names></name>; <name><surname>Daly</surname><given-names>M. J.</given-names></name><article-title>Regional
Missense Constraint Improves Variant Deleteriousness Prediction</article-title>. <source>BioRxiv.</source><year>2017</year>, <elocation-id>148353</elocation-id><pub-id pub-id-type="doi">10.1101/148353</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Pejaver</surname><given-names>V.</given-names></name>; <name><surname>Urresti</surname><given-names>J.</given-names></name>; <name><surname>Lugo-Martinez</surname><given-names>J.</given-names></name>; <name><surname>Pagel</surname><given-names>K. A.</given-names></name>; <name><surname>Lin</surname><given-names>G. N.</given-names></name>; <name><surname>Nam</surname><given-names>H.-J.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Sebat</surname><given-names>J.</given-names></name>; <name><surname>Iakoucheva</surname><given-names>L. M.</given-names></name>; et al. <article-title>Inferring the Molecular and Phenotypic Impact
of Amino Acid Variants with MutPred2</article-title>. <source>Nat. Commun.</source><year>2020</year>, <volume>11</volume>, <elocation-id>5918</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19669-x</pub-id>.<pub-id pub-id-type="pmid">33219223</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Schwarz</surname><given-names>J. M.</given-names></name>; <name><surname>Rödelsperger</surname><given-names>C.</given-names></name>; <name><surname>Schuelke</surname><given-names>M.</given-names></name>; <name><surname>Seelow</surname><given-names>D.</given-names></name><article-title>MutationTaster Evaluates
Disease-causing Potential of Sequence Alterations</article-title>. <source>Nat. Methods</source><year>2010</year>, <volume>7</volume>, <fpage>575</fpage><pub-id pub-id-type="doi">10.1038/nmeth0810-575</pub-id>.<pub-id pub-id-type="pmid">20676075</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Reva</surname><given-names>B.</given-names></name>; <name><surname>Antipin</surname><given-names>Y.</given-names></name>; <name><surname>Sander</surname><given-names>C.</given-names></name><article-title>Predicting
the Functional Impact
of Protein Mutations: Application to Cancer Genomics</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>, <volume>39</volume>, <fpage>e118</fpage><pub-id pub-id-type="doi">10.1093/nar/gkr407</pub-id>.<pub-id pub-id-type="pmid">21727090</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Vaser</surname><given-names>R.</given-names></name>; <name><surname>Adusumalli</surname><given-names>S.</given-names></name>; <name><surname>Leng</surname><given-names>S. N.</given-names></name>; <name><surname>Sikic</surname><given-names>M.</given-names></name>; <name><surname>Ng</surname><given-names>P. C.</given-names></name><article-title>SIFT Missense
Predictions for Genomes</article-title>. <source>Nat. Protoc.</source><year>2016</year>, <volume>11</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.1038/nprot.2015.123</pub-id>.<pub-id pub-id-type="pmid">26633127</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Pollard</surname><given-names>K. S.</given-names></name>; <name><surname>Hubisz</surname><given-names>M. J.</given-names></name>; <name><surname>Rosenbloom</surname><given-names>K. R.</given-names></name>; <name><surname>Siepel</surname><given-names>A.</given-names></name><article-title>Detection of Nonneutral
Substitution Rates on Mammalian Phylogenies</article-title>. <source>Genome Res.</source><year>2010</year>, <volume>20</volume>, <fpage>110</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1101/gr.097857.109</pub-id>.<pub-id pub-id-type="pmid">19858363</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Garber</surname><given-names>M.</given-names></name>; <name><surname>Guttman</surname><given-names>M.</given-names></name>; <name><surname>Clamp</surname><given-names>M.</given-names></name>; <name><surname>Zody</surname><given-names>M. C.</given-names></name>; <name><surname>Friedman</surname><given-names>N.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>Identifying Novel Constrained Elements by Exploiting biased Substitution
Patterns</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>i54</fpage>–<lpage>i62</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp190</pub-id>.<pub-id pub-id-type="pmid">19478016</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Consortium</surname><given-names>G. P.</given-names></name><article-title>A Map of
Human Genome Variation from Population Scale Sequencing</article-title>. <source>Nature</source><year>2010</year>, <volume>467</volume>, <fpage>1061</fpage><pub-id pub-id-type="doi">10.1038/nature09534</pub-id>.<pub-id pub-id-type="pmid">20981092</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="conf-proc" id="cit50"><person-group person-group-type="allauthors"><name><surname>Lundberg</surname><given-names>S. M.</given-names></name>; <name><surname>Lee</surname><given-names>S.-I.</given-names></name></person-group><article-title>A Unified Approach
to Interpreting Model Predictions</article-title>. In <source>Advances
in Neural Information Processing Systems</source><year>2017</year>30 p <fpage>4765</fpage>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Grimm</surname><given-names>D. G.</given-names></name>; <name><surname>Azencott</surname><given-names>C. A.</given-names></name>; <name><surname>Aicheler</surname><given-names>F.</given-names></name>; <name><surname>Gieraths</surname><given-names>U.</given-names></name>; <name><surname>MacArthur</surname><given-names>D. G.</given-names></name>; <name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Daly</surname><given-names>M. J.</given-names></name>; <name><surname>Smoller</surname><given-names>J. W.</given-names></name>; et al. <article-title>The
Evaluation of Tools used to Predict the
Impact of Missense Variants is Hindered by Two Types of Circularity</article-title>. <source>Hum. Mutat.</source><year>2015</year>, <volume>36</volume>, <fpage>513</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22768</pub-id>.<pub-id pub-id-type="pmid">25684150</pub-id></mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Pedregosa</surname><given-names>F.</given-names></name>; <name><surname>Varoquaux</surname><given-names>G.</given-names></name>; <name><surname>Gramfort</surname><given-names>A.</given-names></name>; <name><surname>Michel</surname><given-names>V.</given-names></name>; <name><surname>Thirion</surname><given-names>B.</given-names></name>; <name><surname>Grisel</surname><given-names>O.</given-names></name>; <name><surname>Blondel</surname><given-names>M.</given-names></name>; <name><surname>Prettenhofer</surname><given-names>P.</given-names></name>; <name><surname>Weiss</surname><given-names>R.</given-names></name>; <name><surname>Dubourg</surname><given-names>V.</given-names></name><article-title>Scikit-learn:
Machine Learning in
Python</article-title>. <source>J. Mach. Learn. Res.</source><year>2011</year>, <volume>12</volume>, <fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Malhis</surname><given-names>N.</given-names></name>; <name><surname>Jacobson</surname><given-names>M.</given-names></name>; <name><surname>Jones</surname><given-names>S. J.</given-names></name>; <name><surname>Gsponer</surname><given-names>J.</given-names></name><article-title>LIST-S2: Taxonomy
based
Sorting of Deleterious Missense Mutations across Species</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>, <volume>48</volume>, <fpage>W154</fpage>–<lpage>W161</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa288</pub-id>.<pub-id pub-id-type="pmid">32352516</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>M. S.</given-names></name>; <name><surname>Fan</surname><given-names>X.</given-names></name>; <name><surname>Chung</surname><given-names>W. K.</given-names></name>; <name><surname>Shen</surname><given-names>Y.</given-names></name><article-title>Predicting
Functional Effect of Missense Variants using Graph Attention Neural
Networks</article-title>. <source>Nat. Mach. Intell.</source><year>2022</year>, <volume>4</volume>, <fpage>1017</fpage>–<lpage>1028</lpage>. <pub-id pub-id-type="doi">10.1038/s42256-022-00561-w</pub-id>.<pub-id pub-id-type="pmid">37484202</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Dong</surname><given-names>C.</given-names></name>; <name><surname>Wei</surname><given-names>P.</given-names></name>; <name><surname>Jian</surname><given-names>X.</given-names></name>; <name><surname>Gibbs</surname><given-names>R.</given-names></name>; <name><surname>Boerwinkle</surname><given-names>E.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name><article-title>Comparison
and Integration of Deleteriousness
Prediction Methods for Nonsynonymous SNVs in Whole Exome Sequencing
Studies</article-title>. <source>Hum. Mol. Genet.</source><year>2015</year>, <volume>24</volume>, <fpage>2125</fpage>–<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu733</pub-id>.<pub-id pub-id-type="pmid">25552646</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Raimondi</surname><given-names>D.</given-names></name>; <name><surname>Tanyalcin</surname><given-names>I.</given-names></name>; <name><surname>Ferté</surname><given-names>J.</given-names></name>; <name><surname>Gazzo</surname><given-names>A.</given-names></name>; <name><surname>Orlando</surname><given-names>G.</given-names></name>; <name><surname>Lenaerts</surname><given-names>T.</given-names></name>; <name><surname>Rooman</surname><given-names>M.</given-names></name>; <name><surname>Vranken</surname><given-names>W.</given-names></name><article-title>DEOGEN2: Prediction
and Interactive Visualization of Single Amino Acid Variant Deleteriousness
in Human Proteins</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>W201</fpage>–<lpage>W206</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx390</pub-id>.<pub-id pub-id-type="pmid">28498993</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Takeda</surname><given-names>J.-i.</given-names></name>; <name><surname>Nanatsue</surname><given-names>K.</given-names></name>; <name><surname>Yamagishi</surname><given-names>R.</given-names></name>; <name><surname>Ito</surname><given-names>M.</given-names></name>; <name><surname>Haga</surname><given-names>N.</given-names></name>; <name><surname>Hirata</surname><given-names>H.</given-names></name>; <name><surname>Ogi</surname><given-names>T.</given-names></name>; <name><surname>Ohno</surname><given-names>K.</given-names></name><article-title>InMeRF: Prediction
of Pathogenicity of Missense Variants by Individual Modeling for Each
Amino Acid Substitution</article-title>. <source>NAR Genomics Bioinf.</source><year>2020</year>, <volume>2</volume>, <elocation-id>lqaa038</elocation-id><pub-id pub-id-type="doi">10.1093/nargab/lqaa038</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Sun</surname><given-names>S.</given-names></name>; <name><surname>Weile</surname><given-names>J.</given-names></name>; <name><surname>Roth</surname><given-names>F. P.</given-names></name><article-title>Improved
Pathogenicity Prediction for Rare Human Missense Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2021</year>, <volume>108</volume>, <fpage>1891</fpage>–<lpage>1906</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2021.08.012</pub-id>.<pub-id pub-id-type="pmid">34551312</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Zhi</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name><article-title>MetaRNN: Differentiating
Rare Pathogenic
and Rare Benign Missense SNVs and InDels using Deep Learning</article-title>. <source>Genome Med.</source><year>2022</year>, <volume>14</volume>, <fpage>115</fpage><pub-id pub-id-type="doi">10.1186/s13073-022-01120-z</pub-id>.<pub-id pub-id-type="pmid">36209109</pub-id></mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Qi</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>C.</given-names></name>; <name><surname>Long</surname><given-names>J. J.</given-names></name>; <name><surname>Chung</surname><given-names>W. K.</given-names></name>; <name><surname>Guan</surname><given-names>Y.</given-names></name>; <name><surname>Shen</surname><given-names>Y.</given-names></name><article-title>MVP Predicts the Pathogenicity
of Missense Variants by Deep Learning</article-title>. <source>Nat.
Commun.</source><year>2021</year>, <volume>12</volume>, <elocation-id>510</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20847-0</pub-id>.<pub-id pub-id-type="pmid">33479230</pub-id></mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Ngeow</surname><given-names>J.</given-names></name>; <name><surname>Sesock</surname><given-names>K.</given-names></name>; <name><surname>Eng</surname><given-names>C.</given-names></name><article-title>Clinical Implications
for Germline
PTEN Spectrum Disorders</article-title>. <source>Endocrinol. Metab.
Clin. North Am.</source><year>2017</year>, <volume>46</volume>, <fpage>503</fpage>–<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecl.2017.01.013</pub-id>.<pub-id pub-id-type="pmid">28476234</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Colonna</surname><given-names>M.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name><article-title>TREM2 Variants: New Keys to Decipher
Alzheimer Disease Pathogenesis</article-title>. <source>Nat. Rev. Neurosci.</source><year>2016</year>, <volume>17</volume>, <fpage>201</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.7</pub-id>.<pub-id pub-id-type="pmid">26911435</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Foulkes</surname><given-names>W. D.</given-names></name>; <name><surname>Priest</surname><given-names>J. R.</given-names></name>; <name><surname>Duchaine</surname><given-names>T. F.</given-names></name><article-title>DICER1:
Mutations, microRNAs and
Mechanisms</article-title>. <source>Nat. Rev. Cancer</source><year>2014</year>, <volume>14</volume>, <fpage>662</fpage>–<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3802</pub-id>.<pub-id pub-id-type="pmid">25176334</pub-id></mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Jia</surname><given-names>P.</given-names></name>; <name><surname>Zhao</surname><given-names>Z.</given-names></name><article-title>VarWalker: Personalized
Mutation Network Analysis of Putative Cancer
Genes from Next-generation Sequencing Data</article-title>. <source>PLoS Comput. Biol.</source><year>2014</year>, <volume>10</volume>, <elocation-id>e1003460</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003460</pub-id>.<pub-id pub-id-type="pmid">24516372</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Petrovski</surname><given-names>S.</given-names></name>; <name><surname>Gussow</surname><given-names>A. B.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Halvorsen</surname><given-names>M.</given-names></name>; <name><surname>Han</surname><given-names>Y.</given-names></name>; <name><surname>Weir</surname><given-names>W. H.</given-names></name>; <name><surname>Allen</surname><given-names>A. S.</given-names></name>; <name><surname>Goldstein</surname><given-names>D. B.</given-names></name><article-title>The Intolerance
of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity</article-title>. <source>PLoS Genet.</source><year>2015</year>, <volume>11</volume>, <elocation-id>e1005492</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005492</pub-id>.<pub-id pub-id-type="pmid">26332131</pub-id></mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>González-Pérez</surname><given-names>A.</given-names></name>; <name><surname>López-Bigas</surname><given-names>N.</given-names></name><article-title>Improving
the Assessment of the Outcome of Nonsynonymous
SNVs with a Consensus Deleteriousness Score, Condel</article-title>. <source>Am. J. Hum. Genet.</source><year>2011</year>, <volume>88</volume>, <fpage>440</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.03.004</pub-id>.<pub-id pub-id-type="pmid">21457909</pub-id></mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Fadista</surname><given-names>J.</given-names></name>; <name><surname>Oskolkov</surname><given-names>N.</given-names></name>; <name><surname>Hansson</surname><given-names>O.</given-names></name>; <name><surname>Groop</surname><given-names>L.</given-names></name><article-title>LoFtool: a
Gene Intolerance
Score based on Loss-of-function Variants in 60706 Individuals</article-title>. <source>Bioinformatics</source><year>2017</year>, <volume>33</volume>, <fpage>471</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv602</pub-id>.<pub-id pub-id-type="pmid">27563026</pub-id></mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="conf-proc" id="cit68"><person-group person-group-type="allauthors"><name><surname>Khan</surname><given-names>M. E.</given-names></name>; <name><surname>Dutt</surname><given-names>D. N.</given-names></name></person-group> In <source>Expectation-maximization
(EM) Algorithm for Instantaneous Frequency Estimation with Kalman
Smoother</source>, 12th European Signal Processing Conference, <year>2004</year>; pp <fpage>1797</fpage>–<lpage>1800</lpage>.</mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>Mészáros</surname><given-names>B.</given-names></name>; <name><surname>Erdős</surname><given-names>G.</given-names></name>; <name><surname>Dosztányi</surname><given-names>Z.</given-names></name><article-title>IUPred2A: Context-dependent Prediction
of Protein Disorder as a Function of Redox State and Protein Binding</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>W329</fpage>–<lpage>W337</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky384</pub-id>.<pub-id pub-id-type="pmid">29860432</pub-id></mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Dosztányi</surname><given-names>Z.</given-names></name>; <name><surname>Mészáros</surname><given-names>B.</given-names></name>; <name><surname>Simon</surname><given-names>I.</given-names></name><article-title>ANCHOR: Web Server
for Predicting Protein Binding Regions in Disordered Proteins</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>2745</fpage>–<lpage>2746</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp518</pub-id>.<pub-id pub-id-type="pmid">19717576</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="publisher-id">ci</journal-id>
    <journal-id journal-id-type="coden">jcisd8</journal-id>
    <journal-title-group>
      <journal-title>Journal of Chemical Information and Modeling</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1549-9596</issn>
    <issn pub-type="epub">1549-960X</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10685454</article-id>
    <article-id pub-id-type="pmid">37947586</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jcim.3c00950</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MMPatho: Leveraging Multilevel Consensus and Evolutionary
Information for Enhanced Missense Mutation Pathogenic Prediction</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Ge</surname>
          <given-names>Fang</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Arif</surname>
          <given-names>Muhammad</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">∥</xref>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>Yan</surname>
          <given-names>Zihao</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <name>
          <surname>Alahmadi</surname>
          <given-names>Hanin</given-names>
        </name>
        <xref rid="aff6" ref-type="aff">#</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <name>
          <surname>Worachartcheewan</surname>
          <given-names>Apilak</given-names>
        </name>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath6">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6786-8053</contrib-id>
        <name>
          <surname>Yu</surname>
          <given-names>Dong-Jun</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath7">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3394-8709</contrib-id>
        <name>
          <surname>Shoombuatong</surname>
          <given-names>Watshara</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <aff id="aff1"><label>†</label>School
of Geographic and Biologic Information, <institution>Nanjing University of Posts and Telecommunications</institution>, 9 Wenyuanlu, Nanjing 210023, <country>China</country></aff>
      <aff id="aff2"><label>‡</label>Center
for Research Innovation and Biomedical Informatics, Faculty of Medical
Technology, <institution>Mahidol University</institution>, Bangkok 10700, <country>Thailand</country></aff>
      <aff id="aff3"><label>§</label>School
of Computer Science and Engineering, <institution>Nanjing
University of Science and Technology</institution>, 200 Xiaolingwei, Nanjing 210094, <country>China</country></aff>
      <aff id="aff4"><label>∥</label>College
of Science and Engineering, <institution>Hamad Bin Khalifa
University</institution>, Doha 34110, <country>Qatar</country></aff>
      <aff id="aff5"><label>⊥</label>Department
of Community Medical Technology, Faculty of Medical Technology, <institution>Mahidol University</institution>, Bangkok 10700, <country>Thailand</country></aff>
      <aff id="aff6"><label>#</label>College of
Computer Science and Engineering, <institution>Taibah
University</institution>, Madinah 344, <country>Saudi Arabia</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label> Email: <email>njyudj@njust.edu.cn</email>.</corresp>
      <corresp id="cor2"><label>*</label> Email: <email>watshara.sho@mahidol.ac.th</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>10</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>27</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <volume>63</volume>
    <issue>22</issue>
    <fpage>7239</fpage>
    <lpage>7257</lpage>
    <history>
      <date date-type="received">
        <day>22</day>
        <month>06</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>23</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>21</day>
        <month>10</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0012" id="ab-tgr1"/>
      </p>
      <p>Understanding the
pathogenicity of missense mutation (MM) is essential
for shed light on genetic diseases, gene functions, and individual
variations. In this study, we propose a novel computational approach,
called MMPatho, for enhancing missense mutation pathogenic prediction.
First, we established a large-scale nonredundant MM benchmark data
set based on the entire Ensembl database, complemented by a focused
blind test set specifically for pathogenic GOF/LOF MM. Based on this
data set, for each mutation, we utilized Ensembl VEP v104 and dbNSFP
v4.1a to extract variant-level, amino acid-level, individuals’
outputs, and genome-level features. Additionally, protein sequences
were generated using ENSP identifiers with the Ensembl API, and then
encoded. The mutant sites’ ESM-1b and ProtTrans-T5 embeddings
were subsequently extracted. Then, our model group (MMPatho) was developed
by leveraging upon these efforts, which comprised ConsMM and EvoIndMM.
To be specific, ConsMM employs individuals’ outputs and XGBoost
with SHAP explanation analysis, while EvoIndMM investigates the potential
enhancement of predictive capability by incorporating evolutionary
information from ESM-1b and ProtT5-XL-U50, large protein language
embeddings. Through rigorous comparative experiments, both ConsMM
and EvoIndMM were capable of achieving remarkable AUROC (0.9836 and
0.9854) and AUPR (0.9852 and 0.9902) values on the blind test set
devoid of overlapping variations and proteins from the training data,
thus highlighting the superiority of our computational approach in
the prediction of MM pathogenicity. Our Web server, available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>, allows researchers to predict the pathogenicity (alongside the
reliability index score) of MMs using the ConsMM and EvoIndMM models
and provides extensive annotations for user input. Additionally, the
newly constructed benchmark data set and blind test set can be accessed
via the data page of our web server.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="doi">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61772273</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Nanjing University of Posts and Telecommunications</institution>
            <institution-id institution-id-type="doi">10.13039/501100005374</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NY223062</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Research Council of Thailand</institution>
            <institution-id institution-id-type="doi">10.13039/501100004704</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>N42A660380</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Natural Science Foundation of Jiangsu Province</institution>
            <institution-id institution-id-type="doi">10.13039/501100004608</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>BK20201304</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Mahidol University</institution>
            <institution-id institution-id-type="doi">10.13039/501100004156</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>N42A660380</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="doi">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>62072243</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ci3c00950</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ci3c00950</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <label>1</label>
    <title>Introduction</title>
    <p>The investigation of genetic variations, including MM, insertion,
deletion, and other genetic alteration, profoundly influences an individual’s
physiology, susceptibility to diseases, and response to medications.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Specially, studying these variations offers insights into genetic
diversity and its associations with disease onset, progression, and
treatment response.<sup><xref ref-type="bibr" rid="ref3">3</xref>−<xref ref-type="bibr" rid="ref5">5</xref></sup> This comprehension of genetic factors facilitates
the identification of specific alterations that contribute to disease
development and enables the advancement of targeted therapies and
personalized medicine approaches.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p>
    <p>MMs are common genetic variations associated with human diseases.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Till now, various computational methods have
been developed to predict MM pathogenicity.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Traditional machine learning techniques (e.g., SVM and RF) have
laid foundations for advanced methodologies<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> (like SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> PolyPhen,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> PROVEAN,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> CADD<sup><xref ref-type="bibr" rid="ref4">4</xref></sup>). These methodologies utilize sophisticated feature extraction
techniques from diverse data sources (e.g., sequence, structure, and
evolution) to differentiate between pathogenic and benign variations.
Deep learning technologies (e.g., Transformer) have emerged in variation
pathogenicity prediction, autonomously learning complex patterns and
features from extensive genomic and proteomic data sets.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Consensus methods integrate individual predictions
to improve accuracy and reliability, addressing biases and providing
comprehensive pathogenicity assessments.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref></sup> Benchmark data (e.g., ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> dbSNP<sup><xref ref-type="bibr" rid="ref15">15</xref></sup>) have been established for performance comparisons
of prediction methods.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> More specifically,
deep learning excels at capturing complex relationships in data, but
requires larger training sets and computational resources.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Consensus methods enhance reliability by integrating
multiple predictions,<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> while traditional methods offers
interpretable models for biological insights.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p>
    <p>ESM<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtTrans<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> are prominent models in protein sequence analysis
and interpretation,
trained on extensive protein sequence databases. ESM models (e.g.,
ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup>) capture evolutionary information
using self-attention mechanisms, accounting for long-range dependencies
in protein sequences. ProtTrans models (e.g, ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup>) leverage NLP transformers to capture relationships
between amino acids (AA) and structural, functional, and evolutionary
characteristics of proteins.</p>
    <p>Despite considerable efforts, there
are several critical issues
that need to be addressed. First, it is crucial to establish a comprehensive
and nonredundant data set on a large-scale, which incorporates known
effects. In-depth discussions regarding data quality, integration
methods, and potential biases are necessary. Second, it is essential
to develop computational models and perform analyses on feature importance,
interactions, and contributions. Lastly, it holds significant importance
to compare the classification abilities of individual outputs and
embeddings derived from large-scale protein language models.</p>
    <p>In this work, we focused on the following key aspects. (1) Construction
of benchmark data sets: We constructed one nonredundant MM benchmark
data set and one blind test set (focusing especially on pathogenic
GOF/LOF MM). (2) Feature generation: By utilizing the Ensembl VEP
v104 and its plugins (e.g., dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup>), we generated variant-level, AA-level, individuals’ outputs,
and genome-level features. (3) Protein sequence retrieval: By leveraging
ENSP identifiers and the Ensembl API, we retrieved encoded protein
sequences corresponding to query variations. (4) Embedding generation:
We used bio_embeddings<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> to generate ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> embeddings for each mutant site, which captured essential characteristics
and features of mutant AAs. (5) Model development: We developed an
interpretable model group, MMPatho, which consisted of ConsMM and
EvoIndMM. ConsMM utilized individuals’ outputs and employed
XGBoost with SHAP analyses. On the other hand, EvoIndMM incorporated
evolutionary information from ESM-1b and ProtT5-XL-U50 to enhance
the predictive capability.</p>
  </sec>
  <sec id="sec2">
    <label>2</label>
    <title>Materials and Methods</title>
    <sec id="sec2.1">
      <label>2.1</label>
      <title>Construction of the Benchmark Data Set and
Blind Test Set</title>
      <sec id="sec2.1.1">
        <label>2.1.1</label>
        <title>Benchmark Data Set Construction</title>
        <p>We downloaded the entire Ensembl database (6.18GB) from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://web.expasy.org/swissvar.html">https://web.expasy.org/swissvar.html</uri>, which includes variants from various sources (e.g., ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> gnomAD,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> UniProt,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> COSMIC<sup><xref ref-type="bibr" rid="ref24">24</xref></sup>) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A). To select related MMs, we applied two filters: variant
type (setting as MM or missense) and clinical significance (setting
as benign/likely benign or pathogenic/likely pathogenic), getting
622,270 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). We then applied five additional filters to remove unwanted
mutations: (1) those with conflicting interpretations of pathogenicity,
(2) uncertain significance, (3) repetitive and inconsistent MMs from
different sources, (4) variants classified as benign and pathogenic/likely
pathogenic, and (5) variants being likely benign and pathogenic/likely
pathogenic (obtaining 91,072 variants, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C). Using the Ensembl variant effect predictor,
we mapped the mutations to GRCh38, excluding inconsistent chromosome/position
and unmatched mutations, getting 77,700 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D). Following the processing
illustrated in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, the benchmark data set consists of 37,317 benign and 40,383 pathogenic
in 2,595 and 3,294 proteins, respectively. However, a subset of variants
lacked annotations when processed with Ensembl VEP. Consequently,
we excluded these variants/proteins. Eventually, we obtained a large-scale
nonredundant MM benchmark data set (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p>
        <fig id="fig1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Workflow of benchmark data set and blind test
set construction.
(A) Variations in the Ensembl Database, (B) Selecting, (C) Filtering,
and (D) Mapping: the procedures for benchmark data forming. (E) GOF/LOF
Variations and (F) gnomAD Database (v2.1.1): pathogenic GOF/LOF and
benign variants sources.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0001" id="gr1" position="float"/>
        </fig>
        <table-wrap id="tbl1" position="float">
          <label>Table 1</label>
          <caption>
            <title>Statistical
Summary of Missense Mutations
and Proteins in the Benchmark Data Set and Blind Test Set</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center"> </th>
                <th colspan="2" align="center" char=".">number
of variant<hr/></th>
                <th colspan="2" align="center" char=".">number
of protein<hr/></th>
              </tr>
              <tr>
                <th style="border:none;" align="center">data type</th>
                <th style="border:none;" align="center" char=".">benign/likely benign</th>
                <th style="border:none;" align="center" char=".">pathogenic/likely pathogenic</th>
                <th style="border:none;" align="center" char=".">benign/likely benign</th>
                <th style="border:none;" align="center" char=".">pathogenic/likely pathogenic</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">Benchmark data
set</td>
                <td style="border:none;" align="char" char=".">34,602</td>
                <td style="border:none;" align="char" char=".">38,476</td>
                <td style="border:none;" align="char" char=".">2439</td>
                <td style="border:none;" align="char" char=".">3115</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">blind test set</td>
                <td style="border:none;" align="char" char=".">2919</td>
                <td style="border:none;" align="char" char=".">3039</td>
                <td style="border:none;" align="char" char=".">675</td>
                <td style="border:none;" align="char" char=".">703</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="sec2.1.2">
        <label>2.1.2</label>
        <title>Blind
Test Set Construction</title>
        <p>We
downloaded pathogenic GOF/LOF variants<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> (HGMD_based), which contains 9,619 variants. From this set, we selected
single nucleotide variants occurring in protein coding regions, excluded
variants overlapped with in the benchmark data set (getting 3039 variants, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E). Subsequently,
for the gene set within the GOF/LOF data, we searched each gene in
gnomAD and applied the following filters to get benign variants: (1)
remove variants stored in ClinVar; (2) retained MMs with an allele
frequency &gt;0.1%; (3) kept MMs with clinical significance being
as
benign or likely benign; (4) remove MMs overlapped with the benchmark
data set. This process yielded 2919 variants (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>F). Finally, we merged the pathogenic and
benign variants, removing redundant ones to construct a blind test
set (presented in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p>
      </sec>
    </sec>
    <sec id="sec2.2">
      <label>2.2</label>
      <title>Feature Extraction</title>
      <sec id="sec2.2.1">
        <label>2.2.1</label>
        <title>Ensembl
VEP Outputs and Individual Predictions/Annotations</title>
        <p>On a CentOS
v6.10 computer with 32 CPU kernels, we installed Ensembl
VEP v140<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> along with the formatted and
well-indexed human GRCh37 assembly data. Additionally, we incorporated
various plugins (e.g., dbNSFP v4.1a,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> Blosum62,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> ExAC<sup><xref ref-type="bibr" rid="ref23">23</xref></sup>) (please refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Texts S1 and S2</ext-link> detailed information about database versions and
plugins). These tools offer comprehensive features for each variant,
categorizing into four groups: variant-level, AA-level, individuals’
outputs, and genome-level features.</p>
        <p>(1) Variant-level features.
Location: variant’s coordinates for annotation extraction.
Allele: variant allele used for consequence calculation. Consequence:
type of consequence associated with the variant. Position: cDNA_position,
CDS_position, and Protein_position indicate relative base pair positions
in cDNA sequence, coding sequence, and protein AAs, respectively.
IMPACT: subjective impact classification of consequence type (e.g.,
moderate, modifier, low). CANONICAL: indicates whether the transcript
is canonical for the gene. ENSP: Protein identifier. GENE_PHENO: indicates
whether the gene is associated with a phenotype, disease, or trait.
CLIN_SIG: ClinVar clinical significance of the dbSNP variant.</p>
        <p>(2) AA-level features. Wildtype and mutant AAs were obtained from
Ensembl VEP v104.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Additional features
(including molecular weight, hydrophobicity, isoelectric point, residue
volume) were extracted for wild-type and mutant AAs. Furthermore,
the differences between two type AAs were also calculated, namely,
damino_frq_diff, V_residue_diff, Hydrophobicity_diff, Isoelectric_point_diff,
etc.</p>
        <p>(3) Individuals’ outputs. Ensembl VEP v104<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> and dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> offer an extensive
range of MM effect predictions and annotations using multiple methods.
This encompasses thirty-one prediction algorithms, such as (SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Polyphen2-HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> FATHMM,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> DANN,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Eigen,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> REVEL,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> PrimateAI,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> ClinPred<sup><xref ref-type="bibr" rid="ref34">34</xref></sup>). Additionally,
nine conservation scores (e.g., bStatistic, phyloP30way_mammal, GERP++<sup><xref ref-type="bibr" rid="ref35">35</xref></sup>) and other functional annotations are also provided.</p>
        <p>(4) Genome-level features. We acquired genome-level features from
multiple databases, including gnomAD_exomes, ESP6500, and ExAC. For
example, 1000Gp3_AFR_AF represents the alternative allele frequency
in 1000Gp3 African descendant samples. ESP6500_EA_AF denotes the alternative
allele frequency in European American samples from ESP6500 (Please
refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S1</ext-link> for more information
about the extracted features).</p>
      </sec>
    </sec>
    <sec id="sec2.2.2">
      <label>2.2.2</label>
      <title>Amino
acid embeddings</title>
      <p>For each
MM, we calculated AA-level embedding features from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtTransT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> These features originated from protein sequences acquired by using
the ENSP ID and API functions. During protein sequence retrieval,
some variants returned empty information. To maintain the embedding
quality, we filtered out such variants with empty returns.</p>
      <p>(1)
ESM-1b embeddings. We utilized the bio_embeddings<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> to obtain ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> embeddings
for each AA at the mutant site. These 1280-dimensional vectors effectively
encode crucial AA properties, including physicochemical properties,
and evolutionary conservations.</p>
      <p>(2) ProtTransT5-XL-U50 embeddings.
By employing the ProtTransT5XLU5<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> embedder
from bio_embeddings,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> we leveraged the
potential of the 1024-dimensional vector
for each mutant AA. This approach facilitated the extraction of valuable
insights from protein sequences, capturing AA’s properties
such as hydrophobicity, charge, and size.</p>
    </sec>
  </sec>
  <sec id="sec2.2.3">
    <label>2.2.3</label>
    <title>Distribution of Features</title>
    <p>We executed an elaborate investigation
into the disparities in
distribution of features utilized for classifying genome variations
as either pathogenic or benign, with a particular emphasis on the
annotated “benchmark data set” missense mutations (listed
in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). We applied
Kernel Density Estimation (KDE)<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> to portray
efficiently the intricate dynamism of these distributions in a continuous,
and unbiased manner.</p>
    <p>We opted to showcase a subset of 12 distinct
features out of the
total 884 features extracted in <xref rid="sec2.2.1" ref-type="other">Sections 2.2.1–2.2.2</xref>. The features selected for presentation exhibited remarkable differences
in their distributions. For instance, as depicted in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A, the gnomAD_exomes_ASJ_AF
feature demonstrated a highly significant distribution contrast (<italic>p</italic>-value: 1.622517e-274). Similarly, <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>E highlighted the distribution disparity
of the Hydrophobicity_diff feature (<italic>p</italic>-value: 1.587287e-48),
while <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>K revealed
the distinct distribution pattern of esm1b_90 (<italic>p</italic>-value:
2.531859e-235). <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>L illustrated the pronounced distribution discrepancy of prott5_570
(<italic>p</italic>-value: 4.379378e-220). These exemplary features
were chosen to exemplify the analytical power of feature distributions
in discerning the classification potential of the extracted attributes.</p>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Analyses
of the extracted features with <italic>p</italic>-values
using the KDE function. (A) gnomAD_exomes_ASJ_AF (<italic>p</italic>-value = 1.622817e-274), (B) Isoelectric_point_diff (<italic>p</italic>-value = 2.627391e-21), (C) Molecular_weight_diff (<italic>p</italic>-value = 0.00074061), (D) Molecular_weight_wt (<italic>p</italic>-value = 1.560005e-11), (E) Hydrophobicity_diff (<italic>p</italic>-value = 1.587287e-48), (F) codeToVal_diff (<italic>p</italic>-value
= 0.00102270), (G) V_residue_wt (<italic>p</italic>-value = 1.286094e-16),
(H) V_residue_diff (<italic>p</italic>-value = 4.680308e-12), (I)
CADD_raw_rankscore_gh19 (<italic>p</italic>-value = 0.0), (J) GERP++_NR
(<italic>p</italic>-value = 1.118603e-46), (K) esm1b_90 (<italic>p</italic>-value = 2.531859e-235), and (L) prott5_570 (<italic>p</italic>-value
= 4.379378e-220). Note: “Label 0” and “Label
1” represent the benign and pathogenic variation class, respectively.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0002" id="gr2" position="float"/>
    </fig>
    <p>In conclusion, our comprehensive analysis effectively
demonstrates
how feature distributions, aided by KDE and selective visualization,
aid in distinguishing different classes of genome variations, thereby
enhancing the understanding of genome variation impacts.</p>
  </sec>
  <sec id="sec3">
    <label>3</label>
    <title>Workflow of ConsMM and EvoIndMM</title>
    <p>In this work, we developed
an integrated model group of models
termed MMPatho, consisting of two distinct models: ConsMM (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>) and EvoIndMM (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). Importantly, ConsMM
solely employs individual outputs as inputs, whereas EvoIndMM integrates
Ensembl VEP outputs along with embeddings generated from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p>
    <fig id="fig3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Workflow
of the ConsMM model. (A) Feature Extraction, (B) Pathogenic
Mutation Identification using LightGBM, XGBoost, and CatBoost, (C)
Utilizing the Optimal Model for Prediction and Model Explanation,
(D) Analysis of Feature Dependence, and (E) Analysis of Feature Importance.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0003" id="gr3" position="float"/>
    </fig>
    <fig id="fig4" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Architecture of the EvoIndMM model. (A) Protein Sequence
Generation
and Inputs Creation for ProtT5-XL-U50 and ESM-1b embedders, embedding
Generation from ProtT5-XL-U50 and ESM-1b, (B) Feature Extraction via
Ensembl VEP and its Plugins, (C) Feature Selection through PCA, and
(D) XGBoost Model Training.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0004" id="gr4" position="float"/>
    </fig>
    <p>Within ConsMM, we e exclusively implemented 34 individuals’
predictions or conservation scores procured from Ensembl VEP and dbNSFP,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> which include SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> CADD,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> ClinPred,<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> DANN,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Eigen,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> FATHMM<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> (fathmm-MKL,<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> fathmm-XF<sup><xref ref-type="bibr" rid="ref38">38</xref></sup>), FitCons<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> (GM12878, H1_hESC, HUVEC), GenoCanyon,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> LRT,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> MPC,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> MutPred2,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> MutationTaster,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> MutationAssessor,<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> Polyphen2_HDIV and Polyphen2_HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> REVEL,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> SIFT4G,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> BayesDel,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> PrimateAI.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> Also
include nine conservation scores, e.g., bStatistic, phyloP100way_vertebrate,
phastCons17way_primate,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> GERP++,<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> SiPhy,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> and others.</p>
    <p>Conversely, for EvoIndMM, we broadened the feature set beyond mere
predictions/annotations, integrating additional variant-level, amino
acid-level, and genome-level features sourced from dbSNP,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> ClinVar,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> UniProt,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> gnomAD,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> 1000Gp3,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> ESP<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and others. Additionally, we also generated
variant characteristic from ESM-1b,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and
ProtT5-XL-U50.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Please refer to the Readme
page of our Web server for viewing feature contributions in the ConsMM
or EvoIndMM model.</p>
    <sec id="sec3.1">
      <label>3.1</label>
      <title>ConsMM</title>
      <p>The ConsMM
workflow (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>)
comprises three
key components: feature extraction (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A), prediction (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B), feature importance analysis, and model
explanation (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C–<xref rid="fig3" ref-type="fig">3</xref>E). In <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A, Ensembl VEP v104 and dbNSFP v4.1a<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> were used to obtain predictions and annotations for multiple individuals(e.g.,
SIFT<sup><xref ref-type="bibr" rid="ref10">10</xref></sup>). In <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B, the extracted features were input into
LightGBM, XGBoost, and CatBoost to derive the optimal model. Finally,
in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C–E,
the feature importance and interaction dependencies were analyzed
using SHAP<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S3</ext-link> introduced SHAP and XGBoost), aiming to provide a comprehensive
explanation for the prediction model (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S4</ext-link> listed the evaluation indices).</p>
    </sec>
    <sec id="sec3.2">
      <label>3.2</label>
      <title>EvoIndMM</title>
      <p><xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref> depicts
the stepwise construction process
of EvoIndMM, involving the following key steps: (1) Retrieval of Encoded
Protein Sequences: Protein sequences in FASTA format are retrieved
for ProtT5-XL-U50<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> and ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> embedders using the Ensembl API and ENSP identifiers.
Filter options are applied to exclude specific mutations (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). (2) Feature Extraction
through the Ensembl VEP: Ensembl VEP v104 is employed to extract feature
vectors, including variant-level, AA-level, individual outputs, and
genome-level features. Additionally, for each mutant site AA, ESM-1b
and ProtT5-XL-U50 embedders generate 1120 and 1280-dimensional feature
vectors, respectively (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A, <xref rid="fig4" ref-type="fig">4</xref>B). (3) Benchmark Data Splitting
and Model Training: The benchmark data is partitioned into training
data and test set. PCA is then utilized to select features from VEP,
ESM-1b, and ProtT5-XL-U50, using a threshold of &gt;0.1 or 0.05. Subsequently,
the XGBoost model is trained using the training data (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref><bold>C-</bold><xref rid="fig4" ref-type="fig">4</xref><bold>D</bold>). By following this systematic approach, EvoIndMM
ensures the accurate prediction of MM pathogenicity by integrating
diverse features and embedding techniques.</p>
    </sec>
    <sec id="sec3.3">
      <label>3.3</label>
      <title>Avoiding
Protein Overlap for Model Fairness</title>
      <p>The study by Grimm et
al. highlights a potential flaw in the modeling
process: the inclusion of different variations of a single protein
in both the training and testing sets may lead to artificially inflated
model performance during testing.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Such
inflation can occur if the model merely mimics specific variation
patterns from the training data without genuinely learning to apply
these patterns to novel variations. To ensure validity and prevent
data leakage, it is critical to maintain separate training and testing
sets that do not concurrently include different variations of the
same protein.</p>
      <p>To this end, we employed protein IDs as sorting
criteria when distributing distinct protein variations between the
training (80%) and testing (20%) sets of the benchmark data set (training:
58786 and testing: 14292 for ConsMM), utilizing “train_test_split”
from sklearn.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> This allocation strategy
ensures that proteins and their variations are exclusively assigned
to either the training or the testing set, thereby boosting the reliability
of the model’s performance assessment.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <label>4</label>
    <title>Results and Discussions</title>
    <sec id="sec4.1">
      <label>4.1</label>
      <title>Performance Comparison
of ConsMM and EvoIndMM</title>
      <sec id="sec4.1.1">
        <label>4.1.1</label>
        <title>Performance of ConsMM
on the Test Set of
Benchmark Data Set</title>
        <p>To optimize parameter settings and experimental
design, the following steps were taken. (1) Grid Search Cross-Validation
and Model Selection: in GridSearchCV, we conducted 5-fold cross-validation
with 3 repetitions to thoroughly explore a predefined grid of hyperparameters
and determine the best-performing model. (2) Parameter Settings: For
XGBoost, the chosen settings were a “learning rate”
of 0.01, a binary logistic regression objective, a subsample ratio
of 0.5, the “base_score” as the mean of “y_train”,
the “eval_metric” as “log_loss”, “max_depth”
of 4, and “n_estimators” of 300. In contrast, CatBoost
and LightGBM underwent extensive grid searches for iterations, learning
rates, and tree depths. The best parameter configurations were identified
as follows: CatBoost (“iterations”=400, “learning_rate”=0.1,
“depth”=4) and LightGBM (“iterations”=400,
“learning_rate”=0.01, “depth”=4). The
CatBoost, XGBoost, and LightGBM models were meticulously fine-tuned
and evaluated, and the comparison results are documented in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> (further details for LightGBM,
XGBoost, and CatBoost can be found in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Texts S5–S7</ext-link>).</p>
        <fig id="fig5" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Comparison of CatBoost, XGBoost, and LightGBM on the test set of
the benchmark data set. (A) ROC curves of CatBoost, XGBoost, and LightGBM.
(B) PR curves of CatBoost, XGBoost, and LightGBM. (C) <italic>Pre</italic>, <italic>NPV</italic>, <italic>Recall</italic>, <italic>Spe</italic>, <italic>ACC</italic>, <italic>MCC</italic>, and <italic>F</italic><sub>1</sub> values of CatBoost, XGBoost, and LightGBM.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0005" id="gr5" position="float"/>
        </fig>
        <table-wrap id="tbl2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Confusion Matrix and Three Types of
Errors of CatBoost, XGBoost, and LightGBM on the Test Set of Benchmark
Data Set</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">model name</th>
                <th style="border:none;" align="center">TP</th>
                <th style="border:none;" align="center">TN</th>
                <th style="border:none;" align="center">FP</th>
                <th style="border:none;" align="center">FN</th>
                <th style="border:none;" align="center" char=".">ER</th>
                <th style="border:none;" align="center" char=".">FPR</th>
                <th style="border:none;" align="center" char=".">FNR</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">CatBoost</td>
                <td style="border:none;" align="left">7339 (51.35%)</td>
                <td style="border:none;" align="left">5516 (38.60%)</td>
                <td style="border:none;" align="left">839 (5.87%)</td>
                <td style="border:none;" align="left">598 (4.18%)</td>
                <td style="border:none;" align="char" char=".">0.0587</td>
                <td style="border:none;" align="char" char=".">0.1320</td>
                <td style="border:none;" align="char" char=".">0.0753</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">XGBoost</td>
                <td style="border:none;" align="left">7242 (50.67%)</td>
                <td style="border:none;" align="left">5675 (39.71%)</td>
                <td style="border:none;" align="left">680 (4.76%)</td>
                <td style="border:none;" align="left">695 (4.86%)</td>
                <td style="border:none;" align="char" char=".">0.0476</td>
                <td style="border:none;" align="char" char=".">0.1070</td>
                <td style="border:none;" align="char" char=".">0.0876</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">LightGBM</td>
                <td style="border:none;" align="left">7302 (51.09%)</td>
                <td style="border:none;" align="left">5513 (38.57%)</td>
                <td style="border:none;" align="left">842 (5.89%)</td>
                <td style="border:none;" align="left">635 (4.44%)</td>
                <td style="border:none;" align="char" char=".">0.0589</td>
                <td style="border:none;" align="char" char=".">0.1325</td>
                <td style="border:none;" align="char" char=".">0.0800</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>When comparing the performance of CatBoost,
XGBoost, and LightGBM,
we evaluated multiple metrics (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>) to assess their effectiveness; analyses are given below:
(1) XGBoost outperformed CatBoost and LightGBM with MCC of 0.8052,
compared to 0.7961 and 0.7904, respectively. MCC can capture the overall
model performance, by considering TP, TN, FP, and FN. (2) XGBoost
achieved an ACC score of 0.9038, surpassing CatBoost (0.8995) and
LightGBM (0.8967), indicating better pathogenic variant classification
ability. (3) XGBoost demonstrated a Spe value of 0.8930, outperforming
CatBoost (0.8680) and LightGBM (0.8675), indicating better identification
of negative cases. (4) XGBoost achieved a Pre score of 0.9142, higher
than CatBoost (0.8974) and LightGBM (0.8966), indicating a higher
proportion of correctly predicted positive cases. (5) XGBoost obtained
the highest F<sub>1</sub> score of 0.9133, which combines precision
and recall to represent the balance between them. Considering the
comparisons, XGBoost consistently demonstrated a competitive performance
across multiple metrics. Therefore, we selected XGBoost as the preferred
model for subsequent comparisons and referred to the entire model
as ConsMM for further analyses.</p>
      </sec>
      <sec id="sec4.1.2">
        <label>4.1.2</label>
        <title>Assessing
ConsMM Efficacy: Protein ID-Based
Splitting Vs Nonprotein ID-Based splitting</title>
        <p>To ensure a robust
evaluation of ConsMM, we conducted supplementary testing using data
that did not split based on protein ID. Detailed results from these
tests are provided in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S8, Figure S1, and Table S2</ext-link>.</p>
        <p>Comparative analysis between findings detailed
in <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> and those outlined in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S8, Figure S1, and Table S2</ext-link> reveals subtly lower metrics in the former. For instance,
with reference to the XGBoost classifier, its AUROC value in <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> stands at 0.9650
(Protein ID-Based Separation), which is marginally below that depicted
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S1</ext-link> (0.9764, Non-Protein ID-Based
Separation), marking a decrease of approximately 0.0114. A similar
trend is observed in XGBoost’s AUPR, where <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> displays a score of 0.9715,
slightly under the corresponding value in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S1</ext-link> (0.9802), indicating a decline of roughly 0.0093. This suggests
that employing a protein ID for data segregation provides a more conservative
appraisal of model performance. The ACC and MCC values of XGBoost
in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> (0.9038
and 0.8052 respectively) are fractionally under those given in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S2</ext-link> (0.9208 and 0.8416 respectively), demonstrating
marginal decreases of 0.017 and 0.0364, implying a reduced capacity
of the models to handle imbalanced data and produce balanced predictions
when protein ID separation is used.</p>
        <p>In summary, the results
from the Supporting Information show superior
AUROC, AUPR, ACC, and MCC scores, suggesting improved overall model
performance. Nonetheless, the experiments delineated in <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> utilizing
protein ID for data splitting provide a more conservative and reliable
evaluation, taking into account potential data leakage and model overfitting.
The selection between these two methodologies should be guided by
the specific demands of the task at hand with a preference for <xref rid="sec4.1.1" ref-type="other">Section <xref rid="sec4.1.1" ref-type="other">4.1.1</xref></xref> when a
dependable estimation of model generalizability is required.</p>
      </sec>
      <sec id="sec4.1.3">
        <label>4.1.3</label>
        <title>Feature Importance in ConsMM</title>
        <p>To
gain comprehensive insight into the key features of ConsMM, we plotted
the top 35 features with the highest SHAP values (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A). The findings can be summarized
as follows: (1) The ClinPred_rankscore demonstrates that a higher
value significantly contributes ConsMM to predicting pathogenic variants,
whereas a lower value has a greater impact on predicting benign variants.
Similar contribution patterns can be observed on BayesDel_addAF_score.
(2) Furthermore, the prevalence of red color in features (e.g., BayesDel_addAF_rcore,
BayesDel_addAF_rankscore, MutPred_rankscore, MPC_rankscore, REVEL_rankscore,
ClinPred_score, and CADD_raw_rankscore) indicates feature higher values
strong correlation with classes and their crucial predictive capabilities
in accurately identifying pathogenic variants. (3) Additionally, the
lower values of features (e.g., FATHMM_converted_rankscore, Reliability_index,
SIFT_converted_rankscore, PrimateAI_rankscore, GERP++_NR) highlight
their significant impact on predicting pathogenic variants. (SHAP
values of all features for ConsMM and feature analyses were documented
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S3 and Text S9</ext-link>).</p>
        <fig id="fig6" position="float">
          <label>Figure 6</label>
          <caption>
            <p>SHAP summary plot and
feature interactions for ConsMM. (A) SHAP
summary plot, (B) ClinPred_rankscore with phyloP100way_vertebrate_rankscore,
(C) BayesDel_addAF_rankscore with ClinPred_score, (D) MutPred_rankscore
with ClinPred_rankscore, (E) Eigen_phred_coding with BayesDel_addAF_score,
(F) GERP++_RS with ClinPred_score, (G) Polyphen2_HVAR_rankscore with
BayesDel_addAF_rankscore, (H) bStatistic_converted_rankscore with
GERP++_NR, and <bold>(I)</bold> phastCons100way_vertebrate with CADD_phred.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0006" id="gr6" position="float"/>
        </fig>
        <p>The feature interactions depicted in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B–<xref rid="fig6" ref-type="fig">6</xref>I offer
valuable insights into the joint effects of various features on the
output of ConsMM’s output. Detailed analyses are as follows:<list list-type="simple"><list-item><label>(1)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B, <xref rid="fig6" ref-type="fig">6</xref>C display analogous patterns.
Feature interaction plots exhibit regions of red and blue overlap,
signifying that when both features possess higher values, they synergistically
amplify each other’s impact on ConsMM’s output. In essence,
evaluating these two features collectively augments ConsMM’s
predictive capacity and exerts a positive influence on its predictions.</p></list-item><list-item><label>(2)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>E,<xref rid="fig6" ref-type="fig">6</xref>G, and I reveal
similar patterns.
The aggregate effect of these feature interactions on predictions
deviates from their individual impacts, alluding to the presence of
intricate interactions between features. When one feature exhibits
high while another displays low values, they mutually reinforce each
other, culminating in enhanced predictive prowess for pathogenic variants.</p></list-item><list-item><label>(3)</label><p><xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>D,<xref rid="fig6" ref-type="fig">6</xref>F, and <xref rid="fig6" ref-type="fig">6</xref>H exhibit similar influence. The observed concave
shape indicates
a complex interplay between feature pairs. Within a specific range,
the feature interaction significantly influences prediction outcomes
and combined effect becomes more potent, resulting in a striking aggregation
of red areas. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S2</ext-link> displays the interactions
of other 12 features for ConsMM.</p></list-item></list></p>
      </sec>
    </sec>
    <sec id="sec4.2">
      <label>4.2</label>
      <title>Performance of EvoIndMM with VEP Outputs,
ESM-1b and ProtT5-XL-U50 Embeddings</title>
      <sec id="sec4.2.1">
        <label>4.2.1</label>
        <title>Assessing
the Contribution of Different
Feature Sets</title>
        <p>To assess the impact of different feature sets
on EvoIndMM predictions, ablation experiments were conducted. Experiments
results (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>) provide insights
into feature contributions. <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>A highlights that EvoIndMM with the “Combined”
feature set achieves the highest TN (5515, 47.47%) and lowest FP (416,
3.58%), indicating superior classification performance compared to
EvoIndMM with other feature sets. Additionally, the “Combined”
feature set exhibits the lowest ER (0.0358) among all feature sets.
EvoIndMM with “VEP” demonstrates the lowest FPR (0.0701),
revealing its proficiency in accurately identifying benign variants.
Conversely, EvoIndMM with the “VEP” feature set exhibits
the highest FNR (0.0895), indicating challenges in correctly identifying
pathogenic variants.</p>
        <fig id="fig7" position="float">
          <label>Figure 7</label>
          <caption>
            <p>ROC and PR curves of EvoIndMM on the test set of the benchmark
data set. (A) Confusion matrix of EvoIndMM with VEP outputs, ESM-1b,
ProtT5-XL-U50, or combined feature set, (B) ROC curves, and (C) PR
curves.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0007" id="gr7" position="float"/>
        </fig>
        <table-wrap id="tbl3" position="float">
          <label>Table 3</label>
          <caption>
            <title>Performance Comparison
of EvoIndMM
with Different Features on the Test Set of Benchmark Data Set<xref rid="t3fn1" ref-type="table-fn">a</xref></title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">features</th>
                <th style="border:none;" align="center" char=".">MCC</th>
                <th style="border:none;" align="center" char=".">ACC</th>
                <th style="border:none;" align="center" char=".">recall/sen</th>
                <th style="border:none;" align="center" char=".">Spe</th>
                <th style="border:none;" align="center" char=".">Pre</th>
                <th style="border:none;" align="center" char=".">NPV</th>
                <th style="border:none;" align="center" char=".">F<sub>1</sub></th>
                <th style="border:none;" align="center" char=".">ER</th>
                <th style="border:none;" align="center" char=".">FPR</th>
                <th style="border:none;" align="center" char=".">FNR</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">VEP<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.8348</td>
                <td style="border:none;" align="char" char=".">0.9175</td>
                <td style="border:none;" align="char" char=".">0.9105</td>
                <td style="border:none;" align="char" char=".">0.9241</td>
                <td style="border:none;" align="char" char=".">0.9200</td>
                <td style="border:none;" align="char" char=".">0.9150</td>
                <td style="border:none;" align="char" char=".">0.9152</td>
                <td style="border:none;" align="char" char=".">0.0387</td>
                <td style="border:none;" align="char" char=".">0.0759</td>
                <td style="border:none;" align="char" char=".">0.0895</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">ESM-1b<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.5801</td>
                <td style="border:none;" align="char" char=".">0.7901</td>
                <td style="border:none;" align="char" char=".">0.7633</td>
                <td style="border:none;" align="char" char=".">0.8157</td>
                <td style="border:none;" align="char" char=".">0.7989</td>
                <td style="border:none;" align="char" char=".">0.7823</td>
                <td style="border:none;" align="char" char=".">0.7807</td>
                <td style="border:none;" align="char" char=".">0.0941</td>
                <td style="border:none;" align="char" char=".">0.1843</td>
                <td style="border:none;" align="char" char=".">0.2367</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">ProtT5-XL-U50<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.6137</td>
                <td style="border:none;" align="char" char=".">0.8068</td>
                <td style="border:none;" align="char" char=".">0.7772</td>
                <td style="border:none;" align="char" char=".">0.8351</td>
                <td style="border:none;" align="char" char=".">0.8188</td>
                <td style="border:none;" align="char" char=".">0.7963</td>
                <td style="border:none;" align="char" char=".">0.7975</td>
                <td style="border:none;" align="char" char=".">0.0842</td>
                <td style="border:none;" align="char" char=".">0.1649</td>
                <td style="border:none;" align="char" char=".">0.2228</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">combined<sup>#</sup></td>
                <td style="border:none;" align="char" char=".">0.8390</td>
                <td style="border:none;" align="char" char=".">0.9195</td>
                <td style="border:none;" align="char" char=".">0.9087</td>
                <td style="border:none;" align="char" char=".">0.9299</td>
                <td style="border:none;" align="char" char=".">0.9255</td>
                <td style="border:none;" align="char" char=".">0.9140</td>
                <td style="border:none;" align="char" char=".">0.9170</td>
                <td style="border:none;" align="char" char=".">0.0358</td>
                <td style="border:none;" align="char" char=".">0.0701</td>
                <td style="border:none;" align="char" char=".">0.0913</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t3fn1">
              <label>a</label>
              <p>Note: VEP<sup>#</sup>, ESM-1b<sup>#</sup>, ProtT5-XL-U50<sup>#</sup> mean EvoIndMM only with VEP outputs,
or ESM-1b embeddings, or ProtT5-XL-U50 embeddings. Combined<sup>#</sup> represents the concatenation of VEP outputs, ESM-1b and ProtT5-XL-U50
embeddings.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Analyzing the
results presented in <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>, it is evident that EvoIndMM with the “Combined”
feature set achieves outstanding performance, as reflected by its
highest AUROC (0.9736) and AUPR (0.9738) values. Additionally, EvoIndMM
demonstrates robust agreement between predicted and true classes with
the highest MCC (0.8390) and ACC (0.9195) values, indicating accurate
classification. Besides, EvoIndMM with “VEP” exhibits
superior Recall/Sen (0.9105), showcasing its ability to identify positive
variants effectively. In contrast, EvoIndMM with “ESM-1b″
shows a lower Spe (0.8157), suggesting a higher rate of false positives.
Notably, EvoIndMM with “Combined” achieves the highest
Pre score (0.9255) and F<sub>1</sub> score (0.9170), indicating a
favorable balance between precision and recall.</p>
        <p>In summary,
the “Combined” feature set consistently
outperforms other feature sets across various metrics. The limited
effectiveness of ESM-1b and ProtT5-XL-U50 embeddings in predicting
MM pathogenicity can be attributed to their insufficient individual
pathogenic predictions and annotations, limited coverage of mutation
features, and inadequate representation of functional impacts. In
contrast, the “Combined” feature set outperforms each
single set, indicating the combination provides complementary information
that can enhance predictive performance. The inclusion of the “VEP”
feature set in “Combined”, with its extensive individual-level
predictions and annotations, likely compensates for any limitations
in ESM-1b and ProtT5-XL-U50 embeddings, resulting in improved accuracy
in predicting MM pathogenicity.</p>
      </sec>
      <sec id="sec4.2.2">
        <label>4.2.2</label>
        <title>Assessing
EvoIndMM Efficacy: Protein ID-Based
Splitting vs Nonprotein ID-Based Splitting</title>
        <p>To robustly evaluate
the differential attributes of EvoIndMM, we performed additional analyses
on data that did not split based on protein ID. Detailed results from
these tests are encapsulated in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S10, Table S4, and Figure S3</ext-link>. The “Combined<sup>#</sup>″
feature set of EvoIndMM is employed for a detailed comparative assessment
of performance metrics.</p>
        <p>With respect to the MCC Value, a subtle
decrease of approximately 0.0828 is observed from <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S4</ext-link> (0.8390) to <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> (0.9218), indicating a modest reduction in proficiency
of sample classification. In terms of ACC, a minor decrement of about
0.0416 is noted upon comparison of <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S4</ext-link> with <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>, signaling
a slight decline in the model’s ability to classify samples
correctly. Considering the AUROC Value, a marginal fall of roughly
0.0173 is seen transitioning from <xref rid="fig7" ref-type="fig">Figures <xref rid="fig7" ref-type="fig">7</xref></xref> to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S3</ext-link>, suggesting
a minimal decrease in the model’s competence in distinguishing
positive from negative samples. Regarding the AUPR value, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S3</ext-link> demonstrates a decrease of nearly 0.0185
relative to <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>, denotes a slight deterioration in the equilibrium between precision
and recall. In summation, notwithstanding the apparent reductions
in performance metrics in <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> for EvoIndMM with the “Combined<sup>#</sup>″ feature set, these decreases remain relatively trivial.
This indicates that the model preserves its robust performance even
when adopting protein ID for data partitioning, thereby emphasizing
its dependability in real-world scenarios.</p>
        <p>In light of the experimental
data associated with the data splitting
strategy in <xref rid="sec3.3" ref-type="other">Section <xref rid="sec3.3" ref-type="other">3.3</xref></xref>, along with the comparative evaluations of <xref rid="sec4.2.2" ref-type="other">sections <xref rid="sec4.2.2" ref-type="other">4.2.2</xref></xref> and <xref rid="sec4.1.2" ref-type="other">4.1.2</xref>, it can be deduced that the slight performance decline
noted in the predictive model, attributable to the strategy detailed
in <xref rid="sec3.3" ref-type="other">Section <xref rid="sec3.3" ref-type="other">3.3</xref></xref>, is
an acceptable trade-off. This approach ensures more reliable performance
appraisals and fosters superior generalizability, thereby endorsing
the corresponding marginal decreases in performance.</p>
      </sec>
      <sec id="sec4.2.3">
        <label>4.2.3</label>
        <title>Feature Importance in EvoIndMM</title>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>A presents
the top 35 features for EvoIndMM, ranked by their SHAP values. These
features demonstrate unique impact patterns, summarized as follows:
(1) Features (e.g., ClinPred_rankscore, BayesDel_addAF_rankscore,
REVEL_rankscore, bStatistic_converted_rankscore, VEST4_rankscore,
MutPred_rankscore, MVP_rankscore, CADD_raw_rankscore) enhance significant
the EvoIndMM’s ability to predict pathogenic variants. (2)
Conversely, features like MAX_AF, Reliability_index, gnomAD_exomes_AF,
FATHMM_converted_rankscore, and Molecular_weight_diff have a notable
impact on predicting pathogenic variants when their values are lower.
These observed impact patterns validate the relevance and crucial
predictive capabilities of these features in EvoIndMM (SHAP values
of the top 160 features and feature analyses were documented in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S5 and Text S11</ext-link>).</p>
        <fig id="fig8" position="float">
          <label>Figure 8</label>
          <caption>
            <p>SHAP summary plot and
feature interactions for EvoIndMM. (A) SHAP
summary plot, (B) ClinPred_score interacting with phyloP100way_vertebrate_rankscore,
(C) Eigen_PC_phred_coding with esm1b_909, (D) esm1b_781 with ClinPred_Score,
(E) MPC_rankscore with esm1b_909, (F) MAX_AF with BayesDel_addAF_rankscore,
(G) MutPred_rankscore with ClinPred_rankscore, (H) phyloP100way_vertebrate
with ClinPred_Score, and <bold>(I)</bold> prott5_32 with prott5_410.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0008" id="gr8" position="float"/>
        </fig>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>B–<xref rid="fig8" ref-type="fig">8</xref>I depicts eight feature interactions
that effect
EvoIndMM, with detailed analyses provided below: (1) In <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>B, within the ClinPred_rankscore
range of [0, 0.80], the ClinPred_rankscore and phyloP100way_vertebrate
interaction exerts minimal influence on EvoIndMM’s output.
However, when ClinPred_rankscore values fall within [0.90, 1.0], feature
interaction significantly impacts the model output. Analogous interaction
patterns are discernible in <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>E,G.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>C illustrates
the interaction between Eigen_PC_phred_coding and esm1b_909. Within
the (0, 35) of Eigen_PC_phred_coding, MAX_AF feature values mostly
concentrate between 2 and 4, signifying that Eigen_PC_phred_coding
and esm1b_909 interaction wield greater influence on EvoIndMM’s
output in such range. Similar interaction patterns can be observed
in <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>D–H.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>F illustrates
the interaction of MAX_AF and BayesDel_addAF_rankscore. When MAX_AF
is in the range [0, 1], BayesDel_addAF_rankscore values predominantly
concentrate in the range (−1.0, −0.4). Within such a
range, the negative SHAP values of MAX_AF indicate a significant influence
of this interaction on EnoIndMM’s prediction of benign variants.</p>
        <p><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>I elucidates
the interaction between prott5_32 and prott5_410. When prott5_32 values
lie within [−0.4, 0.15] and prott5_410 within [-0.2, 0.4],
the positive SHAP values for prott5_32 signify their substantial contribution
to EvoIndMM’s prediction of pathogenic variants. Conversely,
as prott5_32 shifts from 0.15 to 0.6 and prott5_410 moves from −0.2
to −0.6, the majority of data points exhibit a blue hue, emphasizing
their influence on EvoIndMM to predict benign variants. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S4</ext-link> showcases the interactions of 12 additional
features for the EvoIndMM model.</p>
      </sec>
    </sec>
    <sec id="sec4.3">
      <label>4.3</label>
      <title>Assessing
the Performance of ConsMM, EvoIndMM
with Four Individual and Seven Meta-Predictors On Blind Test Set</title>
      <p>In this section, we conducted a comprehensive comparison of ConsMM
and EvoIndMM with four individual and seven meta-predictors, including
VEST4,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> PROVEAN,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> LIST-S2,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> gMVP,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> MetaSVM,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> MetaLR,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> M-CAP,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> DEOGEN2,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> InMeRF,<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> VARITY,<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> MetaRNN,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> MVP.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> Detailed information about these predictors
can be found in <xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref> (detailed descriptions), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S6</ext-link> (features
predictor used), and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S12</ext-link> (predictor
description, score range, and threshold setting).</p>
      <table-wrap id="tbl4" position="float">
        <label>Table 4</label>
        <caption>
          <title>Detailed Descriptions of the Compared
Predictors<xref rid="t4fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">name</th>
              <th style="border:none;" align="center">integrated</th>
              <th style="border:none;" align="center">pub-year</th>
              <th style="border:none;" align="center">prediction
technology</th>
              <th style="border:none;" align="center">webserver or web site of predictors</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2013</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://karchinlab.org/apps/appVest.html">http://karchinlab.org/apps/appVest.html</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2015</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://provean.jcvi.org/index.php">http://provean.jcvi.org/index.php</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2020</td>
              <td style="border:none;" align="left">Bayes rule</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://precomputed.list-s2.msl.ubc.ca/">https://precomputed.list-s2.msl.ubc.ca/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="left">no</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">graph attention neural network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/ShenLab/gMVP/">https://github.com/ShenLab/gMVP/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2014</td>
              <td style="border:none;" align="left">support vector machine</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ghttps://doi.org/10.1093/hmg/ddu733">https://doi.org/10.1093/hmg/ddu733</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2014</td>
              <td style="border:none;" align="left">logistic regression</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ghttps://doi.org/10.1093/hmg/ddu733">https://doi.org/10.1093/hmg/ddu733</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2016</td>
              <td style="border:none;" align="left">gradient boosting tree</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://bejerano.stanford.edu/MCAP/">http://bejerano.stanford.edu/MCAP/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2017</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://deogen2.mutaframe.com/">https://deogen2.mutaframe.com/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2020</td>
              <td style="border:none;" align="left">random forest</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/">https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2021</td>
              <td style="border:none;" align="left">gradient boosted trees</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://varity.varianteffect.org/">http://varity.varianteffect.org/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">recurrent neural network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.liulab.science/metarnn.html">http://www.liulab.science/metarnn.html</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2022</td>
              <td style="border:none;" align="left">deep residual network</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/ShenLab/missense">https://github.com/ShenLab/missense</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2023</td>
              <td style="border:none;" align="left">consensus and XGBoost</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="left">yes</td>
              <td style="border:none;" align="left">2023</td>
              <td style="border:none;" align="left">consensus and XGBoost</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t4fn1">
            <label>a</label>
            <p>Note: EvoIndMM evaluated 4969 mutations
(please refer to the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Text S13</ext-link> for reasons),
while others evaluated 5958 mutations. MetaSVM uses MetaSVM_rankscore,
MetaRNN uses MetaRNN_rankscore, gMVP uses gMVP_rankscore, VARITY uses
VARITY_R_rankscore, VEST4 uses VEST4_rankscore, DEOGEN2 uses DEOGEN2_rankscore,
LIST_S2 uses LIST_S2_rankscore, M_CAP uses M_CAP_rankscore, MVP uses
MVP_rankscore, MetaLR uses MetaLR_rankscore, PROVEAN uses PROVEAN_converted_rankscore.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Before embarking upon a formal
comparison, we conducted meticulous
checks at two levels as follows. (1) Variation level: We rigorously
examined the variants in the blind test data set and those in the
model training data set, identifying no instances of overlap; (2)
Protein level: our analysis identified that 448 proteins, identified
by ENSP_id, from the blind test data set were also present in the
training data set. Taking into consideration the presence of overlapping
ENSP_ids, we partitioned our findings into two distinct categories
to facilitate a more meticulous comparison. These categories included
comparison results that only encompassed recurring protein ENSP_ids
(depicted in <xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref> and discussed in <xref rid="sec4.3.1" ref-type="other">Section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>), and those devoid of recurring protein ENSP_ids (illustrated
in <xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref> and delineated
in <xref rid="sec4.3.2" ref-type="other">Section <xref rid="sec4.3.2" ref-type="other">4.3.2</xref></xref>). These findings are also cataloged comprehensively in <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>.</p>
      <table-wrap id="tbl5" position="float">
        <label>Table 5</label>
        <caption>
          <title>Performance
Comparison of ConsMM,
EvoIndMM, and Existing Predictors on the Blind Test Set</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">repeated</th>
              <th style="border:none;" align="center">predictor name</th>
              <th style="border:none;" align="center" char=".">recall/sen</th>
              <th style="border:none;" align="center" char=".">Spe</th>
              <th style="border:none;" align="center" char=".">Pre</th>
              <th style="border:none;" align="center" char=".">NPV</th>
              <th style="border:none;" align="center" char=".">F<sub>1</sub></th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">MCC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="14" style="border:none;" align="left">repeated protein (consisting
of 488 proteins
with 2593 variants)</td>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="char" char=".">0.9407</td>
              <td style="border:none;" align="char" char=".">0.7541</td>
              <td style="border:none;" align="char" char=".">0.8256</td>
              <td style="border:none;" align="char" char=".">0.9114</td>
              <td style="border:none;" align="char" char=".">0.8794</td>
              <td style="border:none;" align="char" char=".">0.8573</td>
              <td style="border:none;" align="char" char=".">0.7156</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="char" char=".">0.8159</td>
              <td style="border:none;" align="char" char=".">0.7368</td>
              <td style="border:none;" align="char" char=".">0.7932</td>
              <td style="border:none;" align="char" char=".">0.7639</td>
              <td style="border:none;" align="char" char=".">0.8044</td>
              <td style="border:none;" align="char" char=".">0.7806</td>
              <td style="border:none;" align="char" char=".">0.5549</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="char" char=".">0.8173</td>
              <td style="border:none;" align="char" char=".">0.7170</td>
              <td style="border:none;" align="char" char=".">0.7813</td>
              <td style="border:none;" align="char" char=".">0.7603</td>
              <td style="border:none;" align="char" char=".">0.7989</td>
              <td style="border:none;" align="char" char=".">0.7725</td>
              <td style="border:none;" align="char" char=".">0.5379</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="char" char=".">0.9135</td>
              <td style="border:none;" align="char" char=".">0.6471</td>
              <td style="border:none;" align="char" char=".">0.7621</td>
              <td style="border:none;" align="char" char=".">0.8581</td>
              <td style="border:none;" align="char" char=".">0.8310</td>
              <td style="border:none;" align="char" char=".">0.7944</td>
              <td style="border:none;" align="char" char=".">0.5897</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="char" char=".">0.9407</td>
              <td style="border:none;" align="char" char=".">0.6264</td>
              <td style="border:none;" align="char" char=".">0.7570</td>
              <td style="border:none;" align="char" char=".">0.8952</td>
              <td style="border:none;" align="char" char=".">0.8389</td>
              <td style="border:none;" align="char" char=".">0.8002</td>
              <td style="border:none;" align="char" char=".">0.6082</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="char" char=".">0.9268</td>
              <td style="border:none;" align="char" char=".">0.6264</td>
              <td style="border:none;" align="char" char=".">0.7543</td>
              <td style="border:none;" align="char" char=".">0.8736</td>
              <td style="border:none;" align="char" char=".">0.8317</td>
              <td style="border:none;" align="char" char=".">0.7925</td>
              <td style="border:none;" align="char" char=".">0.5894</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="char" char=".">0.9596</td>
              <td style="border:none;" align="char" char=".">0.8136</td>
              <td style="border:none;" align="char" char=".">0.8643</td>
              <td style="border:none;" align="char" char=".">0.9421</td>
              <td style="border:none;" align="char" char=".">0.9095</td>
              <td style="border:none;" align="char" char=".">0.8943</td>
              <td style="border:none;" align="char" char=".">0.7896</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="char" char=".">0.9191</td>
              <td style="border:none;" align="char" char=".">0.5876</td>
              <td style="border:none;" align="char" char=".">0.7339</td>
              <td style="border:none;" align="char" char=".">0.8545</td>
              <td style="border:none;" align="char" char=".">0.8161</td>
              <td style="border:none;" align="char" char=".">0.7709</td>
              <td style="border:none;" align="char" char=".">0.5460</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="char" char=".">0.8954</td>
              <td style="border:none;" align="char" char=".">0.7843</td>
              <td style="border:none;" align="char" char=".">0.8370</td>
              <td style="border:none;" align="char" char=".">0.8584</td>
              <td style="border:none;" align="char" char=".">0.8652</td>
              <td style="border:none;" align="char" char=".">0.8457</td>
              <td style="border:none;" align="char" char=".">0.6875</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="char" char=".">0.8375</td>
              <td style="border:none;" align="char" char=".">0.7921</td>
              <td style="border:none;" align="char" char=".">0.8329</td>
              <td style="border:none;" align="char" char=".">0.7976</td>
              <td style="border:none;" align="char" char=".">0.8352</td>
              <td style="border:none;" align="char" char=".">0.8172</td>
              <td style="border:none;" align="char" char=".">0.6300</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="char" char=".">0.8961</td>
              <td style="border:none;" align="char" char=".">0.9974</td>
              <td style="border:none;" align="char" char=".">0.9977</td>
              <td style="border:none;" align="char" char=".">0.8858</td>
              <td style="border:none;" align="char" char=".">0.9442</td>
              <td style="border:none;" align="char" char=".">0.9414</td>
              <td style="border:none;" align="char" char=".">0.8885</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="char" char=".">0.9693</td>
              <td style="border:none;" align="char" char=".">0.5789</td>
              <td style="border:none;" align="char" char=".">0.7401</td>
              <td style="border:none;" align="char" char=".">0.9385</td>
              <td style="border:none;" align="char" char=".">0.8394</td>
              <td style="border:none;" align="char" char=".">0.7948</td>
              <td style="border:none;" align="char" char=".">0.6100</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="char" char=".">0.9296</td>
              <td style="border:none;" align="char" char=".">0.8878</td>
              <td style="border:none;" align="char" char=".">0.9111</td>
              <td style="border:none;" align="char" char=".">0.9106</td>
              <td style="border:none;" align="char" char=".">0.9203</td>
              <td style="border:none;" align="char" char=".">0.9109</td>
              <td style="border:none;" align="char" char=".">0.8196</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="char" char=".">0.9150</td>
              <td style="border:none;" align="char" char=".">0.9617</td>
              <td style="border:none;" align="char" char=".">0.9719</td>
              <td style="border:none;" align="char" char=".">0.8866</td>
              <td style="border:none;" align="char" char=".">0.9426</td>
              <td style="border:none;" align="char" char=".">0.9341</td>
              <td style="border:none;" align="char" char=".">0.8675</td>
            </tr>
            <tr>
              <td rowspan="14" style="border:none;" align="left">nonrepeated protein
(consisting of 420 proteins
with 3365 variants)</td>
              <td style="border:none;" align="left">VEST4</td>
              <td style="border:none;" align="char" char=".">0.9539</td>
              <td style="border:none;" align="char" char=".">0.7864</td>
              <td style="border:none;" align="char" char=".">0.8028</td>
              <td style="border:none;" align="char" char=".">0.9492</td>
              <td style="border:none;" align="char" char=".">0.8719</td>
              <td style="border:none;" align="char" char=".">0.8663</td>
              <td style="border:none;" align="char" char=".">0.7461</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PROVEAN</td>
              <td style="border:none;" align="char" char=".">0.8249</td>
              <td style="border:none;" align="char" char=".">0.7625</td>
              <td style="border:none;" align="char" char=".">0.7600</td>
              <td style="border:none;" align="char" char=".">0.8269</td>
              <td style="border:none;" align="char" char=".">0.7912</td>
              <td style="border:none;" align="char" char=".">0.7923</td>
              <td style="border:none;" align="char" char=".">0.5872</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">LIST-S2</td>
              <td style="border:none;" align="char" char=".">0.8399</td>
              <td style="border:none;" align="char" char=".">0.6909</td>
              <td style="border:none;" align="char" char=".">0.7125</td>
              <td style="border:none;" align="char" char=".">0.8255</td>
              <td style="border:none;" align="char" char=".">0.7709</td>
              <td style="border:none;" align="char" char=".">0.7620</td>
              <td style="border:none;" align="char" char=".">0.5344</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">gMVP</td>
              <td style="border:none;" align="char" char=".">0.9221</td>
              <td style="border:none;" align="char" char=".">0.6625</td>
              <td style="border:none;" align="char" char=".">0.7136</td>
              <td style="border:none;" align="char" char=".">0.9032</td>
              <td style="border:none;" align="char" char=".">0.8046</td>
              <td style="border:none;" align="char" char=".">0.7863</td>
              <td style="border:none;" align="char" char=".">0.6005</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaSVM</td>
              <td style="border:none;" align="char" char=".">0.9402</td>
              <td style="border:none;" align="char" char=".">0.5807</td>
              <td style="border:none;" align="char" char=".">0.6716</td>
              <td style="border:none;" align="char" char=".">0.9141</td>
              <td style="border:none;" align="char" char=".">0.7835</td>
              <td style="border:none;" align="char" char=".">0.7522</td>
              <td style="border:none;" align="char" char=".">0.5523</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaLR</td>
              <td style="border:none;" align="char" char=".">0.9327</td>
              <td style="border:none;" align="char" char=".">0.6091</td>
              <td style="border:none;" align="char" char=".">0.6851</td>
              <td style="border:none;" align="char" char=".">0.9085</td>
              <td style="border:none;" align="char" char=".">0.7900</td>
              <td style="border:none;" align="char" char=".">0.7634</td>
              <td style="border:none;" align="char" char=".">0.5671</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-CAP</td>
              <td style="border:none;" align="char" char=".">0.9483</td>
              <td style="border:none;" align="char" char=".">0.8540</td>
              <td style="border:none;" align="char" char=".">0.8555</td>
              <td style="border:none;" align="char" char=".">0.9477</td>
              <td style="border:none;" align="char" char=".">0.8995</td>
              <td style="border:none;" align="char" char=".">0.8990</td>
              <td style="border:none;" align="char" char=".">0.8027</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DEOGEN2</td>
              <td style="border:none;" align="char" char=".">0.9333</td>
              <td style="border:none;" align="char" char=".">0.5608</td>
              <td style="border:none;" align="char" char=".">0.6596</td>
              <td style="border:none;" align="char" char=".">0.9022</td>
              <td style="border:none;" align="char" char=".">0.7730</td>
              <td style="border:none;" align="char" char=".">0.7385</td>
              <td style="border:none;" align="char" char=".">0.5269</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">InMeRF</td>
              <td style="border:none;" align="char" char=".">0.9115</td>
              <td style="border:none;" align="char" char=".">0.8295</td>
              <td style="border:none;" align="char" char=".">0.8298</td>
              <td style="border:none;" align="char" char=".">0.9114</td>
              <td style="border:none;" align="char" char=".">0.8688</td>
              <td style="border:none;" align="char" char=".">0.8686</td>
              <td style="border:none;" align="char" char=".">0.7411</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">VARITY</td>
              <td style="border:none;" align="char" char=".">0.8704</td>
              <td style="border:none;" align="char" char=".">0.8261</td>
              <td style="border:none;" align="char" char=".">0.8203</td>
              <td style="border:none;" align="char" char=".">0.8748</td>
              <td style="border:none;" align="char" char=".">0.8446</td>
              <td style="border:none;" align="char" char=".">0.8473</td>
              <td style="border:none;" align="char" char=".">0.6959</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MetaRNN</td>
              <td style="border:none;" align="char" char=".">0.9016</td>
              <td style="border:none;" align="char" char=".">0.9972</td>
              <td style="border:none;" align="char" char=".">0.9966</td>
              <td style="border:none;" align="char" char=".">0.9174</td>
              <td style="border:none;" align="char" char=".">0.9467</td>
              <td style="border:none;" align="char" char=".">0.9516</td>
              <td style="border:none;" align="char" char=".">0.9063</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">MVP</td>
              <td style="border:none;" align="char" char=".">0.9483</td>
              <td style="border:none;" align="char" char=".">0.5830</td>
              <td style="border:none;" align="char" char=".">0.6746</td>
              <td style="border:none;" align="char" char=".">0.9252</td>
              <td style="border:none;" align="char" char=".">0.7884</td>
              <td style="border:none;" align="char" char=".">0.7572</td>
              <td style="border:none;" align="char" char=".">0.5645</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ConsMM</td>
              <td style="border:none;" align="char" char=".">0.9283</td>
              <td style="border:none;" align="char" char=".">0.9364</td>
              <td style="border:none;" align="char" char=".">0.9301</td>
              <td style="border:none;" align="char" char=".">0.9348</td>
              <td style="border:none;" align="char" char=".">0.9292</td>
              <td style="border:none;" align="char" char=".">0.9325</td>
              <td style="border:none;" align="char" char=".">0.8648</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">EvoIndMM</td>
              <td style="border:none;" align="char" char=".">0.9261</td>
              <td style="border:none;" align="char" char=".">0.9840</td>
              <td style="border:none;" align="char" char=".">0.9851</td>
              <td style="border:none;" align="char" char=".">0.9213</td>
              <td style="border:none;" align="char" char=".">0.9547</td>
              <td style="border:none;" align="char" char=".">0.9532</td>
              <td style="border:none;" align="char" char=".">0.9082</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="fig9" position="float">
        <label>Figure 9</label>
        <caption>
          <p>Several evaluation
values of the compared predictors on the blind
test set (with repeated protein with training data) (A) ROC curves,
(B) PR curves, (C) ACC values, (D) MCC values.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0009" id="gr9" position="float"/>
      </fig>
      <fig id="fig10" position="float">
        <label>Figure 10</label>
        <caption>
          <p>Several
evaluation values of the compared predictors on the blind
test set (with nonrepeated protein with training data) (A) ROC curves,
(B) PR curves, (C) ACC values, (D) MCC values.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0010" id="gr10" position="float"/>
      </fig>
      <sec id="sec4.3.1">
        <label>4.3.1</label>
        <title>Comparison Results of Repeated Proteins</title>
        <p>We pursued
an in-depth analysis based on the comparative results
shown in <xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>,
partial information from <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>, as follows:<list list-type="simple"><list-item><p>(1) Integrated versus individual predictors:
Among individual
predictors, VEST4 demonstrated superior performance with an MCC of
0.7156, AUROC of 0.9414, and an AUPR of 0.9484. Meanwhile, among integrated-predictors,
MetaRNN stood out with an MCC of 0.8885, an AUROC of 0.9936, and an
AUPR of 0.9955. Evidently, integrated-predictors (e.g., MetaRNN) that
utilize a combination of multiple predictive factors outperform individual
predictors. The MCC of MetaRNN IS 0.1729 higher than that of VEST4,
indicating that integrated-predictors greatly exceed individual predictors
in terms of correlation between predictions and actual values.</p></list-item><list-item><p>(2) Top predictors based on existing methods:
Based
on the evaluation metrics of MCC, AUROC, and AUPR, the most distinguished
predictor is MetaRNN (with MCC: 0.8885, AUROC: 0.9936, and AUPR: 0.9955).
Following closely, M-CAP demonstrates significant predictive power
with an MCC of 0.7983, an AUROC of 0.9529, and an AUPR of 0.9407.
InMeRF also delivers commendable results, achieving an MCC of 0.7195,
an AUROC of 0.9349, and an AUPR of 0.9289. MetaRNN<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> utilizes 16 different scoring tools such as SIFT,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Polyphen2_HDIV and Polyphen2_HVAR,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> along with eight conservation scores and allele
frequency information from 1000 Gp3,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> ExAC,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and gnomAD.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> It
employs complex recurrent neural networks for prediction, demonstrating
high integration and learning capabilities. M-CAP<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> incorporates nine deleteriousness prediction scores and
seven conservation scores, employing gradient boosting trees for prediction.
This approach can handle diverse data types and exhibits robustness
against noise, leading to improved predictive accuracy. InMeRF<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> employs Rankscores of 34 tools available in
dbNSFP v4.0a,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> including SIFT,,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> SIFT4G,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Polyphen2_HDIV,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> etc. By integration of the strengths of these
tools, enhanced prediction accuracy. Although these predictors employ
different methodologies, they all demonstrate strong integration and
learning capabilities, robustness against noise, and improved prediction
accuracy through the combination of various tools.</p></list-item><list-item><p>(3) Comparison of ConsMM and EvoIndMM with top three
existing predictors: ConsMM has an MCC of 0.8196, AUROC of 0.9777,
and AUPR of 0.9837, while EvoIndMM has an MCC of 0.8675, AUROC of
0.9844, and AUPR of 0.9905. Both demonstrate superior performance
on all three metrics (MCC, AUROC, and AUPR) compared to InMeRF and
M-CAP in the top three predictors but slightly fall short of MetaRNN.
This suggests that ConsMM and EvoIndMM exhibit high performance in
terms of prediction accuracy and correlation with actual results.
Collectively, the three most optimal predictors are ConsMM, EvoIndMM,
and MetaRNN, among all predictors.</p></list-item><list-item><p>(4)
Reasons for superior performance of top three predictors:
Analyzing the terms of “Integrated” and “Prediction
technology” (listed in Table 4), “Features Predictor
used” (listed in Table S6), it is easily seen that MetaRNN,
ConsMM, and EvoIndMM all belong to the category of meta-predictors.
Unlike traditional individual prediction predictors, they integrate
outputs from multiple prediction methods/models to enhance the comprehensiveness
and accuracy of prediction results.</p></list-item></list></p>
        <p>The
superior performances of ConsMM and EvoIndMM can
be attributed to several key factors. First, they were trained on
a newly constructed, large-scale nonredundant data set that encompasses
all known MMs gathered from the entire Ensembl database. Second, consensus
technology bolsters the accuracy and reliability by integrating multiple
prediction methods and annotations. Third, employing the powerful
XGBoost algorithm enables the effective handling of intricate feature
relationships, increasing predictive power and robustness. Lastly,
additional data sources such as EvoIndMM’s use of VEP outputs,
ESM-1b, and ProtT5-XU embeddings further optimize the predictions.
In conclusion, the outstanding performance of ConsMM and EvoIndMM
derives from the synergy of these elements, fully exploiting the outputs
from various tools and advanced machine learning technologies. Their
approaches capture complex relationships within data, enriching information,
and thus enabling accurate and comprehensive predictions of MM pathogenicity.</p>
      </sec>
    </sec>
    <sec id="sec4.3.2">
      <label>4.3.2</label>
      <title>Comparison Results with Nonrepeated Proteins</title>
      <p>Utilizing the results portrayed in <xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref>, partial data from <xref rid="tbl5" ref-type="other">Tables <xref rid="tbl5" ref-type="other">5</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S7</ext-link>, we executed
a thorough analysis as follows:</p>
      <sec id="sec4.3.2.1">
        <p>(1) Comparative analysis of
evaluation metrics: Similar to the
results depicted in <xref rid="sec4.3.1" ref-type="other">Section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>, VEST4 notably outperformed all other individual predictors,
achieving an MCC of 0.7461, an AUROC of 0.9544, and an AUPR of 0.9488.
Among the existing integrated predictors, MetaRNN, M-CAP, and InMeRF
emerged as the top three performers exhibiting respective MCC, AUROC,
and AUPR scores of 0.9063, 0.9905, 0.9920; 0.8027, 0.9578, 0.9464;
and 0.7411, 0.9416, 0.9303. Notwithstanding, even though ConsMM and
EvoIndMM, positing MCC, AUROC, and AUPR measures of 0.8648, 0.9836,
0.9854 and 0.9082, 0.9852, 0.9902 correspondingly, trailed behind
MetaRNN marginally, they nevertheless surpassed both M-CAP and InMeRF
in terms of performance efficacy.</p>
        <p>(2) Comparative analysis of
performance metric–repeated protein vs nonrepeated protein
group: The performance metrics of VEST4, M-CAP, InMeRF, ConsMM, and
EvoIndMM revealed marginally superior outcomes for the “nonrepeated
protein” group, as demonstrated by the average ACC, MCC, AUROC,
and AUPR scores of 0.9121, 0.8257, 0.9701, and 0.9647 respectively.
In contrast, the corresponding metrics for the “Repeated protein”
group yielded averaged ACC, MCC, AUROC, and AUPR values of 0.8957,
0.8077, 0.9660, and 0.9697. Furthermore, MetaRNN demonstrated unwavering,
top-tier performance across both categories, thereby attesting to
its inherent robustness and capacity for generalization. Within the
confines of the “nonrepeated protein” group, ConsMM
and EvoIndMM surpassed almost all competing predictors (except for
MetaRNN) on evaluated metrics.</p>
        <p>(3) Underlying factors for observed
phenomena: The disparities
in predictive efficacy observed between “Repeated protein”
and “Nonrepeated protein” groups could be attributed
to the following factors. (A) Data distribution variations: A significant
discrepancy in data distribution between these data sets could be
a key factor. It is plausible to presume that different data distributions
exist, with nonrepeated proteins possibly favoring specific predictive
models. Such distinct distributions likely influence a model’s
ability to generalize and forecast accurately. (B) Influence of the
Protein Characteristics: The novel ConsMM and EvoIndMM models leverage
feature embeddings from amino acid mutation sites, acquired via ESM1b
and ProtT5 pretraining, rather than relying on features extracted
from the entire protein sequence. Consequently, these methodologies
demonstrate minimal variation in their predictive performances when
applied to either the “Repeated protein” or “Nonrepeated
protein” group.</p>
        <p>(4) Additional experiment on unsegmented
blind test data: Beyond
the experiments detailed in <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref>, we conducted an additional set of tests. In this experiment, the
blind test data set was evaluated entirely independently, devoid of
any segmentation or group-based analysis (please refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S5 and Tables S8,S9</ext-link> for further details).
An inclusive comparison of these results (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Figure S5 and Tables S8,S9</ext-link>) with those from <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref> indicates that this new performance metrics set typically lies between <xref rid="sec4.3.1" ref-type="other">Sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec4.3.2" ref-type="other">4.3.2</xref> results. Across all experiment sets, most
performance metrics of the predictors display insignificant differences.
Herein, for meticulous result comparisons, we persist in employing
the grouped performance metrics as the principal evaluation indicators
for our predictors. This conservative methodology ensures the highest
level of validity and reliability of our experimental outcomes.</p>
      </sec>
    </sec>
  </sec>
  <sec id="sec4.4">
    <label>4.4</label>
    <title>Case Study</title>
    <p>In this section, we analyzed
12 pathogenic GOF or LOF variations
in nine genes (DICER1, PTEN, CDKN2A, TREM2, SCN5A, GABRA1, KCNH2,
KCNQ1, RET) that are associated with diseases. For instance, PTEN
is associated with hereditary cancer syndromes, like Cowden syndrome
and Bannayan-Riley-Ruvalcaba syndrome,<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> while TREM2 is linked to neurodegenerative diseases, such as Alzheimer’s
disease.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> Detailed information about these
variations can be found in <xref rid="tbl6" ref-type="other">Tables <xref rid="tbl6" ref-type="other">6</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S10</ext-link>, and the heatmap
of predictors for the 12 variations is presented in <xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>.</p>
    <fig id="fig11" position="float">
      <label>Figure 11</label>
      <caption>
        <p>Heatmap of predictors
for 12 variations.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_0011" id="gr11" position="float"/>
    </fig>
    <table-wrap id="tbl6" position="float">
      <label>Table 6</label>
      <caption>
        <title>Detailed
Information on 12 Pathogenic
GOF/LOF Variations<xref rid="t6fn1" ref-type="table-fn">a</xref></title>
      </caption>
      <table frame="hsides" rules="groups" border="0">
        <colgroup>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
        </colgroup>
        <thead>
          <tr>
            <th style="border:none;" align="center">variations</th>
            <th style="border:none;" align="center">verdict</th>
            <th style="border:none;" align="center">symbol</th>
            <th style="border:none;" align="center">Pfam_dom</th>
            <th style="border:none;" align="center">inheritance</th>
            <th style="border:none;" align="center">cDNA_pos</th>
            <th style="border:none;" align="center">CDS_pos</th>
            <th style="border:none;" align="center">Protein_pos</th>
            <th style="border:none;" align="center">AA</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td style="border:none;" align="left">14_95598904_G/C</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">DICER1</td>
            <td style="border:none;" align="left">PF00270</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">547/10331</td>
            <td style="border:none;" align="left">255/5769</td>
            <td style="border:none;" align="left">85/1922</td>
            <td style="border:none;" align="left">I/M</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_89653846_C/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">PTEN</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1501/9027</td>
            <td style="border:none;" align="left">144/1212</td>
            <td style="border:none;" align="left">48/403</td>
            <td style="border:none;" align="left">N/K</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">9_21971152_T/C</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">CDKN2A</td>
            <td style="border:none;" align="left">PF12796</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">245/880</td>
            <td style="border:none;" align="left">206/504</td>
            <td style="border:none;" align="left">69/167</td>
            <td style="border:none;" align="left">E/G</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">3_38662376_C/T</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">SCN5A</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">763/8504</td>
            <td style="border:none;" align="left">569/6051</td>
            <td style="border:none;" align="left">190/2016</td>
            <td style="border:none;" align="left">R/Q</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">5_161309659_G/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">GABRA1</td>
            <td style="border:none;" align="left">PF02931</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1010/4273</td>
            <td style="border:none;" align="left">655/1371</td>
            <td style="border:none;" align="left">219/456</td>
            <td style="border:none;" align="left">D/N</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">3_38598763_C/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">SCN5A</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">4452/8504</td>
            <td style="border:none;" align="left">4258/6051</td>
            <td style="border:none;" align="left">1420/2016</td>
            <td style="border:none;" align="left">G/R</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">7_150649683_A/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">KCNH2</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">1789/4286</td>
            <td style="border:none;" align="left">1387/3480</td>
            <td style="border:none;" align="left">463/1159</td>
            <td style="border:none;" align="left">F/L</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">11_2592576_C/T</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">KCNQ1</td>
            <td style="border:none;" align="left">PF00520</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">734/3245</td>
            <td style="border:none;" align="left">626/2031</td>
            <td style="border:none;" align="left">209/676</td>
            <td style="border:none;" align="left">S/F</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">11_2608811_G/T</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">KCNQ1</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">ADAR</td>
            <td style="border:none;" align="left">1248/3245</td>
            <td style="border:none;" align="left">1140/2031</td>
            <td style="border:none;" align="left">380/676</td>
            <td style="border:none;" align="left">R/S</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43609061_A/G</td>
            <td style="border:none;" align="left">GOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">Outside_domain</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">2049/5659</td>
            <td style="border:none;" align="left">1817/3345</td>
            <td style="border:none;" align="left">606/1114</td>
            <td style="border:none;" align="left">Y/C</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43619231_A/G</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">PF07714</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">2922/5659</td>
            <td style="border:none;" align="left">2690/3345</td>
            <td style="border:none;" align="left">897/1114</td>
            <td style="border:none;" align="left">R/Q</td>
          </tr>
          <tr>
            <td style="border:none;" align="left">10_43615611_G/A</td>
            <td style="border:none;" align="left">LOF</td>
            <td style="border:none;" align="left">RET</td>
            <td style="border:none;" align="left">PF07714</td>
            <td style="border:none;" align="left">AD</td>
            <td style="border:none;" align="left">3146/5659</td>
            <td style="border:none;" align="left">2914/3345</td>
            <td style="border:none;" align="left">972/1114</td>
            <td style="border:none;" align="left">R/G</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="t6fn1">
          <label>a</label>
          <p>Note: Verdict, Pfam_dom, and Inheritance
information were collected from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://itanlab.shinyapps.io/goflof/">https://itanlab.shinyapps.io/goflof/</uri>. Pfam_dom: protein domains built on sequence similarity and functional
characteristics. Inheritance information includes AD (Autosomal Dominant)
and ADAR (Adenosine Deaminases Acting on RNA). cDNA_pos: cDNA_position,
CDS_pos: CDS_position, Protein_pos: Protein_position, AA: amino acid.
cDNA_position, CDS_position, Protein_position, Amino_acids, and ENSP
information were collected from Ensembl VEP. The variant positions
indicate the amino acid’s position in the protein and the base
pair’s position in the cDNA or coding sequence. Utilizing ENSP
and the Ensembl API enables retrieval of the encoded protein sequence.
Besides, 14_95598904_G/C is in protein ENSP00000437256; 10_89653846_C/A
in ENSP00000361021; 9_21971152_T/C in ENSP00000418915; 3_38662376_C/T
and 3_38598763_C/G in ENSP00000410257; 5_161309659_G/A in ENSP00000393097;
7_150649683_A/G in ENSP00000262186; 11_2592576_C/T and 11_2608811_G/T
in ENSP00000155840; 10_43609061_A/G, 10_43619231_A/G, and 10_43615611_G/A
in ENSP00000347942.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>Among
the variations shown in <xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>, our developed models (ConsMM and EvoIndMM)
generally exhibited superior performance compared to other predictors,
except for the 14_95598904_G/C variation in the DICER1 gene, which
is linked to tumors like childhood multicystic nephroma and pulmonary
cystic lung lesions.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> As indicated in <xref rid="tbl6" ref-type="other">Tables <xref rid="tbl6" ref-type="other">6</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">S10</ext-link>, this MM (I to M at the 85th site in ENSP00000437256)
could potentially lead to a loss of function in DICER1. The Essentiality
score<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> for DICER1 is 0.924045225, signifying
its significant role in biological processes and its RVIS score<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> is −1.52, indicating heightened vulnerability
to variations.</p>
    <p>ConsMM and EvoIndMM are developed through extensive
predictions
and annotations derived from multiple individual predictors. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S10</ext-link> provides several indicators suggesting
the benign nature of 14_95598904_G/C. According to these tools, this
variant is predicted as tolerated (0.14, SIFT<sup><xref ref-type="bibr" rid="ref10">10</xref></sup>), benign (0.053, PolyPhen<sup><xref ref-type="bibr" rid="ref2">2</xref></sup>), and neutral
(0.253, Condel<sup><xref ref-type="bibr" rid="ref66">66</xref></sup>), indicating a lack of
significant pathogenic effects. Furthermore, CADD (18.84),<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> REVEL<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> (0.656), LoFtool<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> (0.233), and ExACpLI<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> (1.0) scores suggest a minor impact on pathogenicity and a lower
probability of causing loss of gene function.</p>
    <p>EvoIndMM, incorporates
embeddings from ESM-1b<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and ProtT5-XL-U50,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> capturing
physicochemical properties and evolutionary conservation. Analyzing
the scores in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">Table S10</ext-link>, multiple indicators
point toward minimal alterations in the protein sequence. The IUPRED2<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> score (0.1731) indicates a low tendency for
disorder, while the ANCHOR2<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> score (0.277)
suggests limited binding regions. Besides, the RSA score (0.247) implies
no significant impact on solvent accessibility, and the Zfit score
(−1.063) signifies a minor effect on protein structure and
function. The RSA_class is categorized as “B”, indicating
a minor effect on protein solvent accessibility. Additionally, the
“helix_prob” (0.694), “beta_prob” (0.003),
and “coil_prob” (0.303) values suggest no significant
disruption to the protein’s secondary structure.</p>
  </sec>
  <sec id="sec5">
    <label>5</label>
    <title>Conclusions</title>
    <p>Our study contributes to the understanding of
MM pathogenicity.
In this work, we first constructed a nonredundant MM benchmark data
set and a blind test set that specifically focused on pathogenic GOF/LOF
MM. Then, by utilizing Ensembl VEP v104 and plugins (e.g., dbNSFP
v4.1a), we extracted variant-level, AA-level, individuals’
outputs, and genome-level features for each variation. Additionally,
we collected encoded protein sequences using ENSP identifiers and
Ensembl API, and generated embeddings from ESM-1b and ProtT5-XL-U50
for each mutant site AA. Based on the newly constructed data and extracted
features, we developed the interpretable model group MMPatho, consisting
of ConsMM and EvoIndMM. ConsMM utilized individuals’ outputs
and employed XGBoost with SHAP analyses, achieving outstanding prediction
performance, while EvoIndMM enhanced the model’s predictive
capacity by incorporating evolutionary characteristics derived from
ESM-1b and ProtT5-XL-U50. Extensive comparative experiments demonstrated
the remarkable efficacy of ConsMM and EvoIndMM. Our findings can give
certain contribution to the advancement of MM research and provide
valuable tools and data resources for understanding the functional
implications of variations in genetic disease.</p>
  </sec>
</body>
<back>
  <notes notes-type="data-availability" id="notes-1">
    <title>Data Availability Statement</title>
    <p>For easy access,
we implemented a Web server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://csbio.njust.edu.cn/bioinf/mmpatho/">http://csbio.njust.edu.cn/bioinf/mmpatho/</uri>) for MM pathogenicity prediction with reliability index score. Additionally,
we uploaded our newly constructed benchmark data set and blind test
set are available at the data page of our Web server. Also, the source
python code used in this paper is available at MMPatho server and
on GitHub.</p>
  </notes>
  <notes id="notes-3" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jcim.3c00950?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.3c00950</ext-link>.<list id="silist" list-type="simple"><list-item><p>Text S1: The versions
of the databases used in Ensembl
VEP v104; Text S2: The detailed plugins information installed in Ensembl
VEP v104; Text S3: Powerful classification using XGBoost and SHAP-based
feature importance analysis; Text S4: Performance evaluation measures;
Text S5: The detailed introduction and parameter settings of LightGBM;
Text S6: The detailed introduction and parameter settings of XGBoost;
Text S7: The detailed introduction and parameter settings of CatBoost;
Text S8: Performance of ConsMM on the test set of benchmark data set
(not using protein ID as the criteria for training and test data splitting);
Text S9: The 80 features importance in ConsMM; Text S10: Assessing
the contribution of different feature sets (not using protein ID as
the criteria for training and test data splitting); Text S11: The
one hundred-60 features importance in EvoIndMM; Text S12: Output description
for state-of-the-art methods in variant pathogenicity prediction on
blind test set; Text S13: The variation number changes during data
procedure in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A of the manuscript; Figure S1: Comparison of CatBoost, XGBoost,
and LightGBM on the test set of the benchmark data set (not using
protein ID as the criteria for training and test data splitting);
Figure S2: Twelve feature interactions for ConsMM; Figure S3: The
ROC and PR curves of EvoIndMM on the test set of the benchmark data
set (not using protein ID as the criteria for training and test data
splitting); Figure S4: Twelve feature interactions for EvoIndMM; Figure
S5: The ROC and PR curves of the compared predictors on the blind
test set (without splitting the blind test data into “repeated
protein” and “non-repeated protein” groups);
Table S1: The detailed descriptions of the features extracted from
Ensembl VEP and dbNSFP; Table S2: Confusion matrix and three types
of errors of CatBoost, XGBoost, and LightGBM on the test set of benchmark
data set (not using protein ID as the criteria for training and test
data splitting); Table S3: Feature importance in the ConsMM model;
Table S4: Performance comparison of EvoIndMM with different features
on the test set of benchmark data set (not using protein ID as the
criteria for training and test data splitting); Table S5: Top 160
feature importance in the EvoIndMM model; Table S6. Detailed descriptions
of the compared predictors; Table S7: The confusion matrix and three
types of ConsMM, EvoIndMM, and existing predictors on the blind test
set; Table S8: Performance comparison of ConsMM, EvoIndMM, and existing
predictors on the blind test set (without splitting the blind test
data into “repeated protein” and “nonrepeated
protein” groups); Table S9: The confusion matrix and three
types of ConsMM, EvoIndMM, and existing predictors on the blind test
set (without splitting the blind test data into “repeated protein”
and “nonrepeated protein” groups); Table S10: Detailed
information on the 12 variants for case study (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jcim.3c00950/suppl_file/ci3c00950_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci3c00950_si_001.pdf">
        <caption>
          <p>ci3c00950_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="COI-statement" id="notes-2">
    <p>The authors
declare no competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work
was supported by the Natural Science Research Start-up
Foundation of Recruiting Talents of Nanjing University of Posts and
Telecommunications (Grant No. NY223062), the National Natural Science
Foundation of China (62372234 and 62072243), the Natural Science Foundation
of Jiangsu (BK20201304), the National Research Council of Thailand
and Mahidol University (N42A660380), and the Specific League Funds
from Mahidol University.</p>
  </ack>
  <glossary id="dl1">
    <def-list>
      <title>Abbreviations</title>
      <def-item>
        <term>CADD</term>
        <def>
          <p>combined annotation-dependent depletion;</p>
        </def>
      </def-item>
      <def-item>
        <term>CatBoost</term>
        <def>
          <p>categorical
boosting;</p>
        </def>
      </def-item>
      <def-item>
        <term>ClinVar</term>
        <def>
          <p>clinical variants;</p>
        </def>
      </def-item>
      <def-item>
        <term>COSMIC</term>
        <def>
          <p>catalogue of somatic mutations
in cancer;</p>
        </def>
      </def-item>
      <def-item>
        <term>ConsMM</term>
        <def>
          <p>consensus MM pathogenic prediction;</p>
        </def>
      </def-item>
      <def-item>
        <term>dbNSFP</term>
        <def>
          <p>database for nonsynonymous SNPs’
functional predictions;</p>
        </def>
      </def-item>
      <def-item>
        <term>dbSNP</term>
        <def>
          <p>single nucleotide polymorphism
database;</p>
        </def>
      </def-item>
      <def-item>
        <term>ENSP</term>
        <def>
          <p>Ensembl
protein;</p>
        </def>
      </def-item>
      <def-item>
        <term>Ensembl VEP</term>
        <def>
          <p>Ensembl variant effect predictor;</p>
        </def>
      </def-item>
      <def-item>
        <term>ESM</term>
        <def>
          <p>evolutionary scale modeling;</p>
        </def>
      </def-item>
      <def-item>
        <term>ExAC</term>
        <def>
          <p>exome aggregation consortium;</p>
        </def>
      </def-item>
      <def-item>
        <term>EvoIndMM</term>
        <def>
          <p>evolutionary
information and
individual outputs for MM pathogenic prediction;</p>
        </def>
      </def-item>
      <def-item>
        <term>GOF/LOF</term>
        <def>
          <p>gain of function, loss of function;</p>
        </def>
      </def-item>
      <def-item>
        <term>gnomAD</term>
        <def>
          <p>genome aggregation
database;</p>
        </def>
      </def-item>
      <def-item>
        <term>HGMD</term>
        <def>
          <p>human
gene mutation database;</p>
        </def>
      </def-item>
      <def-item>
        <term>LightGBM</term>
        <def>
          <p>light gradient boosting machine;</p>
        </def>
      </def-item>
      <def-item>
        <term>PolyPhen-2</term>
        <def>
          <p>polymorphism phenotyping
v2;</p>
        </def>
      </def-item>
      <def-item>
        <term>PROVEAN</term>
        <def>
          <p>protein
variation effect analyzer;</p>
        </def>
      </def-item>
      <def-item>
        <term>ProtTrans</term>
        <def>
          <p>protein transformer;</p>
        </def>
      </def-item>
      <def-item>
        <term>REVEL</term>
        <def>
          <p>rare exome variant ensemble learner;</p>
        </def>
      </def-item>
      <def-item>
        <term>SHAP</term>
        <def>
          <p>Shapley additive explanations;</p>
        </def>
      </def-item>
      <def-item>
        <term>SIFT</term>
        <def>
          <p>sorting intolerant
from tolerant;</p>
        </def>
      </def-item>
      <def-item>
        <term>SwissVar</term>
        <def>
          <p>variants in UniProtKB/Swiss-Prot;</p>
        </def>
      </def-item>
      <def-item>
        <term>VEST4</term>
        <def>
          <p>variant effect scoring tool v4;</p>
        </def>
      </def-item>
      <def-item>
        <term>XGBoost</term>
        <def>
          <p>eXtreme gradient
boosting.</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Tavtigian</surname><given-names>S. V.</given-names></name>; <name><surname>Byrnes</surname><given-names>G. B.</given-names></name>; <name><surname>Goldgar</surname><given-names>D. E.</given-names></name>; <name><surname>Thomas</surname><given-names>A.</given-names></name><article-title>Classification of Rare
Missense Substitutions, using Risk Surfaces, with Genetic-and Molecular-epidemiology
Applications</article-title>. <source>Hum. Mutat.</source><year>2008</year>, <volume>29</volume>, <fpage>1342</fpage>–<lpage>1354</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20896</pub-id>.<pub-id pub-id-type="pmid">18951461</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Adzhubei</surname><given-names>I. A.</given-names></name>; <name><surname>Schmidt</surname><given-names>S.</given-names></name>; <name><surname>Peshkin</surname><given-names>L.</given-names></name>; <name><surname>Ramensky</surname><given-names>V. E.</given-names></name>; <name><surname>Gerasimova</surname><given-names>A.</given-names></name>; <name><surname>Bork</surname><given-names>P.</given-names></name>; <name><surname>Kondrashov</surname><given-names>A. S.</given-names></name>; <name><surname>Sunyaev</surname><given-names>S. R.</given-names></name><article-title>A Method and Server
for Predicting Damaging Missense Mutations</article-title>. <source>Nat. Methods</source><year>2010</year>, <volume>7</volume>, <fpage>248</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Choi</surname><given-names>Y.</given-names></name>; <name><surname>Chan</surname><given-names>A. P.</given-names></name><article-title>PROVEAN
Web Server: a Tool to Predict the Functional
Effect of Amino Acid Substitutions and Indels</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>2745</fpage>–<lpage>2747</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv195</pub-id>.<pub-id pub-id-type="pmid">25851949</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Rentzsch</surname><given-names>P.</given-names></name>; <name><surname>Witten</surname><given-names>D.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Shendure</surname><given-names>J.</given-names></name>; <name><surname>Kircher</surname><given-names>M.</given-names></name><article-title>CADD: Predicting
the Deleteriousness of Variants Throughout the Human Genome</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>, <volume>47</volume>, <fpage>D886</fpage>–<lpage>D894</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1016</pub-id>.<pub-id pub-id-type="pmid">30371827</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Kircher</surname><given-names>M.</given-names></name>; <name><surname>Witten</surname><given-names>D. M.</given-names></name>; <name><surname>Jain</surname><given-names>P.</given-names></name>; <name><surname>O’roak</surname><given-names>B. J.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Shendure</surname><given-names>J.</given-names></name><article-title>A General Framework for Estimating
the Relative Pathogenicity of Human Genetic Variants</article-title>. <source>Nat. Genet.</source><year>2014</year>, <volume>46</volume>, <fpage>310</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2892</pub-id>.<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Carter</surname><given-names>H.</given-names></name>; <name><surname>Douville</surname><given-names>C.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Karchin</surname><given-names>R.</given-names></name><article-title>Identifying
Mendelian Disease Genes with the Variant Effect Scoring Tool</article-title>. <source>BMC Genomics</source><year>2013</year>, <volume>14</volume>, <fpage>S3</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-14-S3-S3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Quan</surname><given-names>L.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Lyu</surname><given-names>Q.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name><article-title>DAMpred: Recognizing Disease-associated
nsSNPs through Bayes-guided Neural-network Model Built on Low-resolution
Structure Prediction of Proteins and Protein-protein Interactions</article-title>. <source>J. Mol. Biol.</source><year>2019</year>, <volume>431</volume>, <fpage>2449</fpage>–<lpage>2459</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2019.02.017</pub-id>.<pub-id pub-id-type="pmid">30796987</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Capriotti</surname><given-names>E.</given-names></name>; <name><surname>Ozturk</surname><given-names>K.</given-names></name>; <name><surname>Carter</surname><given-names>H.</given-names></name><article-title>Integrating Molecular
Networks with
Genetic Variant Interpretation for Precision Medicine</article-title>. <source>Wiley Interdiscip. Rev. Syst. Biol. Med.</source><year>2019</year>, <volume>11</volume>, <elocation-id>e1443</elocation-id><pub-id pub-id-type="doi">10.1002/wsbm.1443</pub-id>.<pub-id pub-id-type="pmid">30548534</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Hassan</surname><given-names>M. S.</given-names></name>; <name><surname>Shaalan</surname><given-names>A. A.</given-names></name>; <name><surname>Dessouky</surname><given-names>M. I.</given-names></name>; <name><surname>Abdelnaiem</surname><given-names>A. E.</given-names></name>; <name><surname>ElHefnawi</surname><given-names>M.</given-names></name><article-title>A Review Study: Computational Techniques for Expecting
the Impact of Non-synonymous Single Nucleotide Variants in Human Diseases</article-title>. <source>Gene</source><year>2019</year>, <volume>680</volume>, <fpage>20</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2018.09.028</pub-id>.<pub-id pub-id-type="pmid">30240882</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Ng</surname><given-names>P. C.</given-names></name>; <name><surname>Henikoff</surname><given-names>S.</given-names></name><article-title>SIFT: Predicting
Amino Acid Changes that Affect Protein
Function</article-title>. <source>Nucleic Acids Res.</source><year>2003</year>, <volume>31</volume>, <fpage>3812</fpage>–<lpage>3814</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Quang</surname><given-names>D.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>DanQ: a Hybrid Convolutional
and Recurrent Deep Neural Network for
Quantifying the Function of DNA Sequences</article-title>. <source>Nucleic
Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>e107</fpage><pub-id pub-id-type="doi">10.1093/nar/gkw226</pub-id>.<pub-id pub-id-type="pmid">27084946</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Jagadeesh</surname><given-names>K. A.</given-names></name>; <name><surname>Wenger</surname><given-names>A. M.</given-names></name>; <name><surname>Berger</surname><given-names>M. J.</given-names></name>; <name><surname>Guturu</surname><given-names>H.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Bernstein</surname><given-names>J. A.</given-names></name>; <name><surname>Bejerano</surname><given-names>G.</given-names></name><article-title>M-CAP Eliminates a
Majority of Variants of Uncertain Significance in Clinical Exomes
at High Sensitivity</article-title>. <source>Nat. Genet.</source><year>2016</year>, <volume>48</volume>, <fpage>1581</fpage>–<lpage>1586</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3703</pub-id>.<pub-id pub-id-type="pmid">27776117</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Bendl</surname><given-names>J.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Salanda</surname><given-names>O.</given-names></name>; <name><surname>Pavelka</surname><given-names>A.</given-names></name>; <name><surname>Wieben</surname><given-names>E. D.</given-names></name>; <name><surname>Zendulka</surname><given-names>J.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>PredictSNP:
Robust and Accurate Consensus Classifier for Prediction of Disease-related
Mutations</article-title>. <source>PLoS Comput. Biol.</source><year>2014</year>, <volume>10</volume>, <elocation-id>e1003440</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003440</pub-id>.<pub-id pub-id-type="pmid">24453961</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Landrum</surname><given-names>M. J.</given-names></name>; <name><surname>Lee</surname><given-names>J. M.</given-names></name>; <name><surname>Riley</surname><given-names>G. R.</given-names></name>; <name><surname>Jang</surname><given-names>W.</given-names></name>; <name><surname>Rubinstein</surname><given-names>W. S.</given-names></name>; <name><surname>Church</surname><given-names>D. M.</given-names></name>; <name><surname>Maglott</surname><given-names>D. R.</given-names></name><article-title>ClinVar:
Public Archive of Relationships
among Sequence Variation and Human Phenotype</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>, <volume>42</volume>, <fpage>D980</fpage>–<lpage>D985</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1113</pub-id>.<pub-id pub-id-type="pmid">24234437</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Sherry</surname><given-names>S. T.</given-names></name>; <name><surname>Ward</surname><given-names>M.-H.</given-names></name>; <name><surname>Kholodov</surname><given-names>M.</given-names></name>; <name><surname>Baker</surname><given-names>J.</given-names></name>; <name><surname>Phan</surname><given-names>L.</given-names></name>; <name><surname>Smigielski</surname><given-names>E. M.</given-names></name>; <name><surname>Sirotkin</surname><given-names>K.</given-names></name><article-title>dbSNP: the NCBI Database of Genetic
Variation</article-title>. <source>Nucleic Acids Res.</source><year>2001</year>, <volume>29</volume>, <fpage>308</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id>.<pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Rives</surname><given-names>A.</given-names></name>; <name><surname>Meier</surname><given-names>J.</given-names></name>; <name><surname>Sercu</surname><given-names>T.</given-names></name>; <name><surname>Goyal</surname><given-names>S.</given-names></name>; <name><surname>Lin</surname><given-names>Z.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>D.</given-names></name>; <name><surname>Ott</surname><given-names>M.</given-names></name>; <name><surname>Zitnick</surname><given-names>C. L.</given-names></name>; <name><surname>Ma</surname><given-names>J.</given-names></name>; <name><surname>Fergus</surname><given-names>R.</given-names></name><article-title>Biological Structure
and Function Emerge from Scaling
Unsupervised Learning to 250 Million Protein Sequences</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2021</year>, <volume>118</volume>, <elocation-id>e2016239118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2016239118</pub-id>.<pub-id pub-id-type="pmid">33876751</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Elnaggar</surname><given-names>A.</given-names></name>; <name><surname>Heinzinger</surname><given-names>M.</given-names></name>; <name><surname>Dallago</surname><given-names>C.</given-names></name>; <name><surname>Rehawi</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Jones</surname><given-names>L.</given-names></name>; <name><surname>Gibbs</surname><given-names>T.</given-names></name>; <name><surname>Feher</surname><given-names>T.</given-names></name>; <name><surname>Angerer</surname><given-names>C.</given-names></name>; <name><surname>Steinegger</surname><given-names>M.</given-names></name><article-title>Prottrans: Toward Understanding the Language of Life
through Self-supervised Learning</article-title>. <source>ITPAM</source><year>2021</year>, <volume>44</volume>, <fpage>7112</fpage>–<lpage>7127</lpage>.</mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Mou</surname><given-names>C.</given-names></name>; <name><surname>Dong</surname><given-names>Y.</given-names></name>; <name><surname>Tu</surname><given-names>Y.</given-names></name><article-title>dbNSFP v4: a Comprehensive
Database of Transcript-specific Functional Predictions and Annotations
for Human Nonsynonymous and Splice-site SNVs</article-title>. <source>Genome Med.</source><year>2020</year>, <volume>12</volume>, <fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1186/s13073-020-00803-9</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Jian</surname><given-names>X.</given-names></name>; <name><surname>Boerwinkle</surname><given-names>E.</given-names></name><article-title>dbNSFP: a
Lightweight Database of
Human Nonsynonymous SNPs and Their Functional Predictions</article-title>. <source>Hum. Mutat.</source><year>2011</year>, <volume>32</volume>, <fpage>894</fpage>–<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21517</pub-id>.<pub-id pub-id-type="pmid">21520341</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Dallago</surname><given-names>C.</given-names></name>; <name><surname>Schütze</surname><given-names>K.</given-names></name>; <name><surname>Heinzinger</surname><given-names>M.</given-names></name>; <name><surname>Olenyi</surname><given-names>T.</given-names></name>; <name><surname>Littmann</surname><given-names>M.</given-names></name>; <name><surname>Lu</surname><given-names>A. X.</given-names></name>; <name><surname>Yang</surname><given-names>K. K.</given-names></name>; <name><surname>Min</surname><given-names>S.</given-names></name>; <name><surname>Yoon</surname><given-names>S.</given-names></name>; <name><surname>Morton</surname><given-names>J. T.</given-names></name>; <name><surname>Rost</surname><given-names>B.</given-names></name><article-title>Learned Embeddings from Deep Learning
to Visualize and Predict Protein Sets</article-title>. <source>Curr.
Protoc.</source><year>2021</year>, <volume>1</volume>, <elocation-id>e113</elocation-id><pub-id pub-id-type="doi">10.1002/cpz1.113</pub-id>.<pub-id pub-id-type="pmid">33961736</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>Francioli</surname><given-names>L. C.</given-names></name>; <name><surname>Tiao</surname><given-names>G.</given-names></name>; <name><surname>Cummings</surname><given-names>B. B.</given-names></name>; <name><surname>Alföldi</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Collins</surname><given-names>R. L.</given-names></name>; <name><surname>Laricchia</surname><given-names>K. M.</given-names></name>; <name><surname>Ganna</surname><given-names>A.</given-names></name>; <name><surname>Birnbaum</surname><given-names>D. P.</given-names></name>; et al. <article-title>The Mutational Constraint
Spectrum Quantified from Variation in 141,456 Humans</article-title>. <source>Nature</source><year>2020</year>, <volume>581</volume>, <fpage>434</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id>.<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><article-title>UniProt: the Universal
Protein Knowledgebase in 2023</article-title>. <source>Nucleic Acids
Res.</source><year>2023</year>, <volume>51</volume>, <fpage>D523</fpage>–<lpage>D531</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac1052</pub-id>.<pub-id pub-id-type="pmid">36408920</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Lek</surname><given-names>M.</given-names></name>; <name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>Minikel</surname><given-names>E. V.</given-names></name>; <name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Banks</surname><given-names>E.</given-names></name>; <name><surname>Fennell</surname><given-names>T.</given-names></name>; <name><surname>O’Donnell-Luria</surname><given-names>A. H.</given-names></name>; <name><surname>Ware</surname><given-names>J. S.</given-names></name>; <name><surname>Hill</surname><given-names>A. J.</given-names></name>; <name><surname>Cummings</surname><given-names>B. B.</given-names></name>; et al. <article-title>Analysis of Protein-coding
Genetic Variation in 60,706 Humans</article-title>. <source>Nature</source><year>2016</year>, <volume>536</volume>, <fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nature19057</pub-id>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Forbes</surname><given-names>S. A.</given-names></name>; <name><surname>Bindal</surname><given-names>N.</given-names></name>; <name><surname>Bamford</surname><given-names>S.</given-names></name>; <name><surname>Cole</surname><given-names>C.</given-names></name>; <name><surname>Kok</surname><given-names>C. Y.</given-names></name>; <name><surname>Beare</surname><given-names>D.</given-names></name>; <name><surname>Jia</surname><given-names>M.</given-names></name>; <name><surname>Shepherd</surname><given-names>R.</given-names></name>; <name><surname>Leung</surname><given-names>K.</given-names></name>; <name><surname>Menzies</surname><given-names>A.</given-names></name>; et al. <article-title>COSMIC: Mining Complete
Cancer Genomes in the Catalogue
of Somatic Mutations in Cancer</article-title>. <source>Nucleic Acids
Res.</source><year>2011</year>, <volume>39</volume>, <fpage>D945</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq929</pub-id>.<pub-id pub-id-type="pmid">20952405</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Sevim
Bayrak</surname><given-names>C.</given-names></name>; <name><surname>Stein</surname><given-names>D.</given-names></name>; <name><surname>Jain</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Nadkarni</surname><given-names>G. N.</given-names></name>; <name><surname>Van Vleck</surname><given-names>T. T.</given-names></name>; <name><surname>Puel</surname><given-names>A.</given-names></name>; <name><surname>Boisson-Dupuis</surname><given-names>S.</given-names></name>; <name><surname>Okada</surname><given-names>S.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; et al. <article-title>Identification of Discriminative
Gene-level and Protein-level Features Associated with Pathogenic Gain-of-function
and Loss-of-function Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2021</year>, <volume>108</volume>, <fpage>2301</fpage>–<lpage>2318</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2021.10.007</pub-id>.<pub-id pub-id-type="pmid">34762822</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>McLaren</surname><given-names>W.</given-names></name>; <name><surname>Gil</surname><given-names>L.</given-names></name>; <name><surname>Hunt</surname><given-names>S. E.</given-names></name>; <name><surname>Riat</surname><given-names>H. S.</given-names></name>; <name><surname>Ritchie</surname><given-names>G. R.</given-names></name>; <name><surname>Thormann</surname><given-names>A.</given-names></name>; <name><surname>Flicek</surname><given-names>P.</given-names></name>; <name><surname>Cunningham</surname><given-names>F.</given-names></name><article-title>The Ensembl Variant Effect Predictor</article-title>. <source>Genome Biol.</source><year>2016</year>, <volume>17</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id>.<pub-id pub-id-type="pmid">26753840</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Henikoff</surname><given-names>S.</given-names></name>; <name><surname>Henikoff</surname><given-names>J. G.</given-names></name><article-title>Amino Acid Substitution
Matrices from Protein Blocks</article-title>. <source>Proc. Natl. Acad.
Sci. U.S.A.</source><year>1992</year>, <volume>89</volume>, <fpage>10915</fpage>–<lpage>10919</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.22.10915</pub-id>.<pub-id pub-id-type="pmid">1438297</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Barker</surname><given-names>G. L.</given-names></name>; <name><surname>Edwards</surname><given-names>K. J.</given-names></name>; <name><surname>Day</surname><given-names>I. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name><article-title>Predicting the Functional,
Molecular, and Phenotypic Consequences of Amino Acid Substitutions
using Hidden Markov Models</article-title>. <source>Hum. Mutat.</source><year>2013</year>, <volume>34</volume>, <fpage>57</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22225</pub-id>.<pub-id pub-id-type="pmid">23033316</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Quang</surname><given-names>D.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>DANN: a Deep
Learning Approach for
Annotating the Pathogenicity of Genetic Variants</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>761</fpage>–<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu703</pub-id>.<pub-id pub-id-type="pmid">25338716</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Ionita-Laza</surname><given-names>I.</given-names></name>; <name><surname>McCallum</surname><given-names>K.</given-names></name>; <name><surname>Xu</surname><given-names>B.</given-names></name>; <name><surname>Buxbaum</surname><given-names>J. D.</given-names></name><article-title>A Spectral
Approach
Integrating Functional Genomic Annotations for Coding and Noncoding
Variants</article-title>. <source>Nat. Genet.</source><year>2016</year>, <volume>48</volume>, <fpage>214</fpage><pub-id pub-id-type="doi">10.1038/ng.3477</pub-id>.<pub-id pub-id-type="pmid">26727659</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Ioannidis</surname><given-names>N. M.</given-names></name>; <name><surname>Rothstein</surname><given-names>J. H.</given-names></name>; <name><surname>Pejaver</surname><given-names>V.</given-names></name>; <name><surname>Middha</surname><given-names>S.</given-names></name>; <name><surname>McDonnell</surname><given-names>S. K.</given-names></name>; <name><surname>Baheti</surname><given-names>S.</given-names></name>; <name><surname>Musolf</surname><given-names>A.</given-names></name>; <name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>Holzinger</surname><given-names>E.</given-names></name>; <name><surname>Karyadi</surname><given-names>D.</given-names></name>; et al. <article-title>REVEL: An Ensemble Method for Predicting the Pathogenicity
of Rare Missense Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2016</year>, <volume>99</volume>, <fpage>877</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.08.016</pub-id>.<pub-id pub-id-type="pmid">27666373</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Sundaram</surname><given-names>L.</given-names></name>; <name><surname>Gao</surname><given-names>H.</given-names></name>; <name><surname>Padigepati</surname><given-names>S. R.</given-names></name>; <name><surname>McRae</surname><given-names>J. F.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Kosmicki</surname><given-names>J. A.</given-names></name>; <name><surname>Fritzilas</surname><given-names>N.</given-names></name>; <name><surname>Hakenberg</surname><given-names>J.</given-names></name>; <name><surname>Dutta</surname><given-names>A.</given-names></name>; <name><surname>Shon</surname><given-names>J.</given-names></name>; et al. <article-title>Predicting
the Clinical
Impact of Human Mutation with Deep Neural Networks</article-title>. <source>Nat. Genet.</source><year>2018</year>, <volume>50</volume>, <fpage>1161</fpage>–<lpage>1170</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0167-z</pub-id>.<pub-id pub-id-type="pmid">30038395</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Feng</surname><given-names>B. J.</given-names></name><article-title>PERCH:
a Unified Framework for Disease Gene Prioritization</article-title>. <source>Hum. Mutat.</source><year>2017</year>, <volume>38</volume>, <fpage>243</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23158</pub-id>.<pub-id pub-id-type="pmid">27995669</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Alirezaie</surname><given-names>N.</given-names></name>; <name><surname>Kernohan</surname><given-names>K. D.</given-names></name>; <name><surname>Hartley</surname><given-names>T.</given-names></name>; <name><surname>Majewski</surname><given-names>J.</given-names></name>; <name><surname>Hocking</surname><given-names>T. D.</given-names></name><article-title>ClinPred:
Prediction Tool to Identify Disease-relevant Nonsynonymous Single-nucleotide
Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2018</year>, <volume>103</volume>, <fpage>474</fpage>–<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2018.08.005</pub-id>.<pub-id pub-id-type="pmid">30220433</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Davydov</surname><given-names>E. V.</given-names></name>; <name><surname>Goode</surname><given-names>D. L.</given-names></name>; <name><surname>Sirota</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>G. M.</given-names></name>; <name><surname>Sidow</surname><given-names>A.</given-names></name>; <name><surname>Batzoglou</surname><given-names>S.</given-names></name><article-title>Identifying
a High Fraction of the Human Genome to
be Under Selective Constraint using GERP++</article-title>. <source>PLoS Comput. Biol.</source><year>2010</year>, <volume>6</volume>, <elocation-id>e1001025</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1001025</pub-id>.<pub-id pub-id-type="pmid">21152010</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Chen</surname><given-names>Y.-C.</given-names></name><article-title>A Tutorial
on Kernel Density Estimation and Recent Advances</article-title>. <source>Biostatistics Epidemiol.</source><year>2017</year>, <volume>1</volume>, <fpage>161</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1080/24709360.2017.1396742</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Rogers</surname><given-names>M. F.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Day</surname><given-names>I. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name>; <name><surname>Campbell</surname><given-names>C.</given-names></name><article-title>An Integrative
Approach
to Predicting the Functional Effects of Non-coding and Coding Sequence
Variation</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>1536</fpage>–<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv009</pub-id>.<pub-id pub-id-type="pmid">25583119</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Rogers</surname><given-names>M. F.</given-names></name>; <name><surname>Shihab</surname><given-names>H. A.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Gaunt</surname><given-names>T. R.</given-names></name>; <name><surname>Campbell</surname><given-names>C.</given-names></name><article-title>FATHMM-XF: Accurate
Prediction of Pathogenic Point
Mutations via Extended Features</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>511</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx536</pub-id>.<pub-id pub-id-type="pmid">28968714</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Gulko</surname><given-names>B.</given-names></name>; <name><surname>Hubisz</surname><given-names>M. J.</given-names></name>; <name><surname>Gronau</surname><given-names>I.</given-names></name>; <name><surname>Siepel</surname><given-names>A.</given-names></name><article-title>A Method for Calculating
Probabilities of Fitness Consequences for Point Mutations Across the
Human Genome</article-title>. <source>Nat. Genet.</source><year>2015</year>, <volume>47</volume>, <fpage>276</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3196</pub-id>.<pub-id pub-id-type="pmid">25599402</pub-id></mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Lu</surname><given-names>Q.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Sun</surname><given-names>J.</given-names></name>; <name><surname>Cheng</surname><given-names>Y.</given-names></name>; <name><surname>Cheung</surname><given-names>K.-H.</given-names></name>; <name><surname>Zhao</surname><given-names>H.</given-names></name><article-title>A Statistical
Framework to Predict Functional Non-coding Regions in the Human Genome
through Integrated Analysis of Annotation Data</article-title>. <source>Sci. Rep.</source><year>2015</year>, <volume>5</volume>, <elocation-id>10576</elocation-id><pub-id pub-id-type="doi">10.1038/srep10576</pub-id>.<pub-id pub-id-type="pmid">26015273</pub-id></mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Chun</surname><given-names>S.</given-names></name>; <name><surname>Fay</surname><given-names>J. C.</given-names></name><article-title>Identification of
Deleterious Mutations within Three
Human Genomes</article-title>. <source>Genome Res.</source><year>2009</year>, <volume>19</volume>, <fpage>1553</fpage>–<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.1101/gr.092619.109</pub-id>.<pub-id pub-id-type="pmid">19602639</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Kosmicki</surname><given-names>J. A.</given-names></name>; <name><surname>Karczewski</surname><given-names>K. J.</given-names></name>; <name><surname>O’Donnell-Luria</surname><given-names>A. H.</given-names></name>; <name><surname>Pierce-Hoffman</surname><given-names>E.</given-names></name>; <name><surname>MacArthur</surname><given-names>D. G.</given-names></name>; <name><surname>Neale</surname><given-names>B. M.</given-names></name>; <name><surname>Daly</surname><given-names>M. J.</given-names></name><article-title>Regional
Missense Constraint Improves Variant Deleteriousness Prediction</article-title>. <source>BioRxiv.</source><year>2017</year>, <elocation-id>148353</elocation-id><pub-id pub-id-type="doi">10.1101/148353</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Pejaver</surname><given-names>V.</given-names></name>; <name><surname>Urresti</surname><given-names>J.</given-names></name>; <name><surname>Lugo-Martinez</surname><given-names>J.</given-names></name>; <name><surname>Pagel</surname><given-names>K. A.</given-names></name>; <name><surname>Lin</surname><given-names>G. N.</given-names></name>; <name><surname>Nam</surname><given-names>H.-J.</given-names></name>; <name><surname>Mort</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Sebat</surname><given-names>J.</given-names></name>; <name><surname>Iakoucheva</surname><given-names>L. M.</given-names></name>; et al. <article-title>Inferring the Molecular and Phenotypic Impact
of Amino Acid Variants with MutPred2</article-title>. <source>Nat. Commun.</source><year>2020</year>, <volume>11</volume>, <elocation-id>5918</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19669-x</pub-id>.<pub-id pub-id-type="pmid">33219223</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Schwarz</surname><given-names>J. M.</given-names></name>; <name><surname>Rödelsperger</surname><given-names>C.</given-names></name>; <name><surname>Schuelke</surname><given-names>M.</given-names></name>; <name><surname>Seelow</surname><given-names>D.</given-names></name><article-title>MutationTaster Evaluates
Disease-causing Potential of Sequence Alterations</article-title>. <source>Nat. Methods</source><year>2010</year>, <volume>7</volume>, <fpage>575</fpage><pub-id pub-id-type="doi">10.1038/nmeth0810-575</pub-id>.<pub-id pub-id-type="pmid">20676075</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Reva</surname><given-names>B.</given-names></name>; <name><surname>Antipin</surname><given-names>Y.</given-names></name>; <name><surname>Sander</surname><given-names>C.</given-names></name><article-title>Predicting
the Functional Impact
of Protein Mutations: Application to Cancer Genomics</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>, <volume>39</volume>, <fpage>e118</fpage><pub-id pub-id-type="doi">10.1093/nar/gkr407</pub-id>.<pub-id pub-id-type="pmid">21727090</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Vaser</surname><given-names>R.</given-names></name>; <name><surname>Adusumalli</surname><given-names>S.</given-names></name>; <name><surname>Leng</surname><given-names>S. N.</given-names></name>; <name><surname>Sikic</surname><given-names>M.</given-names></name>; <name><surname>Ng</surname><given-names>P. C.</given-names></name><article-title>SIFT Missense
Predictions for Genomes</article-title>. <source>Nat. Protoc.</source><year>2016</year>, <volume>11</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.1038/nprot.2015.123</pub-id>.<pub-id pub-id-type="pmid">26633127</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Pollard</surname><given-names>K. S.</given-names></name>; <name><surname>Hubisz</surname><given-names>M. J.</given-names></name>; <name><surname>Rosenbloom</surname><given-names>K. R.</given-names></name>; <name><surname>Siepel</surname><given-names>A.</given-names></name><article-title>Detection of Nonneutral
Substitution Rates on Mammalian Phylogenies</article-title>. <source>Genome Res.</source><year>2010</year>, <volume>20</volume>, <fpage>110</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1101/gr.097857.109</pub-id>.<pub-id pub-id-type="pmid">19858363</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Garber</surname><given-names>M.</given-names></name>; <name><surname>Guttman</surname><given-names>M.</given-names></name>; <name><surname>Clamp</surname><given-names>M.</given-names></name>; <name><surname>Zody</surname><given-names>M. C.</given-names></name>; <name><surname>Friedman</surname><given-names>N.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name><article-title>Identifying Novel Constrained Elements by Exploiting biased Substitution
Patterns</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>i54</fpage>–<lpage>i62</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp190</pub-id>.<pub-id pub-id-type="pmid">19478016</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Consortium</surname><given-names>G. P.</given-names></name><article-title>A Map of
Human Genome Variation from Population Scale Sequencing</article-title>. <source>Nature</source><year>2010</year>, <volume>467</volume>, <fpage>1061</fpage><pub-id pub-id-type="doi">10.1038/nature09534</pub-id>.<pub-id pub-id-type="pmid">20981092</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="conf-proc" id="cit50"><person-group person-group-type="allauthors"><name><surname>Lundberg</surname><given-names>S. M.</given-names></name>; <name><surname>Lee</surname><given-names>S.-I.</given-names></name></person-group><article-title>A Unified Approach
to Interpreting Model Predictions</article-title>. In <source>Advances
in Neural Information Processing Systems</source><year>2017</year>30 p <fpage>4765</fpage>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Grimm</surname><given-names>D. G.</given-names></name>; <name><surname>Azencott</surname><given-names>C. A.</given-names></name>; <name><surname>Aicheler</surname><given-names>F.</given-names></name>; <name><surname>Gieraths</surname><given-names>U.</given-names></name>; <name><surname>MacArthur</surname><given-names>D. G.</given-names></name>; <name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Cooper</surname><given-names>D. N.</given-names></name>; <name><surname>Stenson</surname><given-names>P. D.</given-names></name>; <name><surname>Daly</surname><given-names>M. J.</given-names></name>; <name><surname>Smoller</surname><given-names>J. W.</given-names></name>; et al. <article-title>The
Evaluation of Tools used to Predict the
Impact of Missense Variants is Hindered by Two Types of Circularity</article-title>. <source>Hum. Mutat.</source><year>2015</year>, <volume>36</volume>, <fpage>513</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22768</pub-id>.<pub-id pub-id-type="pmid">25684150</pub-id></mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Pedregosa</surname><given-names>F.</given-names></name>; <name><surname>Varoquaux</surname><given-names>G.</given-names></name>; <name><surname>Gramfort</surname><given-names>A.</given-names></name>; <name><surname>Michel</surname><given-names>V.</given-names></name>; <name><surname>Thirion</surname><given-names>B.</given-names></name>; <name><surname>Grisel</surname><given-names>O.</given-names></name>; <name><surname>Blondel</surname><given-names>M.</given-names></name>; <name><surname>Prettenhofer</surname><given-names>P.</given-names></name>; <name><surname>Weiss</surname><given-names>R.</given-names></name>; <name><surname>Dubourg</surname><given-names>V.</given-names></name><article-title>Scikit-learn:
Machine Learning in
Python</article-title>. <source>J. Mach. Learn. Res.</source><year>2011</year>, <volume>12</volume>, <fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Malhis</surname><given-names>N.</given-names></name>; <name><surname>Jacobson</surname><given-names>M.</given-names></name>; <name><surname>Jones</surname><given-names>S. J.</given-names></name>; <name><surname>Gsponer</surname><given-names>J.</given-names></name><article-title>LIST-S2: Taxonomy
based
Sorting of Deleterious Missense Mutations across Species</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>, <volume>48</volume>, <fpage>W154</fpage>–<lpage>W161</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa288</pub-id>.<pub-id pub-id-type="pmid">32352516</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>M. S.</given-names></name>; <name><surname>Fan</surname><given-names>X.</given-names></name>; <name><surname>Chung</surname><given-names>W. K.</given-names></name>; <name><surname>Shen</surname><given-names>Y.</given-names></name><article-title>Predicting
Functional Effect of Missense Variants using Graph Attention Neural
Networks</article-title>. <source>Nat. Mach. Intell.</source><year>2022</year>, <volume>4</volume>, <fpage>1017</fpage>–<lpage>1028</lpage>. <pub-id pub-id-type="doi">10.1038/s42256-022-00561-w</pub-id>.<pub-id pub-id-type="pmid">37484202</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Dong</surname><given-names>C.</given-names></name>; <name><surname>Wei</surname><given-names>P.</given-names></name>; <name><surname>Jian</surname><given-names>X.</given-names></name>; <name><surname>Gibbs</surname><given-names>R.</given-names></name>; <name><surname>Boerwinkle</surname><given-names>E.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name><article-title>Comparison
and Integration of Deleteriousness
Prediction Methods for Nonsynonymous SNVs in Whole Exome Sequencing
Studies</article-title>. <source>Hum. Mol. Genet.</source><year>2015</year>, <volume>24</volume>, <fpage>2125</fpage>–<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu733</pub-id>.<pub-id pub-id-type="pmid">25552646</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Raimondi</surname><given-names>D.</given-names></name>; <name><surname>Tanyalcin</surname><given-names>I.</given-names></name>; <name><surname>Ferté</surname><given-names>J.</given-names></name>; <name><surname>Gazzo</surname><given-names>A.</given-names></name>; <name><surname>Orlando</surname><given-names>G.</given-names></name>; <name><surname>Lenaerts</surname><given-names>T.</given-names></name>; <name><surname>Rooman</surname><given-names>M.</given-names></name>; <name><surname>Vranken</surname><given-names>W.</given-names></name><article-title>DEOGEN2: Prediction
and Interactive Visualization of Single Amino Acid Variant Deleteriousness
in Human Proteins</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>W201</fpage>–<lpage>W206</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx390</pub-id>.<pub-id pub-id-type="pmid">28498993</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Takeda</surname><given-names>J.-i.</given-names></name>; <name><surname>Nanatsue</surname><given-names>K.</given-names></name>; <name><surname>Yamagishi</surname><given-names>R.</given-names></name>; <name><surname>Ito</surname><given-names>M.</given-names></name>; <name><surname>Haga</surname><given-names>N.</given-names></name>; <name><surname>Hirata</surname><given-names>H.</given-names></name>; <name><surname>Ogi</surname><given-names>T.</given-names></name>; <name><surname>Ohno</surname><given-names>K.</given-names></name><article-title>InMeRF: Prediction
of Pathogenicity of Missense Variants by Individual Modeling for Each
Amino Acid Substitution</article-title>. <source>NAR Genomics Bioinf.</source><year>2020</year>, <volume>2</volume>, <elocation-id>lqaa038</elocation-id><pub-id pub-id-type="doi">10.1093/nargab/lqaa038</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Sun</surname><given-names>S.</given-names></name>; <name><surname>Weile</surname><given-names>J.</given-names></name>; <name><surname>Roth</surname><given-names>F. P.</given-names></name><article-title>Improved
Pathogenicity Prediction for Rare Human Missense Variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2021</year>, <volume>108</volume>, <fpage>1891</fpage>–<lpage>1906</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2021.08.012</pub-id>.<pub-id pub-id-type="pmid">34551312</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Zhi</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name><article-title>MetaRNN: Differentiating
Rare Pathogenic
and Rare Benign Missense SNVs and InDels using Deep Learning</article-title>. <source>Genome Med.</source><year>2022</year>, <volume>14</volume>, <fpage>115</fpage><pub-id pub-id-type="doi">10.1186/s13073-022-01120-z</pub-id>.<pub-id pub-id-type="pmid">36209109</pub-id></mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Qi</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>C.</given-names></name>; <name><surname>Long</surname><given-names>J. J.</given-names></name>; <name><surname>Chung</surname><given-names>W. K.</given-names></name>; <name><surname>Guan</surname><given-names>Y.</given-names></name>; <name><surname>Shen</surname><given-names>Y.</given-names></name><article-title>MVP Predicts the Pathogenicity
of Missense Variants by Deep Learning</article-title>. <source>Nat.
Commun.</source><year>2021</year>, <volume>12</volume>, <elocation-id>510</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20847-0</pub-id>.<pub-id pub-id-type="pmid">33479230</pub-id></mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Ngeow</surname><given-names>J.</given-names></name>; <name><surname>Sesock</surname><given-names>K.</given-names></name>; <name><surname>Eng</surname><given-names>C.</given-names></name><article-title>Clinical Implications
for Germline
PTEN Spectrum Disorders</article-title>. <source>Endocrinol. Metab.
Clin. North Am.</source><year>2017</year>, <volume>46</volume>, <fpage>503</fpage>–<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecl.2017.01.013</pub-id>.<pub-id pub-id-type="pmid">28476234</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Colonna</surname><given-names>M.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name><article-title>TREM2 Variants: New Keys to Decipher
Alzheimer Disease Pathogenesis</article-title>. <source>Nat. Rev. Neurosci.</source><year>2016</year>, <volume>17</volume>, <fpage>201</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.7</pub-id>.<pub-id pub-id-type="pmid">26911435</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Foulkes</surname><given-names>W. D.</given-names></name>; <name><surname>Priest</surname><given-names>J. R.</given-names></name>; <name><surname>Duchaine</surname><given-names>T. F.</given-names></name><article-title>DICER1:
Mutations, microRNAs and
Mechanisms</article-title>. <source>Nat. Rev. Cancer</source><year>2014</year>, <volume>14</volume>, <fpage>662</fpage>–<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3802</pub-id>.<pub-id pub-id-type="pmid">25176334</pub-id></mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Jia</surname><given-names>P.</given-names></name>; <name><surname>Zhao</surname><given-names>Z.</given-names></name><article-title>VarWalker: Personalized
Mutation Network Analysis of Putative Cancer
Genes from Next-generation Sequencing Data</article-title>. <source>PLoS Comput. Biol.</source><year>2014</year>, <volume>10</volume>, <elocation-id>e1003460</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003460</pub-id>.<pub-id pub-id-type="pmid">24516372</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Petrovski</surname><given-names>S.</given-names></name>; <name><surname>Gussow</surname><given-names>A. B.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Halvorsen</surname><given-names>M.</given-names></name>; <name><surname>Han</surname><given-names>Y.</given-names></name>; <name><surname>Weir</surname><given-names>W. H.</given-names></name>; <name><surname>Allen</surname><given-names>A. S.</given-names></name>; <name><surname>Goldstein</surname><given-names>D. B.</given-names></name><article-title>The Intolerance
of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity</article-title>. <source>PLoS Genet.</source><year>2015</year>, <volume>11</volume>, <elocation-id>e1005492</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005492</pub-id>.<pub-id pub-id-type="pmid">26332131</pub-id></mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>González-Pérez</surname><given-names>A.</given-names></name>; <name><surname>López-Bigas</surname><given-names>N.</given-names></name><article-title>Improving
the Assessment of the Outcome of Nonsynonymous
SNVs with a Consensus Deleteriousness Score, Condel</article-title>. <source>Am. J. Hum. Genet.</source><year>2011</year>, <volume>88</volume>, <fpage>440</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.03.004</pub-id>.<pub-id pub-id-type="pmid">21457909</pub-id></mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Fadista</surname><given-names>J.</given-names></name>; <name><surname>Oskolkov</surname><given-names>N.</given-names></name>; <name><surname>Hansson</surname><given-names>O.</given-names></name>; <name><surname>Groop</surname><given-names>L.</given-names></name><article-title>LoFtool: a
Gene Intolerance
Score based on Loss-of-function Variants in 60706 Individuals</article-title>. <source>Bioinformatics</source><year>2017</year>, <volume>33</volume>, <fpage>471</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv602</pub-id>.<pub-id pub-id-type="pmid">27563026</pub-id></mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="conf-proc" id="cit68"><person-group person-group-type="allauthors"><name><surname>Khan</surname><given-names>M. E.</given-names></name>; <name><surname>Dutt</surname><given-names>D. N.</given-names></name></person-group> In <source>Expectation-maximization
(EM) Algorithm for Instantaneous Frequency Estimation with Kalman
Smoother</source>, 12th European Signal Processing Conference, <year>2004</year>; pp <fpage>1797</fpage>–<lpage>1800</lpage>.</mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>Mészáros</surname><given-names>B.</given-names></name>; <name><surname>Erdős</surname><given-names>G.</given-names></name>; <name><surname>Dosztányi</surname><given-names>Z.</given-names></name><article-title>IUPred2A: Context-dependent Prediction
of Protein Disorder as a Function of Redox State and Protein Binding</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>W329</fpage>–<lpage>W337</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky384</pub-id>.<pub-id pub-id-type="pmid">29860432</pub-id></mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Dosztányi</surname><given-names>Z.</given-names></name>; <name><surname>Mészáros</surname><given-names>B.</given-names></name>; <name><surname>Simon</surname><given-names>I.</given-names></name><article-title>ANCHOR: Web Server
for Predicting Protein Binding Regions in Disordered Proteins</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>2745</fpage>–<lpage>2746</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp518</pub-id>.<pub-id pub-id-type="pmid">19717576</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
